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Abstract
In this thesis the underlying mechanisms behind the phenomenon known as
the BOLD response were investigated.
Functional imaging of the brain relies on the oxygenation level of blood,
therefore the relaxation properties of blood were measured at different oxy-
genations. The relaxation properties of blood are also modified by intro-
duction of a paramagnetic contrast agent and are dependent on the static
magnetic field of the MRI system. These dependencies were also character-
ised. This led to the discovery that the transverse relaxation rate is non-
linearly related to contrast agent concentration. This result was confirmed
by performing a Monte-Carlo simulation.
A measurement of total cerebral blood volume (CBV) change, during
neural activity, was performed at high temporal resolution (TR = 300 ms).
This was achieved by infusing a contrast agent, whilst a visual stimulus was
presented to the volunteer. This technique also provided an interesting and
novel method to test models of the BOLD response. The temporal charac-
teristics of the BOLD response were differentially effected by the contrast
agent, reflecting the dependency of each feature on blood volume change.
This allowed a qualitative understanding of the volume contribution to each
of these characteristics to be gathered.
Two models of the BOLD haemodynamic response were constructed to
describe the contrast agent infusion experiment. Each model was developed
from several existing models of the BOLD response, with the aim of com-
paring empirical and biomechanical model elements. As part of this work an
existing model of BOLD signal change was extended to include the arterial
and venous vasculature. Both models were separately fitted to the exper-
imental total CBV and BOLD signal data. The results of fitting the data
show that existing haemodynamic models cannot fully describe the measured
results.
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Chapter 1
Introduction
1.1 Introduction
The work contained within this thesis began on 22nd September 2003. The
aim of this work was to investigate the haemodynamic response associated
with neural activation, otherwise known as the BOLD response. A particu-
lar emphasis was placed on measuring total cerebral blood volume changes
during a short visual stimulus. This experimental work was subsequently
modelled theoretically. This also involved measurements of intravascular
blood signal in vitro, in order to simulate the changes in the magnetic res-
onance signal. An overview of the chapters describing this work is given in
section 1.3.
The end of 2003 proved to be an exciting time to be a member of the Sir
Peter Mansfield Magnetic Resonance Centre (SPMMRC ), as on 6th October
Peter Mansfield was awarded the Nobel prize for Physiology or Medicine.
The prize was awarded jointly with Paul Lauterbur in recognition of their
independent discovery of magnetic resonance imaging (MRI). Therefore it
seems only fitting that this thesis starts at the beginning. A quick spin
around the early history of MRI.
1
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1.2 A Spin History
The award of the Nobel prize to Peter Mansfield and Paul Lauterbur was by
no means the first to be awarded [1] in relation to magnetic resonance (MR),
see table 1.1. In 1944 Isidor Rabi was awarded the Nobel prize for physics
for his molecular beam experiments. Next came Edward Purcell and Felix
Bloch, in 1952, for the development of nuclear magnetic resonance (NMR).
Richard Ernst and Kurt Wu¨thrich were both awarded the Nobel prize for
chemistry in 1991 and 2002, respectively. The former of these laureates
noted in his Nobel lecture [2] that there are also several other recipients of
the Nobel prize (table 1.2) that have made important contributions to MR.
John van Vleck developed the theory of dia- and paramagnetism, Nicolaas
Bloembergen worked on relaxation theory, and Alexander Mu¨ller contributed
to electron paramagnetic resonance. Hans Dehmelt developed pure nuclear
quadrupole resonance and Norman Ramsey introduced the concept of chem-
ical shift and J-coupling.
In 1973 Paul Lauterbur published [3] the first two-dimensional NMR im-
age of two tubes of water, with the aim of imaging more complex objects.
Several months later, and entirely independently, Peter Mansfield applied
similar techniques to produce [4] one-dimensional images of interleaved sheets
of plastic and camphor. In uniquely British fashion, the rudiments of the
technique were discussed [5] in the tea room of the Department of Physics at
the University of Nottingham. Mansfield’s initial aim was to perform crys-
tallography using the technique. Whilst presenting this work at the First
Specialized Colloque Ampe`re in Krakow the subsequent discussion led him
to the work of Lauterbur. At this point Mansfield realised [6] that imaging
in solids was probably ahead of its time and was consigned to future work.
By imaging biological samples the process was made far easier.
Following a short spell at the University of Illinois, Mansfield moved to
the University of Nottingham. He was recruited to the post by Raymond
Andrew, who had recently been invited to take up the Lancashire-Spencer
chair of physics [7]. Under Andrew’s guidance the department of physics
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became an international hub for NMR research. Mansfield formed his own
group within the department consisting of a postdoc Alan Garroway and
PhD student Peter Grannell. Chief amongst the Andrew group were Waldo
Hinshaw and Bill Moore. In 1974 Hinshaw and Moore attended the ISMAR
conference in Bombay. Lauterbur was also in attendance and gave a talk
on his imaging work. This created a great deal of excitement amongst the
Nottingham contingent and on their return Hinshaw rapidly devised a new
imaging method [8], known as sensitive point imaging. By applying time
dependent magnetic field gradients along two orthogonal axes it was possible
to move this sensitive point around the sample, point by point, and build up
an image. Inevitably this was a very slow process, however reconstructing
images from this data wasn’t very demanding. Digital signal processing was
unheard of at the time and computers of the era could do little more than
arithmetic [9]. Therefore the simplicity of the sensitive point method had
its merits. However, Mansfield and colleagues followed a different approach.
They devised a way of selectively exciting a slice of the sample through the
use of magnetic field gradients and shaped RF pulses [10]. This led to the
line scan imaging [11] technique and the first image of a human finger [12].
Of course Nottingham were not alone [5] in this endeavour. In the UK
research was conducted around two centres. In Nottingham by the Andrew
and Mansfield groups and in Aberdeen by a group headed by John Mal-
lard. They were subsequently joined by EMI, the first commercial entrant,
at the Hammersmith Hospital in London. In the US, groups were led by
Paul Lauterbur and Raymond Damadian and in Europe by Richard Ernst in
Zu¨rich. The Zu¨rich group were the first to suggest two-dimensional Fourier
imaging [13] which was later practically implemented by Bill Edelstein [14] of
the Aberdeen group as spin warp imaging. This was an extremely important
step as it allowed detailed images to be acquired in a reasonable time-scale,
proving that MRI was a viable clinical technique.
In the intervening years rivalry between the different groups was fierce.
In fact so fierce that a third group was formed at Nottingham by Bill Moore
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by splitting the Andrew group, causing subsequent animosity. This added to
the existing acrimony between the Mansfield and Andrew groups, caused by
arguments [6] over an earlier grant proposal to the Medical Research Council.
As Mansfield noted “. . .matters eventually settled down in a quasi steady
state.”. However worse was to come, as in the early 1980’s research funding
cuts left British universities with a massive overstaffing problem. A generous
early retirement scheme was introduced leading to Raymond Andrew and
Bill Moore leaving Nottingham for the US. In addition Waldo Hinshaw had
already left to work for Technicare, after an initial time with GEC. Therefore
by the mid-80’s there was only one group left in Nottingham: the Mansfield
group. The Aberdeen group suffered similarly when Bill Edelstein also left
to work for GE. EMI pulled out of medical imaging and the system at the
Hammersmith was sold to Picker. From then on commercialisation of MRI
was largely conducted by companies based outside of the UK. As one of the
chief members of the EMI project, Ian Young, said [5] “. . .Britain snatched
defeat from the jaws of victory. . . ”.
Still the period between 1980 and 1990 proved to be something of a golden
era for the development of MRI at Nottingham. The acquisition of a 0.5
T superconducting magnet pushed the boundaries of field strength. Act-
ively shielded gradients were developed [15, 16], to prevent the magnet from
quenching during rapidly switched magnetic field gradients. This allowed
Echo Planar Imaging [12] (EPI) to be implemented [17]. The extension
of EPI to a three-dimensional acquisition known as Echo Volumar Imaging
(EVI) was also described [18].
Today the SPMMRC continues to be at the forefront of MRI technology.
This is exemplified by the installation of an ultra-high field 7.0 T whole body
MRI system in 2005, the first in the UK. The emphasis of this thesis is on
the application of MRI to functional neuroimaging. A field that could not
have been foreseen, or even contemplated, when imaging with NMR was first
considered. I think Raymond Andrew summed this up best when he said [5]
“Now new horizons are being unveiled with the development of functional
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MRI. Not only can we think about MRI, but MRI can watch us thinking
about MRI. Furthermore, MRI can watch us thinking about MRI recording
our thoughts on MRI, and so on, to the nth degree.”. Who knows what the
next 35 years have in store. . .
C
H
A
P
T
E
R
1
.
IN
T
R
O
D
U
C
T
IO
N
6
Name Year Category Description
Paul Lauterbur 2003 Medicine For their discoveries concerning magnetic resonance imaging
Peter Mansfield 2003 Medicine
Kurt Wu¨thrich 2002 Chemistry For his development of nuclear magnetic resonance spectroscopy
for determining the three-dimensional structure of biological mac-
romolecules in solution
Richard Ernst 1991 Chemistry For his contributions to the development of the methodology of
high resolution nuclear magnetic resonance (NMR) spectroscopy
Albert Kastler 1966 Physics Optical methods for studying Hertzian resonances
Felix Bloch 1952 Physics For their development of new methods for nuclear magnetic
Edward Purcell 1952 Physics precision measurements and discoveries in connection therewith
Isidor Rabi 1944 Physics For his resonance method for recording the magnetic properties of
atomic nuclei
Table 1.1: Nobel prizes awarded for work in the field of magnetic resonance.
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Name Year Category Description
Norman Ramsey 1989 Physics For the invention of the separated oscillatory fields method and its
use in the hydrogen maser and other atomic clocks
Hans Dehmelt 1989 Physics For the development of the ion trap technique
Alexander Mu¨ller 1987 Physics For their important break-through in the discovery of supercon-
ductivity in ceramic materials
Nicolaas Bloembergen 1981 Physics For their contribution to the development of laser spectroscopy
John van Vleck 1977 Physics For their fundamental theoretical investigations of the electronic
structure of magnetic and disordered systems
Table 1.2: Nobel prize winners who contributed to the field of magnetic resonance.
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1.3 Thesis Overview
The aim of this work was to investigate the underlying mechanisms of the
BOLD response. The following chapters describe the work performed in this
endeavour.
Chapter 2 contains the background theory that underpins this thesis. It
begins with the origins of nuclear magnetic resonance and continues
with the general principles of magnetic resonance imaging. The applic-
ation of these techniques to functional imaging are also discussed.
Chapter 3 presents relaxometry measurements of human blood at 1.5 T, 3.0
T and 7.0 T. The dependence of R1 and R
∗
2 on blood oxygenation and
paramagnetic contrast agent concentration is also investigated. The
aim of these experiments is to inform models of intravascular signal.
Chapter 4 describes a method for measuring total cerebral blood volume
changes with high temporal resolution. This work involves the use of
a paramagnetic contrast agent.
Chapter 5 discusses the use of a biophysical model to simulate the ex-
periment performed in chapter 4. Simulations are performed using a
selection of modelling elements derived from the literature and fitting
performed to the experimental data.
Chapter 6 summarises the results of chapters 3 to 5 and draws general
conclusions about this work. Future work is also discussed.
Chapter 2
Background Theory
2.1 Introduction
This chapter aims to describe the background theory that underpins this
thesis. This theory spans the basic principles of nuclear magnetic resonance,
magnetic resonance imaging and functional imaging.
2.2 Nuclear Magnetic Resonance
The Pauli exclusion principle, formulated in 1924 by Wolfgang Pauli, paved
the way for the discovery of spin angular momentum. The initial idea of a
spin angular momentum associated with the electron was suggested by Ralph
Kronig in order to describe the Pauli degree of freedom. However, following
criticism of his theory by Pauli and Heisenberg he decided not to publish it.
Instead it was left to Goudsmit and Uhlenbeck who in 1926 published [19]
their spinning electrons hypothesis. Despite Pauli’s initial reservations he
formalised these ideas using the then new theory of quantum mechanics.
Finally in 1928 Paul Dirac formulated [20] a relativistic quantum mechanical
wave equation to describe spin-1
2
particles, for which he was awarded the
Nobel Prize for Physics.
The field of Nuclear Magnetic Resonance (NMR) and Magnetic Reson-
9
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ance Imaging (MRI) exists due to the discovery of the intrinsic spin angular
momentum associated with elementary particles. The following sections de-
scribe the utilisation of spin in order to spy on the microscopic environment
of such particles.
2.2.1 Spin Angular Momentum
Classically, a rotating object possesses angular momentum, l = r × p, and
this can take any finite value. However in quantum mechanical systems
angular momentum is quantised, requiring changes in angular momentum to
occur in discrete steps between allowed rotational states. A simple example
of such a system is a diatomic molecule. For a diatomic molecule the total
angular momentum, ltot, of each state is given by,
ltot = ~
√
J(J + 1) (2.1)
where ~ is Planck’s constant divided by 2π and J is an integer value. The
molecule may possess any value of angular momentum permitted by equa-
tion 2.1. This value determines the rotational rate of the molecule but not
the axis with which it rotates. In order to determine this a second quantum
number, mJ , must be defined. This quantum number can take one of 2J +1
integer values: mJ = −J,−J + 1 . . . + J . The value of mJ gives informa-
tion about the direction of rotation. In the absence of a magnetic field these
states are degenerate. This is due to the fact that there are several different
states, i.e. combinations of angular momentum and direction of rotation,
with the same energy. By applying an electric or magnetic field this degener-
acy is removed causing each of the 2J+1 states to possess a slightly different
energy.
Spin angular momentum, lS, or spin is also quantised and can take values
of the following form,
lS = ~
√
S(S + 1) (2.2)
where S is the spin quantum number. All nuclei have an intrinsic value
of this spin quantum number, although not all have non-zero values, see
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Isotope Intrinsic Natural Gyromagnetic
Spin Abundance Ratio / MHz T−1
1H 1
2
100 % 42.58
2H 1 0.015 % 6.54
3H 1
2
0 45.41
12C 0 98.9 % -
13C 1
2
1.1 % 10.71
14N 1 99.6 % 3.08
15N 1
2
0.37 % -4.32
16O 0 100 % -
17O 5
2
0.04 % 5.77
19F 1
2
100 % 40.08
31P 1
2
100 % 17.25
Table 2.1: The MR properties of a selection of nuclei [21].
table 2.1 for some examples. These values can either be whole integer (S =
0, 1, 2 . . .), or half integer (S = 1
2
, 3
2
, 5
2
. . .). It is important to note that
whereas rotational angular momentum is acquired during energetic collisions,
spin angular momentum just exists, it cannot be increased nor decreased. As
well as the magnitude of spin angular momentum, lS, it is possible to define
its direction through a second quantum numbermS with 2S+1 integer states:
mS = −S,−S + 1 . . .+ S. Therefore the magnitude of l with respect to the
conventional axis, z, is given by,
lz = ~mS (2.3)
For example, the intrinsic spin of a hydrogen nucleus (1H) is 1
2
, therefore
mS = ±12 . However, a spin-1 particle, such as deuterium (2H), has three
possible states: mS = −1, 0,+1. Figure 2.1 shows this splitting diagrammat-
ically.
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Figure 2.1: Fine splitting of (a) spin-1
2
and (b) spin-1 atoms.
2.2.2 Magnetic Field Interaction
The magnetic moment of a particle with non-zero spin has the following form.
µ = γlS (2.4)
The constant of proportionality linking spin and magnetism is the gyro-
magnetic ratio, γ. When the nucleus is placed in a magnetic field, B, the
degeneracy of the 2S + 1 spin states is destroyed. The energy, E, of the
magnetic moment in this static field is,
E = −µ ·B (2.5)
This interaction between atoms and magnetic fields was first noted by Pieter
Zeeman [22] in 1897, and is known as the Zeeman effect in his honour.
Assuming that the nuclear magnetic moment is parallel with the applied
magnetic field, a combination of equations 2.3, 2.4 and 2.5 gives the following
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relation.
E = −~γB0mS (2.6)
The magnetic field, B0, is assumed to be static, uniform and parallel to the
z−axis. The energy of a nucleus in a magnetic field is dependent on the
magnetic field and its intrinsic spin. Therefore the allowable energy states
of a given nucleus will be equally spaced. For example a spin-1
2
nucleus will
exhibit two energy states corresponding to the +1
2
and −1
2
spin states. Hence
the difference between these energy states, ∆E, is given by equation 2.7 and
illustrated in figure 2.2.
∆E = ~γB0 = 2µB0 (2.7)
Transitions between the +1
2
and −1
2
states can be induced by the application
of an oscillating magnetic field. The angular frequency of this field is related
to its energy by E = ~ω. By equating this relation with equation 2.7 it is
possible to calculate the characteristic Larmor frequency, ω0, associated with
a given nucleus.
ω0 = γB0 (2.8)
2.2.3 Bulk Magnetisation
The two energy states of a spin-1
2
nucleus, +1
2
and −1
2
, are often described
as the spin-up (↑) and spin-down (↓) states. This nomenclature represents
the fact that the nuclear spins are aligned parallel or antiparallel to the main
magnetic field. The spin-up state has a lower energy and is therefore the
most favourable. However thermal energy permits changes of state from the
low energy spin-up state to the higher energy spin-down state. At room
temperature this leads to a small difference in the populations of spin-up
and spin-down states. The Boltzmann distribution can be used to predict
this population difference,
N↓
N↑
= e
γ~B0
kBT (2.9)
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Figure 2.2: Zeeman splitting for a spin-1
2
nucleus.
where N is the number of spins in the spin-up (↑) and spin-down (↓) states,
kB is Boltzmann’s constant and T is temperature. Expanding the exponential
using a power series yields,
N↓
N↑
≈ 1 + γ~B0
kBT
(2.10)
when γ~B0 ≪ kBT . Therefore the fractional difference in the populations of
the two spin states is,
N↓ −N↑
N↑
≈ γ~B0
kBT
(2.11)
At room temperature in the presence of a 3.0 T magnetic field this population
difference is of the order of 10−6. It is this small population of spins that
is used in the NMR experiment. Conveniently for 1H NMR this Hydrogen
isotope has almost 100 % natural abundance. A further consideration is the
total number of spins available in the sample. From Avogadro’s constant one
mole of atoms contains 1023 particles. Therefore the population difference
is approximately equal to 1023 × 10−6 ≈ 1017 spins per mole. However it
is still possible to increase sensitivity through equation 2.11. This can be
achieved by decreasing the sample temperature or increasing the magnetic
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field. The former is not achievable in the clinical setting, hence the need to
push to ever higher magnetic field strengths. Today’s NMR systems have
magnetic field strengths an order of magnitude larger than early systems,
largely due to the development of the superconducting magnet. Other routes
to higher sensitivity include hyperpolarised noble gases [23] and dynamic
nuclear polarisation [24].
In the NMR experiment the bulk effect of this ensemble of spins is ob-
served. The sum of the individual spin magnetic moments constitutes the
bulk magnetisation, M .
M =
∑
µ (2.12)
2.2.4 Nuclear Induction
It was Felix Bloch who coined the term nuclear induction to describe the
results of his early NMR experiments [25]. Simultaneously and independ-
ently Edward Purcell performed similar experiments [26] and together they
were awarded the Nobel Prize for Physics in 1952. In mid-1946 Bloch formu-
lated [27] a phenomenological description of the experiments he performed
using classical mechanics. In order to simplify the description Bloch made
two assumptions;
1. changes of orientation of each nucleus are solely due to the presence of
external fields
2. the external fields are uniform throughout the sample
Evidently these assumptions are unrealistic, but relaxation effects can be
reintroduced into the Bloch equation. The total spin angular momentum
vector, LS, of the spin ensemble satisfies the classical equation,
dLS
dt
= T (2.13)
where T is the total torque acting upon the nuclei and is equal to,
T =M ×B (2.14)
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Therefore the presence of a magnetic field causes the magnetic moments of
the nuclei to precess, in turn leading to precession of the bulk magnetisation
vector. From equation 2.4 the bulk magnetisation can be rewritten as a
function of the total spin angular momentum.
M = γLS (2.15)
Combining equations 2.13, 2.14 and 2.15 it is possible to derive an expression
for the rate of change of the bulk magnetisation as a function of time.
dM
dt
= γM ×B (2.16)
If equation 2.8 is substituted into this relation it can be shown that the
frequency of this precession is equal to the Larmor frequency, ω0.
dM
dt
= ω ×M (2.17)
If an ensemble of spins, with randomly and isotropically distributed magnetic
moments, are placed in a magnetic field the magnetisation vector, M , will
begin precessing about an axis parallel to that field. This is conventionally
designated the z-axis. In this special case, where relaxation effects are ig-
nored, this vector will also have a persistent component in the transverse x-y
plane. The magnetisation vector will trace out a precessional cone as de-
tailed in figure 2.3. However this is unrealistic, as stated in the introduction
to this section. Section 2.2.6 discusses relaxation processes that cause this
component of the magnetisation in the transverse plane to decay.
2.2.5 Excitation
In practice the NMR experiment uses an oscillating magnetic field to manip-
ulate the energy states of an ensemble of spins. This magnetic field is termed
B1 and oscillates in the radio frequency band.
B1 =


B1 cosωt
B1 sinωt
0

 (2.18)
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Figure 2.3: Precessional cone of the bulk magnetisation vector, M , around
the magnetic field B0k.
At this point it is useful to transform equation 2.16 into a frame of reference
rotating with respect to the z-axis at the Larmor frequency, ω0. Axes x, y
and z are then transformed into x′, y′ and z′ to give,
dM
dt
= γM ×Beff (2.19)
where Beff is the effective magnetic field in the rotating frame and incor-
porates the effects of B1.
Beff =


B1 cosωt
B1 sinωt
B0 − ω0γ

 =


B1
0
0

 (2.20)
The effect of this transformation into the rotating frame is to remove the
time dependence of B1 and to reduce the apparent magnetic field by
ω0
γ
. As
this relation is equivalent to B0 this serves to remove the z
′-component of the
total magnetic field for spins that are on resonance. Therefore the application
of a B1 field causes the magnetisation to rotate away from the z-axis through
an angle θ, see figure 2.4. In the laboratory frame this would be equivalent
to increasing the angle between the precessional cone and the z-axis. This
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Figure 2.4: Magnetisation in the rotating frame following a θ◦ RF pulse.
angle is a function of the amplitude of the B1 pulse and its duration, τ , for
a constant amplitude pulse.
θ = γB1τ (2.21)
A given flip angle can be attained either by a short, high amplitude pulse or
a longer duration, low amplitude pulse.
2.2.6 Relaxation
In section 2.2.4 it was assumed that relaxation does not exist, in order to
simplify the initial derivation. However in practice several mechanisms act
to return the bulk magnetisation to equilibrium. Longitudinal relaxation of
the z-component of the magnetisation occurs as the spins exchange energy
with their surroundings. Transverse relaxation acts to return magnetisation
in the x − y plane to zero. This is achieved by the mutual interaction of
the spins. Both relaxation mechanisms are characterised by time constants
T1 and T2, respectively. In practice a pure T2 relaxation is not observed.
Inhomogeneities in the magnetic field experienced by the spins causes an ad-
ditional relaxation term, T ′2, to be incorporated. This produces the observed
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T ∗2 decay constant.
1
T ∗2
=
1
T2
+
1
T ′2
(2.22)
The effects of relaxation can be incorporated into the mathematical descrip-
tion of magnetisation to produce the general form of the Bloch equations.
dM
dt
= γM ×Beff −


M ′x/T2
M ′y/T2
(M ′z −M0)/T1

 (2.23)
The magnetisation is represented byM and its components in the x′, y′ and
z′ dimensions. The magnetisation at equilibrium is represented by M0.
For spin-1
2
particles the dominant relaxation mechanism is the dipolar
coupling between two spins. Chemical shift anisotropy (CSA) also makes
a significant contribution in macromolecular liquid systems. In both cases
the relaxation is caused by the rapidly fluctuating magnetic fields produced
by these processes. Spins within the sample tumble through space due to
the thermal energy they possess. In direct dipole-dipole coupling the field
imposed by one spin on the other is rapidly changing due to the relative
motion of the two particles. Magnetic fields caused by the CSA effect are
due to molecular electron currents induced by the external magnetic field.
Together these processes add to the external field at each spin location to
produce a tiny variation in both magnitude and direction of that field. For
a given spin location this field will have zero mean and can be quantified by
the mean square value.
< Bx(t) > = 0 (2.24)
< B2x(t) > 6= 0 (2.25)
The rate at which the field fluctuates can be determined using an auto-
correlation function, G. The correlation of the field over different time scales,
τ , can then be determined.
G(τ) =< Bx(t)Bx(t+ τ) > (2.26)
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Correlation is generally large for small values of τ and zero for large values
of τ . A model of this variation is generally assumed to be mono-exponential
decay, where τc is known as the correlation time.
G(τ) =< B2x > e
−|τ |/τc (2.27)
The spectral density, J, of the random field fluctuations is defined as twice
the Fourier transform of the auto-correlation function.
J(ω) = 2
∫ ∞
0
Ge−ıωτ (2.28)
Rapidly fluctuating fields result in short correlation times and a broad spec-
tral density. Conversely slowly changing fields have longer correlation times
leading to a narrower spectral density. For an auto-correlation function of the
form of equation 2.27 the normalised spectral density, J , can be expressed
by the following equation. Normalisation is performed with respect to the
area under the curve.
J (ω) = τc
1 + ω2τ 2c
(2.29)
Relaxation is governed by transitions between spin states brought about by
thermal motion of molecules in the system. Transitions between states are
achieved when a spin is subjected to a magnetic field with a frequency equi-
valent to the spin’s own resonant frequency, or harmonics thereof. In liquids
the correlation time of the randomly modulated field corresponds to the ro-
tational correlation of these molecules. Hence the spectral density function
describes the probability of a spin moving from one state to another. The
Solomon equations formalise this link and predict T1 as a function of spectral
density for the dipole-dipole interaction.
1
T1
=
3
10
b2{J (ω0) + 4J (2ω0)} (2.30)
The function J (n ω0) represents the spectral density at the nth harmonic of
the resonant frequency and b is the dipolar coupling constant,
b = −µ0
4π
~γ2
r3
(2.31)
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where r is the distance between a pair of spins. Similarly an expression for
T2 can be found.
1
T2
=
3
20
b2{3J (0) + 5J (ω0) + 2J (2ω0)} (2.32)
Therefore the relaxation times T1 and T2 vary as a function of magnetic
field. The spectral density of the rotational correlation times is independent
of field. Therefore as the magnetic field increases the spectral density will
vary at harmonics of the Larmor frequency, ω0.
As noted above, the T ′2 component of T
∗
2 is brought about by inhomogen-
eities in the magnetic field experienced by the spins. Aside from the inherent
inhomogeneties of the external magnetic field, local fields are caused by the
magnetic susceptibility, χ, of the sample. This modifies the resultant field at
the spin location to give an effective magnetic field, Beff .
Beff = B0(1 + χ) (2.33)
Where discontinuities in the sample are present, for example at sample
boundaries, magnetic field gradients are produced. This causes an increase
in spin dephasing, which reduces T ∗2 . However this effect can be used in
a beneficial way. For example by introducing a paramagnetic species into
the blood stream, the contrast between blood vessels and tissue can be en-
hanced. The most common contrast agents contain Gadolinium, although
Dysprosium has also been used as a shift agents.
2.2.7 A Simple Pulse Sequence
The simplest NMR experiment consists of a single RF excitation pulse. The
sample, when placed in a magnetic field, is allowed to reach thermal equi-
librium by relaxation of the previously disordered bulk magnetisation. The
excitation pulse is applied to the sample at the spin resonant frequency,
and longitudinal magnetisation is rotated into the transverse plane. Pre-
viously randomly distributed spin magnetisation vectors are brought into
phase. This is followed by a short-lived decay, known as the free induction
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Figure 2.5: A simple pulse sequence.
decay (FID). The FID induces a signal in the RF coil. This signal is then
amplified and recorded and represents the decay of transverse magnetisation
due to T2 and magnetic field inhomgeneity effects. Figure 2.5 describes this
sequence diagrammatically.
2.2.8 Spin Echoes
The spin echo is critical to an extensive range of NMR techniques. It allows
the magnetisation of the spin ensemble to be brought back into phase to
produce what is known as a spin echo. This can be achieved in several ways,
but two of the most common techniques are the Hahn spin echo and the
gradient echo.
Following a 90◦x RF excitation pulse, the phase coherence of the induced
transverse magnetisation begins to disperse. This dephasing effect is caused
by inhomogeneities in the magnetic field, either inherent or due to susceptib-
ility shifts within the sample. Using the method of Carr and Purcell (CP) [28]
a 180◦x pulse is applied to the sample at a time τ . This causes the magnet-
isation that was initially oriented along the +y axis to be flipped onto the
−y axis. Following a further time period τ phase coherence returns and an
echo is formed. The phase accumulation of three spins, subjected to differ-
ent field inhomogeneities, is shown schematically for the rotating frame in
figure 2.6. Initially the differing inhomogeneities experienced by each spin
causes the range of phase values to fan out, with those experiencing the
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Figure 2.6: Hahn spin echo phase evolution.
largest effect accumulating the greatest phase difference. The 180◦x pulse
causes the magnetisation to be mirrored through the x-axis. However phase
changes continue to accumulate in the same sense, causing the magnetisation
to become increasingly refocused along the −y axis. In an alternative form of
this sequence a 180◦y pulse can be applied, which mirrors the magnetisation
through the y-axis, but allows the phase accumulation to continue in the
same direction. Using a sequence such as this refocuses dephasing caused by
static field inhomogeneities. Therefore by repeat application of this method
for different τ values, known as echo times, it is possible to measure T2. This
sequence is often described as a Hahn spin echo, however this is not strictly
true as in Hahn’s original work [29] refocussing was performed by a second
90◦ RF pulse.
In the gradient echo pulse sequence, refocusing is instead performed using
magnetic field gradients. Following the 90◦ RF pulse, an initial gradient is
applied for a time τ , causing dephasing of the spin ensemble. This gradient is
immediately followed by a gradient of the same magnitude, but with reversed
polarity for a time 2τ . This causes the spins to become increasingly in phase,
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Figure 2.7: Inversion recovery pulse sequence for measuring R1.
reaching a maximum at halfway through the second gradient application.
Unlike the CP spin echo, phase dispersion due to field inhomogeneities is not
refocused. Instead it contributes an additional T ′2 component.
2.2.9 Relaxometry
The science of the measurement of NMR relaxation rates is known as re-
laxometry. The relaxation time constants have their associated relaxation
rate.
Ri =
1
Ti
i = 1, 2 (2.34)
The longitudinal relaxation rate is often measured using an inversion recovery
technique. Figure 2.7 shows a simple inversion recovery pulse sequence. An
initial 180◦ inversion pulse is followed a time TI later by a 90◦ pulse. This
flips the current longitudinal magnetisation into the transverse plane where
an NMR signal can be measured. Hence the magnitude of Mz is dependent
on TI and R1. Ideally the shortest possible echo time following the 90
◦ pulse
is used to maximise the acquired signal.
Mz =M0(1− 2e−TI R1) (2.35)
Therefore by repeating this experiment for a range of TI values it is pos-
sible plot out the T1 recovery of the longitudinal magnetisation. There are
several important considerations to be made when performing this experi-
ment. Firstly, when using equation 2.35, it is important that the longitudinal
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Figure 2.8: Gradient echo pulse sequence for measuring R∗2.
magnetisation be allowed to fully recover before the experiment is repeated.
Secondly equation 2.35 is strictly only true for a perfect 180◦ pulse, especially
at high field. In practice this can be difficult to achieve due to inhomogeneit-
ies in the B1 field. Therefore a generalisation of this equation can be derived
for any arbitrary pulse angle, θ.
Mz =M0(1 + (cos θ − 1)e−TI R1) (2.36)
The transverse relaxation rateR∗2 is measured using a simple gradient echo
technique. Figure 2.8 describes the timing of this pulse sequence. Following
a 90◦x pulse, gradient echoes are formed by repeatedly reversing the polarity
of the magnetic field gradient. This will yield multiple signal measurements
at various echo time delays. Assuming that the the signal decay is mono-
exponential, the magnetisation in the y dimension, My, is then dependent on
the echo time, TE.
My =M0e
−TE R∗
2 (2.37)
In order to measure R2 the effect of static field inhomogeneities needs to
be taken into account. The simplest measurement technique utilises multiple
repeats of the CP spin echo sequence, described above. These measurements
trace out the exponential decay of My as a function of TE, enabling the
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Figure 2.9: CPMG pulse sequence for measuring R2.
calculation of T2.
My =M0e
−TE R2 (2.38)
However this sequence does not rewind dephasing due to diffusion. To meas-
ure a more accurate value of T2 the Meiboom-Gill modification [30] of the CP
spin echo technique [28] is used. This is known as the Carr-Purcell-Meiboom-
Gill technique, or CPMG. Figure 2.9 displays the timing of a CPMG se-
quence. In common with the CP spin echo a 90◦x is followed by a series of
180◦ pulses. However this pulse is applied with a 90◦ phase shift with respect
to the initial pulse by applying the 180◦ pulse along the y-axis. This yields
a spin echo at time 2τ . The 180◦ pulse is then repeated with alternating
phase, denoted in figure 2.9 by +y and −y, for odd and even repeats. By
alternating the phase of each 180◦pulse imperfections in the pulse profile are
balanced out. Therefore signal should only be acquired following pairs of
180◦pulses. The echo spacing is described by τCPMG and is equal to 2τ . By
keeping τ short the effect of diffusion can be minimised.
2.3 Magnetic Resonance Imaging
In the decades that followed the discovery of NMR, this fundamental prop-
erty of matter had a large impact on a wide range of scientific fields. In
particular the technique of NMR spectroscopy flourished. Work performed
in the following decades would lead directly to several Nobel prizes for both
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Physics and Chemistry.
In the first half of the 1970’s a great amount of interest was generated
in the idea of producing images using NMR, so called NMR imaging. Paul
Lauterbur [3] realised that by applying a magnetic field which varied across
the sample, local variations in the proton Larmor frequency could be induced.
This enabled the spatial distribution of protons to be measured. This one-
dimensional proton density profile could then be projected through space. By
varying the angular orientation of the magnetic field gradient a number of
projections could be acquired and back-projected [31]. This allowed an image
of the sample to be produced. Lauterbur coined the term zeugmatography to
describe this technique. This term is rarely used, and today NMR imaging
is more commonly known as MRI (Magnetic Resonance Imaging).
At around the same time Peter Mansfield was working on an NMR tech-
nique to investigate crystal lattice structure in solids [4]. Due to limitations
in their apparatus, resolving the structure of CaF2 proved very difficult. In-
stead artificial one-dimensional lattices were produced using thin sheets of
camphor. Later Mansfield acknowledged that by choosing to work with solids
they had made the task far more difficult [6]. However, by making an ana-
logy between optical diffraction and the Fourier transform of the NMR signal,
Mansfield was able to thoroughly describe the imaging problem in terms of
reciprocal space. By visualising the problem in this way it made it possible
to imagine many ways to adequately sample this space and thus create an
image.
Whilst both of these pieces of work added immeasurably to the nascent
field of MRI they represent a small part of any imaging technique. The
following sections describe the major components of an MRI pulse sequence.
2.3.1 Reciprocal Space
In 1973, Mansfield and Grannel [4] produced a generalised theory of how
imaging could be performed using NMR. They noticed that when the NMR
signal was transformed to reciprocal space there were strong mathematical
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similarities between the resulting expression, and those used to describe dif-
fraction of a plane wave.
When the spins within the sample are excited by an RF pulse, and are
subject to time dependent magnetic field gradients, the resultant NMR signal
can be described by the following expression,
S(t) =
∫
drρ(r) exp
(
ıγ
∫ t
0
r ·G(t′)dt′
)
(2.39)
where ρ(r) is the spin density at position r. The magnetic field gradients,
G, are conventionally applied in three orthogonal dimensions; x, y and z.
G(t′) =


dBz(t
′)/dx
dBz(t
′)/dy
dBz(t
′)/dz

 =


Gx
Gy
Gz

 (2.40)
As was noted above, it is possible to perform a transformation to the re-
ciprocal space domain. The reciprocal space domain represents the spatial
frequencies present in the image. The transformation is achieved through
the following parameter.
k = γ
∫ t
0
G(t′)dt′ (2.41)
Reciprocal space is often known as k-space in reference to the wave vector,
k. This vector has an associated wavelength, λ.
λ =
2π
|k| =
2π
k
(2.42)
Applying the k-space transformation to equation 2.39 gives,
S(k) =
∫
drρ(r) exp (ık · r) (2.43)
Application of the Fourier transform to this equation then yields the spin
density at any point across the sample.
ρ(r) =
∫
drS(k) exp (−ık · r) (2.44)
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Figure 2.10: An example of the multiple ways in which a traversal across
k-space can be achieved.
This suggests that in order to produce an image of an object, k-space must
be sufficiently well sampled. For time dependent gradients the exponent of
equation 2.44 can be expanded.
k · r =


xkx
yky
zkz

 (2.45)
The variables kx, ky and kz are independent dimensions of the k vector. By
allowing the x, y and z dimensions of the gradient G(t′) to be modulated
independently in time it is possible to contemplate many k-space sampling
schemes. Figure 2.10 illustrates the variety of ways of moving between two
arbitrary positions in a two-dimensional example of k-space. The ways in
which movements through k-space are achieved are described in the following
sections.
2.3.2 Spatial Encoding
Great care is taken when designing magnets for NMR applications to produce
a highly homogenous magnetic field. However by introducing a carefully
controlled magnetic field inhomogeneity it is possible to gain information
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about the distribution of spins in a sample. In the simplest implementation
of this idea a one-dimensional magnetic field gradient, Gx, is applied, in this
case in the x-dimension. The resultant magnetic field, Bz, in the z-dimension
at point x is,
Bz(x) = B0 +Gx(x) (2.46)
Evidently this can easily be expanded to three orthogonal dimensions, in
order to produce a gradient in any arbitrary direction. By substituting this
supplemented magnetic field into equation 2.8 a spatial variation in the Lar-
mor frequency is observed.
ω(x) = γ(B0 +Gx(x)) (2.47)
Spins located at each point in the sample corresponding to a given value of
x will precess at the same frequency. The FID will, therefore, consist of fre-
quency components corresponding to each value of x. The Fourier transform
of the FID will give the spin density of the sample in the x direction, see
figure 2.11. Extending this process to three-dimensions allows an image to
be formed. This technique was the first to be used to produce images [3] and
is known as projection reconstruction, see section 2.3.4.
However, frequency encoding is not the only way to impose spatial de-
pendence on the NMR signal. An alternative, although often complement-
ary, technique is that of phase encoding. Rather than rely on the frequency
of the spin precession this method is dependent on a spatial variation in
phase. This is possible due to the way the NMR signal is detected. This
measurement approach is known as quadrature signal detection and allows
measurement of phase information as well as frequency.
Following excitation of the spin ensemble a magnetic field gradient is
applied. In this example a y gradient is applied with an amplitude, Gy, and
a time, ty.
φ = γGytyy (2.48)
This leads to an initial phase shift, φ, with respect to the original phase
of the spins. Phase encoding is often used to allow traversal of k-space in
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Figure 2.11: Application of a magnetic field gradient in the x-direction: (a)
spatial variation of spin density in the sample, (b) applied magnetic field
gradient and (c) frequency density plot.
the y direction and is a critical part of the spin warp [14] technique, see
section 2.3.5.
2.3.3 Slice Selection
One of the most important elements of most acquisition strategies is slice
selection. This technique allows a thin slab of spins within the sample to
be excited, prior to the application of switched magnetic field gradients.
Therefore spatial encoding is then only required in two-dimensions.
The most common slice selective pulse profile has the form of a sinc
function. The suitability of this pulse profile for slice selection can be derived
from first principles. If it is assumed that the pulse is applied for a short
period of time, then it is appropriate to neglect relaxation effects. Hence the
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magnetisation can be described by equation 2.16.
dM
dt
= γM ×B
= −γB ×M
During application of a modulated magnetic field, B1, and a magnetic field
gradient, Bz = Gzz, the effective magnetic field, B, in the rotating frame of
reference is,
B =


−γB1
0
−γBz

 =


ω1
0
ω3

 (2.49)
where ω1 represents the magnitude of the RF field and ω3 is the frequency
offset with respect to resonance. Therefore,
dM
dt
=


ω1
0
ω3

×


Mx
My
Mz


=


−ω3My
ω3Mx − ω1Mz
ω1My

 (2.50)
By assuming that ω1 is small it can be assumed that Mz has a constant
value of M0, i.e. very little longitudinal magnetisation is rotated into the
transverse plane. This is known as the low flip angle approximation. The
magnetisation in the transverse plane can then be expressed in terms of the
complex transverse magnetisation, M⊥ =Mx + ıMy.
dM⊥
dt
=
dMx
dt
+ ı
dMy
dt
= −ω3My + ıω3Mx − ıω1
= ıω3(Mx + ıMy)− ıω1
= ıω3M⊥ − ıω1 (2.51)
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By inspection it is noted that,
e−iω3T
[
dM⊥
dt
− ıω3M⊥
]
= −ıω1e−iω3T
d
dt
[
e−iω3TM⊥
]
= −ıω1e−iω3T (2.52)
Integration of this relation, between time points −T and +T , yields the
transverse magnetisation following an RF pulse with a profile described by
ω1.
M⊥(t) = −ıeıω3T
∫ +T
−T
ω1(t)e
−ıω3(t)tdt (2.53)
By substituting ω1 and ω3 for B1 and Gz, respectively, it is possible to de-
scribe M⊥(t) in more familiar terms.
M⊥(T ) = ıγe
−ıγGzzT
∫ +T
−T
B1(T )e
ıγGz(t)ztdt (2.54)
Therefore the slice profile of the magnetisation is the Fourier transform of
the RF pulse envelope, B1(t). To produce a rectangular slice profile involves
calculating the Fourier transform of a top hat function. This produces the
sinc function, sinx/x. Equation 2.54 also states that the magnetisation of
the plane normal to z has a 1st order phase shift. This is easily removed
by applying a subsequent gradient, with reversed polarity, for a time T .
Alternatively for a spin echo sequence a gradient with the same polarity may
be applied following inversion of the spin phases by a 180◦pulse.
Strictly this derivation is only correct for low flip angles of the order of a
few degrees. However sinc pulses work very well at much higher flip angles,
and are routinely used to produce 90◦pulses.
2.3.4 Projection Reconstruction
The first MR imaging technique [3] was introduced by Paul Lauterbur in
1973. This work was inspired by the back-projection techniques already in
use in X-ray computed tomography (CT). It is commonly known as projection
reconstruction (PR).
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In the two-dimensional implementation of this technique, a slice selective
pulse is initially applied. A one-dimensional frequency encoding gradient is
played out during sampling. Multiple excitations are required to sample the
whole of k-space by rotating the direction of the gradient in the imaging
plane. Thus the sequence is time consuming. This is achieved by using two
gradients in the x and y dimensions.
G =
√
G2x +G
2
y (2.55)
α = tan−1
Gy
Gx
(2.56)
The angle, α, formed by the resultant gradient, G, is rotated through 0◦ to
180◦. The data gathered from each gradient orientation are then subjected
to a one-dimensional Fourier transform, to produce a plot of spin density in
that direction. A projection of the spin density is then plotted in a direction
perpendicular to the applied gradient. Back-projecting each of these profiles
produces an image of the object. Unfortunately, as can be seen in figure 2.14,
this process leads to a substantial background signal caused when a projection
assigns spin density where there should be none. This effect can be reduced
by using a filtered back-projection method. In this approach a high-pass filter
is applied to the spin density data, in the frequency domain. This filtered
data is then back-projected, reducing unwanted background intensity.
2.3.5 Spin Warp
Traditionally the most commonly used clinical acquisition technique, the spin
warp method [14] was introduced by the Aberdeen group in 1980. It is an
improvement of an earlier technique known as Fourier zeugmatography [13].
Following a slice selective RF pulse a phase encoding gradient pulse is
applied in the y direction. This is followed by acquisition of the signal dur-
ing the frequency encoding x gradient. A single line of k-space is acquired
during this process. The remainder of k-space is covered by repeating this
sequence whilst changing the amplitude or timing of the phase encoding
CHAPTER 2. BACKGROUND THEORY 35
Signal
Gx
Gy
Gz
90°
RF
Figure 2.12: Projection reconstruction gradient echo pulse sequence diagram.
kx
ky
q
Figure 2.13: Projection reconstruction k-space trajectory.
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Figure 2.14: A simple example of back-projection reconstruction of a simple
object.
gradient. Mathematically the reduction to two-dimensions simplifies equa-
tion 2.43 somewhat.
S(kx, ky) =
∫
dxdyρ(x, y) exp (ı (xkx + yky)) (2.57)
The wave numbers kx and ky describe the way in which k-space is sampled.
In the y direction the addition of the variable n represents the step changes
in Gy at the beginning of each k-space traversal.
kx = γGxtx (2.58)
ky = γGynty (2.59)
Application of a two-dimensional Fourier transform to the acquired data
produces a two-dimensional proton density map in a single step.
ρ(x, y) =
∫
dxdyS(kx, ky) exp (−ı (xkx + yky)) (2.60)
The subtle difference between the Fourier zeugmatography approach and that
of spin warp is in the application of the phase encoding gradient. It is clear
CHAPTER 2. BACKGROUND THEORY 37
Signal
Gx
Gy
Gz
90°
RF
Figure 2.15: Spin warp pulse sequence diagram (Gradient echo variant).
from equation 2.59 that the overall induced phase shift is a function of time
and gradient strength. Therefore the stepping of the phase encode gradient
can be achieved by increasing the gradient strength and fixing the time or fix-
ing the gradient strength and varying the time. The Fourier zeugmatography
method uses the latter approach. This posed a problem in the early days of
whole-body imaging as the homogeneity of magnet systems was not as high
as it is today. From the calculations of Edelstein et al. [14] the contribution
from the inhomogeneity of their magnet, at 20 cm from the iso-centre, was
12 µT . Contrast this with the gradient strength at this position, which was
20 µT , it is clear that this would lead to significant distortion. The spin warp
technique solved this problem by maintaining a fixed gradient pulse length,
but varying the gradient strength. The field inhomogeneity is still present
but by keeping the gradient pulse the same length this extra phase shift is
the same for each line of k-space.
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Figure 2.16: Spin warp k-space trajectory.
2.3.6 Echo Planar Imaging
The acquisition techniques described thus far have been inherently multi-
shot techniques, requiring multiple excitations to form an image. However,
in 1977 Peter Mansfield introduced the concept [12] of forming an image from
a single RF excitation using a technique later named Echo Planar Imaging
(EPI). Implementing this technique proved to be quite difficult due to the
intensive gradient switching and the resultant magnetic field interactions with
conductive structures of the magnet. All of the imaging performed in this
thesis used EPI acquisition.
There are many different EPI implementations. One of the most suc-
cessful, and an approach subsequently used in chapter 4, is the Modulus
Blipped Echo planar Single pulse Technique (MBEST) [17]. The sequence,
shown schematically in figure 2.17 begins with the conventional slice selection
technique. An initial negative phase encoding gradient causes a traversal in
the −ky direction, in order that the whole of k-space may be continuously
sampled in the +ky direction. Similarly a negative frequency encode pulse
places the sampling at the −kx extremity (figure 2.18). The frequency encod-
ing gradient is then rapidly switched in order to produce a series of equally
spaced spin echoes, acquiring k-space alternately in the +kx and −kx direc-
tions. Prior to each frequency encode lobe a short (blipped) phase encode
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pulse increments ky. When performing the two-dimensional Fourier trans-
form of MBEST EPI data care must be taken to reorder alternate lines of
k-space due to the opposing acquisition directions. However as odd and even
lines of k-space are acquired under gradients of opposing polarity differences
may exist between these gradients or their relative alignment. If these dif-
ferences exist an artefact known as the Nyquist ghost can be observed. It
is possible to remove this artefact by correcting the phase of the alternate
lines of k-space. The correction method used in this thesis is described in
section 2.5.4.
EPI suffers from several other artefacts. Chemical shift artefact in brain
images is characterised by a bright halo shifted with respect to the brain. The
protons present in fat and free water precess at a slightly different frequency
due to their chemical environment. As the position of a given proton is
frequency encoded this chemical shift causes a shift in position. Similarly
inhomogeneities in the static magnetic field cause distortions in EPI images.
Susceptibility differences in the head cause local magnetic field variations.
In turn these variations cause the local precessional frequency to be shifted
and hence the position of this volume to be shifted in the image.
Finally, in an extension to EPI is it possible to acquire 3-dimensional data
in a single shot using Echo Volumar Imaging [18] (EVI). A second orthogonal
phase encoding gradient is utilised to spatially encode a slab of the sample.
2.3.7 Partial Fourier Imaging
Partial Fourier imaging allows images to be reconstructed from insufficiently
sampled k-space data. This is possible because the Fourier transform of a
real object is Hermitian [31]. This means that the real part is symmetric and
the imaginary part is asymmetric about the centre of k-space. Therefore,
theoretically, only one half of k-space is required to reconstruct an image.
In practice, due to imperfections in the instrumentation, the object is not
purely real. By acquiring additional lines of k-space in the unsampled half
of k-space it is possible to overcome this problem. The fraction of k-space
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Figure 2.17: Echo Planar Imaging pulse sequence diagram.
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Figure 2.18: Echo Planar Imaging k-space trajectory.
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Figure 2.19: Partial Fourier acquisition in (a) the frequency encoding dimen-
sion and (b) in the phase encoding dimension.
is defined as 1 for full coverage and 0.5 for half coverage. In use the partial
Fourier fraction is typically in the range 0.55−0.75, and is termed half scan
on the Philips systems.
Applying the partial Fourier technique in the frequency encoding direction
allows shorter echo times to be achieved. In the phase encoding direction, a
reduction in scan duration can be achieved. In both cases the field of view
is not affected but the signal to noise ratio (SNR) will be reduced and image
artefacts introduced.
2.4 Instrumentation
The experiments described in this thesis were performed on four MRI sys-
tems based at at the University of Nottingham, see figure 2.20. The lowest
field system, a Philips Achieva 1.5 T, was installed at the Brain and Body
Centre in 2005. The remaining systems were based at the Sir Peter Mans-
field Magnetic Resonance Centre. They include a custom-designed 3.0 T
EPI scanner, a Philips Achieva 3.0 T and a Philips Achieva 7.0 T, the first
to be installed in Europe. The Philips systems were installed in 2005 and the
Nottingham system was developed in-house during the early 1990’s. All of
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(a) Philips Achieva 7.0 T. (b) Philips Achieva 3.0 T.
(c) Nottingham 3.0 T. (d) Philips Achieva 1.5 T.
Figure 2.20: MRI systems used in this thesis.
these systems can be described in terms of four main components; control,
magnet, gradient, RF subsystems.
2.4.1 Control
The MRI scanner is controlled by a computer workstation. The user enters
the required scan parameters and the computer calculates the gradient and
RF waveforms, along with timing information, to send to the spectrometer.
Amplified signals are received by the spectrometer and passed back to the
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Figure 2.21: A schematic diagram of a typical MRI scanner.
computer to be reconstructed. The computer Fourier transforms the data
and displays the image. The Nottingham 3.0 T saves the NMR signal as
time data, which can be Fourier transformed off-line. The Philips systems
save data in the DICOM format. There are also options to save the raw
NMR signal for later reconstruction. Figure 2.21 shows a schematic diagram
of a typical MRI scanner.
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Philips Philips Philips
Achieva Nottingham Achieva Achieva
1.5 T 3.0 T 3.0 T 7.0 T
Manufacturer Philips Oxford Philips Magnex
Field 1.5 T 3.0 T 3.0 T 7.0 T
Shielding Active None Active Fe Box
Cryogen He He / N2 He He
Cryocooler X - X X
Bore 0.9 m 0.92 m 0.9 m 0.9 m
Length 1.57 m 2.5 m 1.57 m 3.4 m
Homogenity† 0.11 0.50 0.24 0.10
DSV 35 cm 30 cm 30 cm 25 cm
Fringe field‡ 4 m / 3 m 16 m / 12 m 5 m / 3 m 12 m / 9 m
Table 2.2: Magnet system parameters for all four systems. †For the specified
diameter homogenous spherical volume (DSV) at iso-centre. ‡Fringe field of
5 G measured axially / radially from iso-centre.
2.4.2 Magnets
The most common whole-body magnet systems rely on superconducting wire
to produce very large magnetic fields. Typically this is a Niobium-Titanium
(Nb-Ti) alloy wound into a solenoid. Ingots of Nb-Ti are drawn out to fine
filaments, which are then bound together by solid Copper. This alloy is a
type-2 superconductor with a critical temperature of 10 K [32]. Below this
temperature the material becomes superconducting, that is it loses all res-
istance. However, this superconductivity can be destroyed by high magnetic
fields, in this case 15 T [32], limiting the maximum magnetic field this magnet
technology can produce. Higher fields are possible using a Niobium-Tin (Nb-
Sn) alloy which has a critical field strength of 24.5 T [32], but this material is
particularly brittle making it difficult to form wires for magnet production.
There are two main strategies for cooling the superconducting wires. The
CHAPTER 2. BACKGROUND THEORY 45
Oxford magnet used in the Nottingham 3.0 T system uses liquid Helium as
a cryogenic coolant. The liquid Helium cryostat is also cooled using liquid
Nitrogen. Since liquid Nitrogen is relatively cheap it is allowed to boil-off
in order to reduce the Helium boil-off rate and hence make the system more
economical. Nitrogen gas is vented to the atmosphere, whilst Helium gas
is piped to a liquefier allowing it to be reused in the School of Physics and
Astronomy. Due to this relatively high boil-off rate, by modern standards,
this magnet must be refilled with Nitrogen once a week and Helium once a
month. The Philips and Magnex magnets differ slightly in their construction.
They use a similar Helium cryostat but, instead of liquid Nitrogen, secondary
cooling is provided by a cryocooler. This reduces boil-off to an even greater
degree, reducing the frequency with which the system must be refilled with
liquid Helium.
Due to the very high magnetic fields produced by superconducting mag-
nets, siting a system can be very difficult. The magnetic field of the magnet
travels way beyond the bore of the magnet and these fringe fields pose a
risk to certain sections of the population. For instance heart pace makers
can be caused to fail in relatively low magnetic fields and the torque impar-
ted on aneurism clips can cause the implant to become dislodged with fatal
consequences. In most cases an acceptable fringe field of 5 G is used when
planning the installation of a magnet. The 5 G fringe field of the Oxford
magnet, present in the Nottingham 3.0 T, is 16 m axially from the iso-centre
and 12 m radially. In this case the 5 G line lies outside of the building and is
isolated from the general public using shrubbery and fencing. Modern clin-
ical systems use active shielding [15] to reduce this distance. This is achieved
by placing additional counter wound loops around the ends of the supercon-
ducting solenoid. This causes the fringe field to decay far more rapidly and
allows the 5 G line of the Phillips Achieva 3.0 T magnet to be reduced to 5.2
m axially and 3.0 m radially. Where active shielding is not suitable, i.e. at
ultra high field (>7.0 T), one final recourse is passive shielding. By placing a
large mass of ferromagnetic material, generally iron, around the magnet the
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fringe field area can be substantially reduced. The Magnex 7.0 T magnet
used in the Philips Achieva 7.0 T system uses this approach. Two hundred
and thirteen tonnes of iron form a box surrounding the magnet and reduce
the 5 G line to 12 m axially and 9 m radially.
A very high degree of homogeneity is required for both MRI and MRS
(Magnetic Resonance Spectroscopy) applications. In MRI inhomogeneity
leads to image distortion and in MRS to spectral line broadening. Supercon-
ducting magnets have inherently high homogeneity. This is improved further
during installation of the magnet using passive shims. The passive shim set
consists of a number of trays spread out around the bore that contain pockets
in to which small pieces of ferromagnetic material can be placed [33]. After
the magnet system is charged an initialisation sequence determines the cur-
rent magnet homogeneity and determines the distribution of shim pieces to
give optimum homogeneity. They are then placed within the pockets and are
slid into place on rails. However, due to the effects of paramagnetism and
diamagnetism within the sample this initial homogeneity can be reduced.
Therefore a set of active shims are placed within the bore of the magnet.
These shims consist of coil windings that produce a magnetic field which
varies with position. First order shims vary linearly with position whereas
second order shims vary quadratically. Currents are applied to the coil wind-
ings using stable power supplies to smooth out the distortions produced by
the object being imaged. In the case of the Philips systems, these currents
are determined automatically following several preparation steps which map
out field inhomogeneity. The Nottingham system is set manually by the
operator viewing a FID on an oscilloscope.
2.4.3 Gradients
The purpose of the gradient coil subsystem is to produce a spatial variation
in the z-component of B0 as a function of the three orthogonal directions
x, y and z. A variation in the z-direction is conventionally achieved using
a Maxwell pair coil arrangement, see figure 2.22. This system consists of
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Figure 2.22: Maxwell pair coil arrangement [34].
a pair of coils with radius r, separated by a distance
√
3d, and yields a
uniform magnetic field gradient with zero magnitude half way between the
coils. This coil system is particularly well suited to MRI applications as it
is easily integrated into a cylindrical geometry. Typically a magnetic field
variation in the x−y plane is accomplished using a saddle coil geometry. The
Golay coil system uses two pairs of saddle coils distributed along the bore of
the magnet, see figure 2.23. However simple coil elements such as this have
been superseded by more advanced coil design techniques. Complex wire
paths can be created through the use of numerical simulations.
Rapidly switching the magnetic field gradients can induce currents in
nearby metal structures. This is a particular problem for MRI systems
based on superconducting magnets. Currents induced in the cryostat and
heat shield, which have low resistance, decay with long time constants des-
troying the intended gradient profile. This problem is exacerbated by the
need to screen the far field of the magnetic field gradient. Further eddy cur-
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Figure 2.23: Golay coil arrangement [35].
rents are induced in this passive conductive screen. This effect limits the
range of applications that can be implemented on a passively shielded sys-
tem. However by using active shielding [15, 16, 36] techniques it is possible
to obviate both of these problems. Extra coil windings are added between
the magnet and the gradient coil to produce opposing magnetic fields, and
hence null magnetic fields external to the gradient coil.
The currents required to drive the gradient coils, and hence produce the
desired gradient profile, are digitally generated by the host console. These
values are then converted to analogue voltages and fed to power amplifiers
to generate the high currents required. Demanding acquisition techniques
such as EPI require very rapidly switched magnetic field gradients. This
requirement is made less demanding by using a resonant gradient coil design,
such as that implemented on the Nottingham 3.0 T system. This enables it to
produce switching frequencies up to 3.9 kHz. Different switching frequencies,
ω, are achieved by modifying the capacitance, C, in the resonant circuit,
ω =
1√
LC
(2.61)
where L is the inductance. In practice the maximum switching frequency
used in this thesis was 1.9 kHz.
The Philips systems use a non-resonant gradient design. All three systems
have approximately similar specifications, see table 2.3. Both the 3.0 T and
7.0 T have a dual mode design. This allows the maximum amplitude of a
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Philips Philips Philips
Achieva Achieva Achieva
1.5 T 3.0 T 7.0 T
Model Nova Quasar Quasar
Mode Single Dual Dual
Max. Amplitude† 66 40 / 80 30 / 60
Max. Slew Rate‡ 160 200 / 100 100 / 50
Table 2.3: Gradient system parameters for the Philips MRI systems.†Units
mT m−1. ‡Units mT m−1 ms−1.
C
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Figure 2.24: Simple RF coil design.
gradient pulse to be traded off against the maximum slew rate. This adds to
the flexibility of the system.
2.4.4 RF
Spin excitation and signal reception are accomplished using RF coils tuned
to the resonant frequency of the nuclei of interest. The simplest RF coil
consists of a loop of wire connected to a capacitor in parallel, see figure 2.24.
In addition the impedance of the RF coil must be matched to the impedance
of the amplifier to maximise signal reception / transmission. By convention
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(a) Nova TEM transmit / receive coil. (b) Nova occipital receive coil.
Figure 2.25: Nottingham RF coils.
RF amplifiers have an impedance of 50 Ω. Another capacitor, CM , connected
in series is used to match the impedance whilst the capacitor, CT , in parallel
is used to tune the system to the Larmor frequency. A coil of this type could
be used as a surface coil, allowing a specific region of the body to be studied
with a high signal to noise ratio. When cross-sections of larger body parts
are required, a volume coil is more appropriate. The most common volume
coil design is known as a bird-cage coil.
The Nottingham system uses a TEM coil design and was built by Nova
Medical. The data described in chapter 4 was acquired using the TEM
transmit coil in conjunction with a quadrature occipital receive coil, also
built by Nova Medical. This combination of coils allowed a homogenous RF
field to be applied to the whole head, and high signal to noise images to be
acquired from the anatomy of interest; the visual cortex.
The Philips systems have a number of interchangeable coils. The largest
of these coils is the body coil and is based on a bird-cage design. This is
largely used as a transmit coil, with reception using more localised coils, and
is built into the bore of the system. Other coils include a quadrature Transmit
/ Receive (T/R) head coil and an 8-channel SENSE head coil. The 8-channel
CHAPTER 2. BACKGROUND THEORY 51
Figure 2.26: Philips’ T/R (left) and 8-channel SENSE (right) RF coils.
SENSE head coil is a receive-only array allowing parallel imaging [37] to be
performed. This is achieved by independently acquiring a reduced number of
k-space lines from each coil element. Reducing the k-space coverage in this
way reduces the field of view, causing each of the images to be wrapped in
the phase encode direction. However an initial coil element sensitivity map
(reference scan) is used to weight the reconstruction of a single unwrapped
image from the 8 wrapped images. Currently the Philips Achieva 7.0 T
system does not have a SENSE coil1, hence the data acquired in chapter 3
used a T/R coil at all field strengths.
2.5 Functional Magnetic Resonance Imaging
The invention of EPI made it possible to freeze biological motion, due to the
very short image acquisition time, allowing images free of motion artefact
to be collected [17]. By applying this technique in a serial manner [38, 39]
it was found that it was possible to detect functional changes in-vivo with
unprecedented spatial resolution. The field of functional MRI (fMRI) grew
1A 16-channel SENSE head coil was delivered in April 2007
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Figure 2.27: Growth in fMRI publications measured as the number of pub-
lications containing the keyword “fMRI” in the citation index Web of Know-
ledge.
rapidly during the 1990’s, as can be seen in figure 2.27 by the increasing
number of publications containing the keyword “fMRI”.
The original, and most commonly used, fMRI technique utilises BOLD
(Blood Oxygenation Level Dependent) contrast. This contrast mechanism
relies upon the oxygenation level of the blood. Red blood cells within
the blood contain haemoglobin, which under normal circumstances is dia-
magnetic. However deoxygenated haemoglobin is paramagnetic and hence
forms local microscopic magnetic field gradients increasing proton dephas-
ing. Neural activity is supported by a haemodynamic response in the local
vasculature. This response leads to an increase in cerebral blood flow (CBF)
to the active region. This serves to satisfy an increase in the rate of oxygen
(CMRO2) and glucose (CMRglu) metabolism by increasing the delivery of
these substrates. In practice the haemodynamic response oversupplies the
active region with oxygenated blood, increasing blood oxygenation down-
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stream of the arteriole in the capillaries and veins. This reduces the concen-
tration of paramagnetic deoxyhaemoglobin and hence reduces susceptibility
induced dephasing. In turn this increases the MR signal. However the reas-
ons for this mismatch are not fully understood and are the subject of ongoing
research.
BOLD fMRI is by far the most common fMRI technique, but there are
alternatives. Arterial Spin Labelling (ASL) techniques allow non-invasive
measurements of CBF to be made, by magnetically tagging the blood water
prior to its passage through tissue, enabling it to be used as a tracer. By
monitoring the progress of this tagged blood water it is possible to quantify
changes in longitudinal magnetisation and measure the modulation of CBF
in response to a stimulus [40]. These measurements are arterially weighted
and do not show changes in venous CBF as the tagged blood will have largely
decayed prior to reaching the venous vasculature. Formerly these measure-
ments were performed by injecting a paramagnetic tracer into the blood [41].
However such techniques are not easily repeatable as they rely on the passage
of a single bolus of contrast agent limiting the utility of this method.
Similarly total cerebral blood volume (CBV) changes can be measured
using contrast agents. This volume measurement consists of contributions
from both the arterial and venous vessels. In humans this is achieved using
techniques such as those described in chapter 4 of this thesis. Again the
use of these techniques is limited and cannot be repeatedly used on a single
subject. A further technique that does not suffer this problem is vascular
space occupancy (VASO) fMRI [42]. By nulling the blood signal and meas-
uring the effect of blood volume change on the tissue signal it is possible to
perform CBV weighted measurements. This technique is hampered by a lack
of quantitation [43] unlike contrast agent techniques.
2.5.1 Cerebral Vasculature
The arterial blood supply to the head is formed by the two common carotid
arteries [44]. Each artery rises within the neck and bifurcates around the
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level of the thyroid to feed the internal and external structures of the head.
The exterior carotid supplies the exterior of the head, including the face
and neck. The internal carotid artery supplies the intracranial space and
is therefore more interesting in the context of this discussion. This vessel
splits further forming a multitude of connecting vessels known as the circle
of Willis. The importance of the brain can be appreciated from the many
layers of redundancy built into the vascular network. For instance there are
a pair of common carotid arteries, each of which branches from a different
vessel of the thoracic network. The circle of Willis is a further example of
this redundancy. If either of the carotid vessels were to become occluded this
structure allows the redistribution of blood from the contralateral vessel in
order to maintain tissue supply.
The cortical arterial system spreads out from the circle of Willis continu-
ally branching and reducing in size across the cortex. These branches are
split into two types, long and short, and penetrate the cortex perpendicu-
larly [45]. The long type pass through the grey matter in order to serve the
white matter alone, whilst the short type only enter the grey matter. Fur-
ther branching of the vasculature produces fine arteries known as arterioles.
In turn the arterioles feed the capillary network either directly or through
metarterioles that may serve 10-100 capillaries. Rather than terminate at
the capillary bed, metarterioles connect to the venous system as so called
thoroughfare channels. The capillary bed terminates when individual capil-
laries merge together to form venules, where blood collects prior to draining
into the venous vasculature.
The surface of the cortex is drained via narrow diameter veins, which
merge and connect with larger diameter vessels such as the superior sagittal
sinus. Redundancy is maintained by linkage of several bilateral vessels at the
cavernous sinuses. The blood continues to descend the intracranial cavity
and joins the internal jugular veins. These vessels pass down into the neck
alongside the internal and common carotid arteries [44].
Whilst the topology of the cerebral vasculature is important in functional
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imaging, the morphology of those vessels is equally important. Arterial vessel
walls consist of three layers [46]. The inner most layer is a base membrane
called the endothelium, which lines the entire cardiovascular system. The
intermediate layer provides the bulk of the thickness of the vessel and is
formed from elastic fibres and smooth muscle fibres. This gives the vessel its
strength and ability to cope with small changes in blood pressure. The final
layer provides additional elastic fibres and collagen. Nerve fibres connect
through this layer to the smooth muscle fibres allowing the tone of the vessel
to be modulated to provide vasoconstriction or vasodilation. Arterioles close
to the artery from which they branch differ only slightly from true arteries.
They show a reduced diameter and contain less elastic tissue, the intermedi-
ate layer mainly consisting of smooth muscle. Arterioles close to the capillary
bed show much reduced vessel wall thickness. The vessel wall is comprised of
an endothelial membrane surrounded by smooth muscle fibres. The vessels
described thus far control the haemodynamic response to increases in de-
mand for oxygen and metabolites. The smooth muscle fibres allow the blood
pressure into the capillary bed to be tightly regulated. At rest, perfusion of
the capillary bed is maintained at a low level, but can be rapidly elevated by
changing muscle tone within the arterial vasculature.
Capillary vessels are the narrowest vessel type and can be barely wide
enough to accommodate a red blood cell passing through. The capillary
vessel wall is formed purely by the endothelium. The function of the capillary
is to exchange oxygen and metabolites for carbon dioxide and waste products.
However cerebral capillaries differ from capillaries elsewhere in the body.
They have an additional protective role that limits which molecules can pass
through to the tissue space and forms the blood brain barrier (BBB). Unlike
conventional capillaries, cerebral capillaries contain tight junctions in order
to seal the gap between cells and produce a continuous blood vessel. It
is possible for light molecules such as oxygen and carbon dioxide to diffuse
through the endothelium and pericytes, but larger molecules cannot. Glucose
has a specific transport mechanism through specialised membrane proteins.
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Figure 2.28: The cerebral vasculature (a) at rest and (b) during focal activ-
ation shown here for the situation where arterial and venous blood volume
increases. Red and blue shading represent oxygenated and deoxygenated
blood, respectively. Blended tones represent the mixed oxygenation states
present in the capillary bed.
The vessel walls of veins consist of the same three layers as arteries, but
with different thicknesses. The middle layer is considerably reduced with
little smooth muscle, whilst the outer layer is the thickest and is constructed
of collagen and elastic fibres. During functional activity increases in arterial
blood pressure, and hence capillary blood velocity, are absorbed by expansion
of the venule and smaller veins. The venous system is a passive system, due
to a lack of smooth muscle and autonomic control, and hence changes in
vessel diameter are driven by arterial pressure changes [47]. In general veins
found in the rest of the body, particularly in the extremities, contain valves
to prevent blood from flowing away from the heart. However in the brain
these valves are absent.
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2.5.2 BOLD Contrast
The purpose of the vasculature is to transport nutrients to tissue, and the me-
dium through which this transport is achieved is blood. Blood is a suspension
of cells dissolved in plasma. The plasma is a straw coloured liquid and is ∼92
% water [46], with the remainder formed by plasma proteins. The cells sus-
pended within the blood are platelets, white blood cells and red blood cells.
Red blood cells make up by far the greatest volume fraction of cells with ∼5
million cells per µl [46]. These cells increase the oxygen carrying capability
of the blood by reversibly bonding oxygen molecules using haemoglobin mo-
lecules. This molecule consists of the globin protein and four iron containing
haem molecules. Each iron ion reversibly combines with oxygen to produce
oxyhaemoglobin. When required the reaction is reversed. Oxygen returns to
the plasma space where it can be passed to tissue to fuel metabolism. Each
red blood cell contains ∼280 million haemoglobin molecules allowing a large
amount of oxygen to be carried. To aid the absorption of oxygen molecules
these cells have a biconcave disc geometry in order to maximise their surface
area.
The majority of the constituent components of blood have little effect
on the MR signal, as they are only weakly diamagnetic. For instance the
magnetic susceptibility shift of oxyhaemoglobin, relative to distilled water,
is −0.26 × 10−7 [48], emphasising its diamagnetic nature. However deoxy-
genated haemoglobin (deoxyhaemoglobin) is paramagnetic with a relative
magnetic susceptibility of +1.57×10−7 [48]. Water protons within the blood
will experience enhanced dephasing causing a reduction in signal. As the
volume fraction of blood in tissue is small this does not produce a marked ef-
fect. However, the magnetic susceptibility gradient formed by paramagnetic
materials in the blood will enhance the dephasing of water protons diffusing
around blood vessels. Assuming a cylindrical vessel aligned perpendicular
to the field, the frequency shift due to this vessel can be expressed in polar
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coordinates, r and θ, by the following relationship [49],
ωlocal
ω0
= 2π∆χ
(a
r
)2
(2 cos2 θ − 1) (2.62)
where ωlocal is the local resonant frequency, a is the vessel radius and ∆χ is
the susceptibility shift between the vessel and the surrounding tissue. The
polar coordinates r and θ represent the distance to the centre of the vessel
and the angle of that line between that line and the z-axis. It is possible to
substitute for ∆χ = (1−Y )∆χdHb in equation 2.62, where ∆χdHb represents
the deoxyhaemoglobin magnetic susceptibility relative to water. Assuming
that the tissue has a susceptibility close to that of water, it is possible to sim-
ulate the effect of different oxygenation levels on local resonant frequency.
Figure 2.29 displays the magnitude of this frequency shift in parts per mil-
lion for three different blood oxygenation fractions (Y); 0.2, 0.5, and 0.8.
Regions of tissue that are subject to these local field shift effects show in-
creased proton dephasing and hence a reduction in MR signal. The effect of
reduced blood oxygenation on the MR signal is therefore not confined to the
vessel. Extravascular dephasing causes highly deoxygenated blood vessels to
appear as dark lines in MR images. Dephasing is greatest when the vessel
is perpendicular to the main magnetic field, and zero when oriented parallel.
Fortunately the tortuosity of the cerebral vasculature means that there is
almost always a component of the vessel that is perpendicular to the main
magnetic field. This may, however, be a problem for structures of the brain
that have an anisotropic distribution of vessels.
As large vessels cause a static dephasing effect the measured contrast is
dependent on the imaging technique employed. Gradient echo techniques are
used to create good contrast between blood vessels and tissue. Large blood
vessels containing deoxygenated blood produce large frequency shifts in the
surrounding tissue and hence good contrast between them. By employing a
spin echo technique [50], it is possible to refocus this dephasing. However
dephasing due to protons diffusing around very small vessels cannot be re-
focused. Mobile water protons that undergo a large displacement, during a
TE period, with respect to the vessel diameter will dynamically average the
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Figure 2.29: Simulation of the frequency shift due to a blood vessel of radius
a = 1 in parts per million. Three blood oxygenation fractions were simulated,
Y=0.2, 0.5, 0.8 (left-right).
vessel magnetic field gradient. This stochastic dephasing cannot be refocused
and hence this contribution is retained. A lot of research [50–53] has been
performed in this area with the aim of using SE to provide better localisation
of neural activity.
Initially BOLD contrast was used to improve venous vessel contrast [54]
by altering the inspired air mixture of mice and rats. Ogawa et al. noted
that the type of anaesthetic used in these experiments had a bearing on the
overall contrast, suggesting that it must alter cerebral haemodynamics by
modulating blood flow. It was already clear that this result would allow
dynamic changes in blood oxygenation to be measured.
2.5.3 BOLD Haemodynamic Response
Dynamic functional MRI utilising BOLD contrast was first described in hu-
mans in 1992 [38, 39]. By applying a stimulus to the subject, whilst serially
imaging using fast imaging methods, it was found that it was possible to
determine which region of the brain was exhibiting changes in blood flow
and metabolism activity. It had been known [55] for sometime that dur-
ing increased neural activity the average oxygenation of blood in the veins
and capillaries increased. This somewhat counterintuitive result is due to
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a mismatch between increases in CBF and oxidative metabolism (CMRO2).
Fox and Raichle [55] showed that whilst at rest good correlation was found
between CBF and CMRO2, this situation differed during dynamic changes.
Metabolic changes of 5 % were accompanied by a CBF change of 29 % seem-
ingly suggesting that these parameters may be transiently uncoupled. This
mismatch has been described as “watering the garden for the sake of one
thirsty flower” [56]. In recent years an alternative hypothesis [57], compat-
ible with the results of Fox and Raichle, but which allows CBF and CMRO2 to
remain coupled has also emerged, known as the oxygen limitation model [57]
(see chapter 5). The coupling of this metabolic response to neural activity
has also been shown [58] to be closely coupled.
Early BOLD fMRI experiments utilised block paradigms, whereby stimuli
were presented for between 30 s and 1 minute [38, 39] (ON period) followed
by a similar length period of rest (OFF period). However with the increasing
availability of MRI systems capable of high temporal resolution EPI these
stimuli became ever shorter and an era of event related paradigms began.
In this regime stimuli are of the order of a few seconds in length [59] or an
instantaneous event, such as a button press. This enabled the temporal and
spatial characteristics of the BOLD haemodynamic response function (HRF)
to be investigated more fully. This only served to underline how little was
known about the biophysical mechanisms underlying this method.
The BOLD haemodynamic response can be broken down into three dis-
tinct temporal features; the initial dip, the positive overshoot and the post-
stimulus undershoot. The early response, or initial dip, is observed during
the first 2-3 seconds following stimulus onset. It is manifested as a negat-
ive change in signal and is thought to be due to a temporal lag between
increased oxidative demand and the corresponding increase in CBF. This
would suggest that this process would occur in close proximity to the site
of neural activation, most likely in the capillary bed or even the intracel-
lular space. Evidently functional paradigms that utilise this feature should
yield higher spatial resolution maps of activation and this has been shown by
CHAPTER 2. BACKGROUND THEORY 61
D
B
O
L
D
Time (seconds)
0 3 15 60
0
Initial Dip
Positive Overshoot
Post-Stimulus Undershoot
Figure 2.30: Temporal features of the BOLD response.
Yacoub et al. [60]. However, although the initial dip has been detected by a
select number of groups [61–64], it is particularly difficult to detect routinely
as the fractional change in BOLD signal is very small. This often leads to
the initial dip being obscured by a combination of instrumental noise, signal
drift and physiological noise. Therefore great care must be taken to remove
physiological noise [65], reduce subject motion and keep instrumental noise
and drift to a minimum.
The main feature of the BOLD response is the positive overshoot. The
duration of this feature is dependent on the stimulus duration. As an ex-
ample, a 5 s visual stimulus produces an overshoot of approximately 15 s
duration. This overshoot represents the main haemodynamic response to
increased neural activity and is a result of increased CBV and blood oxy-
genation. Both of these changes are due increases in CBF resulting from
relaxation of the arteriole smooth muscle, causing dilation of the blood ves-
sel. Dilation of pericytes that adjoin the vessel have also been shown to
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control blood flow [66]. The vessel walls of the capillary bed are thought to
be relatively rigid and expand only slightly, if at all, during changes in CBF.
Instead changes in CBF are absorbed by expansion of the venule, downstream
from the capillary bed. Blood oxygenation decreases along the length of the
capillary bed, reaching a new steady state at the venule. Therefore the spa-
tial specificity of this response is not as high as that suggested for the initial
dip. Yacoub et al. [60] suggest that the limit of this specificity is 2-3 mm,
whereas Turner [67] suggests 4 mm. However this response is very robust
and can be routinely used to produce maps of functional activity.
The final feature is known as the post-stimulus undershoot. The duration
of this feature, given a 5 s visual stimulus, can be anything between 20 s and
40 s, see figure 4.9. It is difficult to accurately determine the duration of
the post-stimulus undershoot as it also displays a relatively small fractional
change in BOLD signal. However, unlike the initial dip, the increased dur-
ation of the undershoot allows this feature to be routinely observed. The
physiological origin of the undershoot has not been conclusively proved. The
work of Mandeville et al. [68] suggested that the post-stimulus undershoot
could be explained by the delayed compliance of the venous vasculature. In
this scenario the additional blood volume provided by the compliant venule
increases the concentration of deoxyhaemoglobin in the imaging voxel. A
delay in the relaxation of this venous balloon, relative to the dynamics of
CBF change, causes the BOLD signal to undershoot its resting state value.
This idea was backed up by observations [69] in rats that showed a transient
lag between CBF and CBV dynamics. An alternative to this explanation [70]
is that the undershoot could be accounted for by elevated oxidative metabol-
ism post-stimulus, in the absence of increased blood flow. The origin of this
elevated metabolism is unknown, at present, but this effect has been observed
in fNIRS (functional Near Infra Red Spectroscopy) experiments [71]. The
reasons for the absence of a CBF response are similarly unknown. However,
it has been suggested [72] that CBF change may be modulated in-directly by
neural activity. Elevated metabolism post-stimulus may therefore represent a
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separate metabolic process that takes place following intense neural activity.
It is clear that current understanding of BOLD haemodynamics is in-
complete. With greater understanding it may be possible to improve the
methodology and inference of BOLD fMRI experiments.
2.5.4 fMRI Data Preparation
Detecting the BOLD haemodynamic response in fMRI data is a multi-step
process, see figure 2.31. The data is prepared using several pre-processing
stages and then subjected to a statistical analysis. The first stage, following
acquisition of data on the scanner, is to reconstruct time data into images.
Data is acquired in k-space and is Fourier transformed into the image do-
main. This is an automatic process on the Philips systems, but requires
user intervention on the Nottingham 3.0 T system. This process will now be
described.
Raw data is transferred from the scanner control workstation, where it
is saved as complex time data. In house software [73] is used to Fourier
transform this data and perform ghost correction. EPI data is prone to an
artefact known as the Nyquist ghost. Sampling of k-space is performed in
alternating directions, due to the reversal of the switch gradient polarity. In
order to perform a two-dimensional Fourier transform this data must be re-
versed. Instrumental timing inaccuracies and magnetic field inhomogeneities
cause the signal from alternate lines to be modulated. This effect causes a
ghost image to be produced in the phase encode direction. This ghost will
have a displacement of N/2 pixels relative to the real image, where N is the
image dimension in pixels. The simplest way to correct this phase shift is by
applying a phase angle correction to each point in alternate lines of k-space.
This is applied in the frequency encode dimension, which in this example is
the x−axis.
θ(x) = θ0 + xθ1 (2.63)
The amount of correction required can be determined by eye and is applied
to every image in the fMRI data set, assuming the phase error is time inde-
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Figure 2.31: The processing steps required to analyse fMRI data. Items col-
oured green are pre-processing steps and items coloured orange are analysis
steps.
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pendent. A two dimensional Fast Fourier Transform (FFT) is then applied.
Images are saved in the Analyze format [74] as 16-bit signed integers. The
dynamic range of this data format (−32, 768 → +32, 767) is maximised by
using an appropriate scaling factor.
A typical fMRI data set will consist of many slices (∼40) allowing the
whole head to be covered. As each slice is acquired discretely, each will have
been acquired at a slightly different time with respect to the other slices.
This will lead to a phase shift of the BOLD haemodynamic response, across
slices, and is of particular importance for event related paradigms. This can
be corrected in SPM2 [75] by correcting the phase shift of each slice to the
beginning of the volume TR, i.e. the time period in which all of the slices
are acquired. In this thesis three slices were acquired in a volume TR of 300
ms, giving a slice TR of 100 ms. The stimulus paradigm was event related
and consisted of 5 s of visual stimulation. The resulting haemodynamic
response had a duration of approximately 45 s and therefore the phase shift
introduced by this slice TR was negligible. Hence slice timing correction was
not performed in this thesis.
Functional analyses rely on the change in a single voxel as a function of
time, rather than space. Therefore it is important that each voxel represents
the same volume of tissue throughout the experiment. This can often be
difficult due to subject motion and instrumental drift causing displacement
of the brain image within the field of view. In order to reduce the effect of
this displacement various motion correction techniques have been developed.
In this thesis, SPM2 [75] was used to correct subject motion. In SPM2
registration is performed between a pair of images. The first image is a
reference image, conventionally the first image of the data set. The second
image is the same imaging slice at another, usually later, time point and is
known as the source. The rigid body transformation required to place the
source image in the same space as the reference image is then calculated.
Motion correction of fMRI data usually uses a 6−parameter transformation.
In translation they consist of the in-plane motion, x and y, and through plane
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motion, z. The rotation about these axes are also included and are known as
pitch, roll and yaw. For a set of points x1, x2, and x3 of a source image, an
affine mapping to points y1, y2, and y3 of the reference image can be defined.
y1 = m11x1 +m12x2 +m13x3 +m14
y2 = m21x1 +m22x2 +m23x3 +m24
y3 = m31x1 +m32x2 +m33x3 +m34
SPM2 represents these mappings as a simple matrix multiplication, y =Mx.


y1
y2
y3

 =


m11 m12 m13 m14
m21 m22 m23 m24
m31 m32 m33 m34




x1
x2
x3
1


Translation, T , and rotation, R, matrices can then be used to describe the
transformation, M , from the source space to the reference space.
M = TR (2.64)
Optimisation is performed for 6−parameters using the Newton-Gauss al-
gorithm [76]. The cost function for this optimisation is the mean squared
error between the source and reference images. The resulting transforma-
tions can then be applied to the source image, and the process repeated for
each image in the fMRI data set. These transformations are also inspected
and if the subject is found to have moved by greater than one voxel then the
dataset is typically discarded.
The data is often smoothed in both the temporal and spatial domains.
Temporal smoothing is normally applied by filtering out nuisance frequencies
in the pixel time-courses. Filtering out low frequency components of a time-
course enables long term drift, due to scanner instability, to be removed. An
increase in the SNR can be achieved by removing high frequencies. The selec-
tion of threshold frequencies must be chosen carefully, so that the frequencies
which describe the haemodynamic response are retained, whilst extraneous
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noise is removed. In the context of this thesis temporal smoothing was not
performed. Low frequencies were required to examine the baseline signal
change as a function of contrast agent concentration. High frequencies were
retained in order that small features of the BOLD response were not removed.
Spatial smoothing can be applied by calculating a weighted sum of nearby
voxels. This can increase the SNR of the image, but will also reduce the spa-
tial resolution. The Full Width Half Maximum (FWHM) of the smoothing
kernel must be selected based on the scale of the expected activated re-
gion [73]. For a given FWHM, an activated area greater than this size will see
an increase in SNR, however areas smaller than the FWHM will see reduced
SNR. Choice of FWHM is, therefore, a compromise and is obviously based
on a prior hypothesis. Spatial smoothing is also important when performing
group analyses. In group analysis individual subject data is registered to
the Montreal Neurological Institute (MNI) template brain, to account for
differences in brain morphology between subjects. Images from individual
subjects in MNI space are then spatially smoothed and inter-subject com-
parisons made. Spatial smoothing was not applied to data in this thesis as
data were analysed on an individual subject basis and it was important to re-
tain high spatial resolution, and reduce the partial volume effect of averaging
several voxels together. The partial volume effect was particularly important
in this respect, as the expected volume change temporal dynamics could be
drastically altered by contributions from large draining veins.
2.5.5 fMRI Data Analysis
Data analysis was also performed in SPM2 [75] in this thesis. SPM2 uses
a General Linear Model (GLM) to detect the haemodynamic response in
the fMRI time-series. A model is set up to describe the effect of interest
including the timing of the stimulus. Hence a good fit between the model
and the time-course data indicates that the data was probably caused by the
stimuli. For a single voxel time-course the simplest model is,
y = βx+ ǫ (2.65)
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where the data, y, is described by an explanatory variable, x, the correlation
of that model, β, and an error term, ǫ. It is likely that there are many
variables, n, that can be used to explain the data and the model can be
easily expanded to include them.
y = β1x1 + β2x2 + . . .+ βnxn (2.66)
When this approach is extended to all pixel time-courses in an image it is
convenient to represent this equation in matrix form.
Y =Xβ + ǫ (2.67)
In this case Y represents the time-course data,X are the explanatory models
otherwise known as the design matirx, β are the correlation coefficients and
ǫ the errors. By fitting this model to the fMRI data it is possible to estimate
the model correlation βˆ = [β1, β2 . . . βn]
T . Equation 2.67 can be re-written
in the following way.
XTY = (XTX)βˆ (2.68)
Hence if (XTX) is invertable,
βˆ = (XTX)−1XTY (2.69)
This approach is particularly efficient in the case of SPM2 as it is implemen-
ted in MATLAB [77], a matrix laboratory. As the errors in the parameter
estimates are known, and normally distributed, it is possible to calculate a
T−statistic,
t =
βi
SEi
(2.70)
where βi is the ith correlation coefficient of βˆ and SEi is the standard error of
the estimation of this parameter. If the correlation coefficient is low relative
to its standard error, then the fit is not significant, and vice versa. A t-
value can then be converted into a z-score or a p-value using the appropriate
transformation.
From the estimation of βˆ it is possible to produce statistical maps, dis-
playing the significance of an explanatory variable at each pixel. To be able
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to distinguish which of these pixels is statistically significant and hence de-
termine true activations a threshold is applied to the map. The simplest
threshold is determined by selecting a level of significance to apply to each
pixel of the statistical map. In SPM2 the default uncorrected threshold is
set at p = 0.001. This represents the probability of a pixel being activated
purely by chance, and is obviously very small. However in fMRI, statistical
maps generally consist of thousands of pixels. Therefore, despite the very low
threshold it is likely that tens of false positives will be detected. This is known
as the multiple comparisons problem. For example, a set of data consisting
of a 64×64 matrix and 40 slices may contains >100,000 pixels inside of the
head. An uncorrected threshold of p = 0.001 will give 100 false activations.
In order to correct this error a Bonferroni correction can be applied. In this
case the significance threshold is divided by the number of comparisons, i.e.
the number of pixels for which βˆ was estimated. In the example above this
would give p = 0.001/100, 000 = 0.00000001. Evidently this is overly conser-
vative and it is not used in practice. Gaussian Random Fields (GRF) theory
estimates the number of statistically independent pixels. This is lower than
the total number of pixels and is due to clustering of significant pixels. GRF
reduces the Bonferroni correction by a factor of approximately 2 − 20 [78]
and allows a corrected probability to be displayed, which is typically set at
p = 0.05.
2.6 Further Reading
In order to gain a greater understanding of the topics covered in this chapter
a wide range of reading was undertaken [21, 31, 73, 76, 78–82]. The author
would like to acknowledge these works and suggest them as sources for further
reading.
Chapter 3
Blood relaxometry
3.1 Introduction
BOLD fMRI techniques use the transverse relaxation properties of blood as
a contrast mechanism. The BOLD effect [83] relies on the oxygenation state
of haemoglobin, the oxygen carrying molecules within red blood cells. As
the blood becomes more deoxygenated its susceptibility, relative to tissue,
increases, which in turn reduces T2 / T
∗
2 due to increased dephasing of water
protons. Changes in metabolism brought about by neuronal activation cause
an increase in venous oxygenation decreasing dephasing and increasing T2 /
T ∗2 .
The measurement of the dependence of T ∗2 on oxygenation and contrast
agent concentration has particular relevance to chapter 5. In this chapter
the BOLD signal is described as a weighted sum of the intravascular blood
signal and the extravascular tissue signal [47]. These signal components
are functions of blood volume change and deoxyhaemoglobin concentration.
The extravascular signal is often modelled using the results of numerical
simulations [84] or by analytical expressions [85]. However the intravascular
signal is generally characterised by empirical results [86]. Measurements of
oxygenation dependence have previously been performed at 1.5 T [86]. In
order to compare the multi-component model, with experimental data from
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chapter 4, measurements of the dependence of R∗2 on both oxygenation and
contrast agent concentration at 3.0 T were required.
Alternative fMRI techniques include ASL fMRI, which directly measures
CBF changes, and the VASO technique [42], which measures changes in CBV.
These techniques rely on the longitudinal relaxation properties of blood. ASL
uses a single RF pulse, or train of RF pulses, to modify the longitudinal
relaxation of arterial blood proximal to the tissue of interest. After a period
of time TI an (tag) image is acquired which elicits longitudinal signal changes
in areas where blood is flowing. In typical implementations a second (control)
image is acquired without modification of the magnetisation of in-flowing
arterial blood. Tag images are then subtracted from control images to yield
a perfusion image which is modulated by blood flow changes that occur on
activation. As field strength increases the T1 of arterial blood increases,
giving rise to an increase in the perfusion weighted difference signal.
The VASO method assumes that the T1 of blood is independent of its
oxygenation state. Therefore, following an inversion pulse, blood with dif-
fering oxygenation will relax to the null point at the same time. This effect
allows the blood signal to be nulled whilst leaving the tissue signal to be
measured. Decreases in signal indicate increases in blood volume.
It is clear that characterising the relaxation properties of blood is very
important. The aim of this study was to measure T1 and T
∗
2 of whole human
blood. The dependence of these parameters on blood oxygenation, contrast
agent concentration and main magnetic field, B0, was considered.
3.2 Theory
Contrast in MRI is due to variations in the relaxation rates R1, R2 and R
∗
2
for different tissue types. This contrast can be enhanced using a number of
agents, and is often achieved by adding small amounts of a paramagnetic
transition metal to the sample of interest. The most common clinical exo-
genous contrast agent is Gadolinium. In its ionic form this metal is toxic,
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and it is chelated to form a stable inert complex for use as an in vivo con-
trast agent. Within the human body blood is an endogenous contrast agent.
Oxyhaemoglobin is only weakly diamagnetic, whereas deoxyhaemoglobin is
paramagnetic. This difference forms the basis of BOLD fMRI.
The mechanisms by which paramagnetic species modify R1 and R2 can
be described by the Solomon-Bloembergen-Morgan equations [87–89]. In the
first instance it will be assumed that the species of interest is Gadolinium,
with the specific case of deoxyhaemoglobin discussed subsequently. The re-
laxation enhancement provided by the introduction of Gadolinium is an ad-
ditive relaxation rate above the underlying diamagnetic effect.
Robsi = R
dia
i +R
para
i i = 1, 2 (3.1)
The paramagnetic contribution increases linearly with concentration, where
the constant of proportionality, ri, is known as the relaxivity.
Robsi = R
dia
i + ri[Gd] i = 1, 2 (3.2)
Unpaired electrons, belonging to the Gadolinium ion, cause the local mag-
netic field to fluctuate rapidly in both magnitude and direction. The interac-
tion of the proton nuclear spins with this field increases the relaxation rate.
The origin of this increase in relaxation rate is generally divided into two
components. They are the so-called inner sphere (IS) and outer sphere (OS)
interactions.
Rparai = R
IS
i +R
OS
i i = 1, 2 (3.3)
The inner sphere contribution represents the interaction of the Gadolinium
electrons and bound water in the first co-ordination sphere of the ion. This
effect is transmitted to bulk protons by chemical exchange. Outer sphere ef-
fects consist of second sphere interactions and interactions of the Gadolinium
ion with bulk protons. Second sphere interactions are caused by water mo-
lecules binding to the inner sphere water or the contrast agents protective
ligand. Bulk protons experience the rapid translational motion of the Gad-
olinium ion and experience additional dephasing. The inner and outer sphere
components can each be described by the following existing theories.
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3.2.1 Inner Sphere Relaxation
Inner sphere proton relaxivity is dependent on exchange of co-ordinated water
protons with the bulk. The theoretical results of Luz and Meiboom [90] and
Swift and Connick [91] provide the description of inner sphere R1 and R2,
respectively,
RIS1 =
qPm
T1m + τm
(3.4)
RIS2 =
qPm
τm
T−22m + τ
−1
m T
−1
2m +∆ω
2
m
(τ−1m + T
−1
2m)
2 +∆ω2m
(3.5)
where q is the number of bound water molecules per ion, Pm is the mole frac-
tion of bound water molecules, τm is the bound water exchange constant, and
∆ωm is the chemical shift difference between bound and bulk water. Bound
water protons relax via dipole-dipole (DD) and scalar or contact mechanisms
(SC). The longitudinal and transverse relaxation time constants T1m and T2m
are therefore a sum of the contributions of these relaxation mechanisms.
1
Tim
=
1
TDDi
+
1
T SCi
i = 1, 2 (3.6)
However the SC mechanism represents only a small change in relaxation
rate, and is therefore neglected in this brief theoretical overview. The dipole-
dipole mechanism dominates and the resulting relaxation time constant can
be described by the Solomon-Bloembergen-Morgan equations.
1
TDD1
=
2
15
γ2I g
2
Sµ
2
B
r2
S(S + 1)
(µ0
4π
)2 [
7
τc2
1 + ω2Sτ
2
c2
+ 3
τc1
1 + ω2Iτ
2
c1
]
(3.7)
1
TDD2
=
1
15
γ2I g
2
Sµ
2
B
r2
S(S+1)
(µ0
4π
)2 [
13
τc2
1 + ω2Sτ
2
c2
+ 3
τc1
1 + ω2Iτ
2
c1
+ 4τc1
]
(3.8)
In equations 3.7 and 3.8, γI is the proton gyromagnetic ratio, gS is the
electron spin g factor, µB is the proton nuclear magnetic moment, r is the
electron spin−proton distance, and ωS and ωI are the proton and electron
Larmor frequencies, respectively. Both equations are only valid for ions with
spin angular momentum quantum number, S, greater than 1
2
. Gadolinium-
III is one such ion, with S = 7
2
. The correlation times, τci, are a function
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of the rotational correlation time of the species, τR, the electronic relaxation
times, Tie, and the water exchange constant τm = 1/kex, where kex is the
chemical exchange rate.
1
τci
=
1
τR
+
1
Tie
+
1
τm
i = 1, 2 (3.9)
By substituting the normalised spectral density function (equation 2.29) into
these expressions it is possible to determine RDDi as a function of the spectral
density of the water protons, J1, and Gadolinium electrons, J2.
1
TDD1
=
2
15
γ2I g
2
Sµ
2
B
r2
S(S + 1)
(µ0
4π
)2
[7J2(ωS) + 3J1(ωI)] (3.10)
1
TDD2
=
1
15
γ2I g
2
Sµ
2
B
r2
S(S + 1)
(µ0
4π
)2
[13J2(ωS) + 3J1(ωI) + 4τc1] (3.11)
When considering the field dependence of equations 3.10 and 3.11 it is worth
noting that τR and τm are field independent. The electronic relaxation rate
τie is dependent on field and this is due to the zero field splitting interaction
(see references [87–89] for more details). Hence the correlation times τci
are relatively unchanged with increasing magnetic field and the profile of
the spectral density is similarly invariant. However the proton and electron
Larmor frequencies are field dependent, and therefore maximum relaxation
enhancement will occur when the spectral density maximum coincides with
this frequency.
Gadolinium concentration dependence is controlled by variables q and
Pm in equations 3.4 and 3.5. All of the currently approved clinical contrast
agents have a single co-ordination site, i.e. q = 1. Inner sphere proton
relaxivity is linearly dependent on q and would appear to be an easy route
to higher relaxivity. However the limit of q = 1 is imposed by the need
for a protective ligand. Ligands that allow more than one water molecule
in the inner sphere are less stable and therefore increase the risk of toxic
Gadolinium being released. As the number of co-ordination sites cannot be
increased, enhanced relaxation can only be achieved by increasing the number
of Gadolinium ions i.e. increasing the concentration.
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3.2.2 Outer Sphere Relaxation
Further relaxation occurs through two mechanisms; second sphere relaxation
and outer sphere relaxation. Second sphere relaxation occurs when water
molecules hydrogen bond to the oxygen atom of bound water in the first co-
ordination sphere. This interaction can be described by equations 3.4−3.5
and 3.10−3.11. In this case the relevant parameters are usually denoted by
a prime, e.g. q′, r′, etc. However second sphere relaxation theory is still
relatively poorly understood. The number of water molecules bound in this
way, q′, and the distance between the proton and the ion are unknowns.
Therefore this component is often neglected.
Outer sphere relaxation is due to translation of the water protons near to
the Gadolinium ion. In order to model this effect the water molecules and
Gadolinium ions are treated as hard spheres allowing ROS1 and R
OS
2 to be
described.
ROS1 = C [3j(ωI) + 7j(ωS)] (3.12)
ROS2 = C [2 + 1.5j(ωI) + 6.5j(ωS)] (3.13)
C =
(
32π
405
)
γ2Iγ
2
S~
2S(S + 1)
NA[Gd]
1000aD
(3.14)
In equation 3.14, NA is Avogadro’s number, [Gd] is the Gadolinium concen-
tration, a is the distance of closest approach of the water molecule and D is
the diffusion constant of the water and Gadolinium solution. The spectral
density functions, j(ω), are non-Lorentzian and mathematically complex.
Several definitions can be found in the literature [88, 92, 93].
Again field dependence of ROS1 and R
OS
2 is due to increasing proton and
electron Larmor frequencies versus static spectral density. In this case the
spectral density function is dependent on the diffusional correlation time,
τD = a
2/D. The Gadolinium concentration dependence is linearly related to
Ri by the variable [Gd].
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3.2.3 Susceptibility Effects
Susceptibility variations within the sample produce an additional contribu-
tion to transverse relaxation. The R′2 (1/T
′
2) component of R
∗
2 (1/T
∗
2 ) is due
to magnetic field inhomogeneities caused by these variations. The local mag-
netic field is described by equation 2.33 (restated below) and is derived from
Curie’s law.
Beff = B0(1 + χ)
Curie’s law states that the magnetisation of a paramagnetic material will
increase linearly with applied magnetic field, B0. This result was obtained
experimentally and shown to be dependent on temperature, Θ, and a con-
stant, C, which is a property of the material.
M = C
B0
Θ
(3.15)
In a physical sense, this law describes the tendency of atomic magnetic mo-
ments to align with a magnetic field, in order to minimise energy. Therefore
increasing B will increase M indefinitely. This cannot be the case as once
100 % of the atoms are aligned with the field, further increases in magnet-
isation are impossible. Once the fraction of aligned atoms becomes large,
Curie’s law begins to break down. At this point the material is said to be
saturated. Equation 2.33 will break from linearity when the magnetic field
is large enough to fully align the paramagnetic atoms.
3.2.4 Application to Gadolinium
The effect of a contrast agent as a function of solute concentration and mag-
netic field can be measured using specialised NMR relaxometry instruments.
These systems measure R1 as a function of magnetic field, or more typically
proton Larmor frequency. Plots of this type are known as NMR dispersion
(NMRD) profiles. For low molecular weight Gadolinium complexes, it has
been shown using this technique [89, 94] that relaxivity reaches a minimum
at typical MRI field strengths. A consideration of the Solomon-Bloembergen
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equations would suggest that the spectral densities of the nuclear and elec-
tron spins are low in magnitude at the Larmor frequencies of these spins.
The dependence of R1 on solute concentration is predicted by equations 3.4
and 3.12. They suggest a linear increase with concentration, which has been
confirmed by experiments [95].
The effect of Gadolinium on transverse relaxation R∗2, is commonly as-
sumed to be linear, as is shown for the R2 component by equations 3.5 and
3.13. Similarly the susceptibility induced R′2 component would be expected
to increase linearly with concentration. The relaxivity variation as a function
of field strength is dependent on the saturation of Gadolinium. The work
described in this chapter will test whether the Gadolinium atoms are satur-
ated at any point over the range of static magnetic fields used in this work;
1.5 T → 7.0 T.
3.2.5 Application to Deoxyhaemoglobin
Red blood cells contain high concentrations of haemoglobin. Haemoglobin
contains Fe2+ which when oxygenated is in the low spin diamagnetic state
(S=0), and when deoxygenated is in the high spin paramagnetic state (S=2).
This change of state causes the R1 and R2 to be dependent on blood oxy-
genation. Assuming that red blood cells (RBC) can be approximated by a
sphere it is possible to apply the theory from the preceding sections to RBCs.
It is known that haemoglobin does not have co-ordinated water molecules
in its inner sphere. This is due to the location of the Fe2+ ion deep within
the protein structure. The Fe2+ is not exposed at the surface. Therefore
the inner sphere relaxation mechanisms do not operate for haemoglobin [96].
The majority of the relaxation enhancement is caused by outer sphere ef-
fects through equations 3.12 and 3.13. The dependence of R1 and R2 on
oxygenation is controlled by the concentration term [Gd], where in this case
[Gd] is the concentration of deoxyhaemoglobin in the blood. Strictly this is
only true for lysed blood as the inhomogenous distribution of susceptibility
causes an additional effect [97, 98]. The magnetic field dependence is due to
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the interplay between diffusional correlation time, τD, and the proton and
electron Larmor frequency.
An R1 NMRD profile of haemoglobin, in either its oxy- or deoxy- states,
could not be found in the literature. Koenig et al. [94] state that they did not
observe a change in R1 with field strength. In the same work they present an
R2 NMRD profile for deoxyhaemoglobin. This result suggests that increases
in R2 are approximately linear over the range of field strengths used in this
chapter (1.5→7.0 T). They also state that outer sphere relaxation effects are
enhanced by the containment of haemoglobin in red blood cells. This process
would produce the additive R′2 component to form R
∗
2. It is difficult to predict
the R′2 contribution with field, but following the Gadolinium predictions it
could be assumed to be linear.
Additional relaxation due to susceptibility differences within the sample
should increase linearly with field strength, as predicted by Curie’s law. As
with Gadolinium this effect may saturate during the range of field strengths
tested, causing Curie’s law to breakdown.
3.3 Method
The aim of this work was to measure the relaxation properties of whole hu-
man blood, and the variation in these properties with oxygenation, contrast
agent concentration and magnetic field strength. As controlled blood sample
preparation was crucial to the final result section 3.3.1 describes this process
in detail. Relaxation properties were measured using imaging techniques and
are described in the subsequent sections.
3.3.1 Blood Preparation
Ethical approval was obtained from the University of Nottingham Medical
School Ethics Committee in November 2005. Informed consent was obtained
from a single volunteer who donated 100 ml of blood. The subject was
asked to abstain from physical exertion before the study, in order to obtain
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samples with resting (low) oxygenation. The blood was stored in twenty 5
ml Lithium heparinised blood tubes in order to prevent clotting. Prior to
the experiment, samples were stored in a refrigerator at 5◦C and used within
48 hours of donation.
Blood oxygenation was modulated by slowly bubbling oxygen through
the sample, in a fume cupboard. The gas flow rate was maintained at a low
level [99] in order to prevent the viscous blood from foaming. Using this tech-
nique it was possible to obtain a range of blood oxygen saturation, Y , values
between 0.48 and 0.84. This range represents the normal physiological range
for venous oxygenation. An oxygenation approaching 1 would be expected
in arterial vessels.
In order to investigate the blood relaxation dependence on contrast agent
concentration small amounts of ProHance [100] were added to samples. Blood
sample tubes were sealed wherever possible to prevent changes in blood oxy-
genation from occurring. Other than exposure to atmospheric oxygen, the
oxygenation of these samples was not altered, and as such represented a
resting level of oxygenation. The samples used in this experiment had a
mean oxygen saturation of Y = 0.66 ± 0.05 and a mean haematocrit of
HCT = 0.43± 0.02. The contrast agent was diluted from its initial concen-
tration of 0.5 M to 50 mM by adding 1 ml of ProHance to 9 ml of distilled
water. A micropipette was used to measure these volumes. In order to con-
trol for differing volumes of blood in each heparinised blood tube the mass of
blood in each tube was measured. Additional blood tubes were weighed and
the blood contained within the storage tube transferred to them. A repeat
measurement of their combined weight was then made. A small volume of
diluted ProHance was added to the samples in the range 25 µl to 250 µl, with
the intention of covering a blood contrast agent concentration range of 0.3
mM to 3 mM. One final weight measurement, of the combined bottle, blood
and contrast agent, allowed an accurate calculation of the blood contrast
agent concentration to be made.
The oxygenation and haematocrit of the blood samples was repeatedly
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50mm
Figure 3.1: Blood sample holder: Various sample locations can be chosen,
enabling imaging of several samples simultaneously.
measured throughout the preparation stage using a Radiometer ABL710
Blood Gas Analyser [101]. Prepared samples were transferred to spherical
containers with an external diameter of 19 mm. Each sphere was sealed by
a 2 mm diameter plastic screw. This enabled removal of the blood sample,
post-experiment, in order to measure blood oxygenation and haematocrit. A
spherical geometry was chosen to minimise the susceptibility artefact associ-
ated with the sample-air boundary. A custom sample holder was used during
experiments, see figure 3.1. It allowed the samples to be suspended above
the surface of the holder thereby retaining the geometrical advantages of a
sphere. Throughout this preparation phase the blood samples were stored
in an electrically heated water bath at 37 ◦C in order to replicate in vivo
conditions.
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3.3.2 Imaging
Imaging was performed on Philips Achieva whole body scanners at magnetic
field strengths of 1.5 T, 3.0 T and 7.0 T. A sample holder was used to place
the blood samples at the centre of a quadrature head coil, which was used
for transmission and reception. Samples were not heated or stirred whilst
within the scanner. However prior to the experiment they were heated to
37◦C and agitated to ensure complete mixing of the blood components. Due
to the short scan durations (<∼ 100 s) of the pulse sequences used in this
experiment it was decided that cooling and settling of the blood would not
have a deleterious effect on the results. The details of the pulse sequences
used in the measurement of T1 and T
∗
2 are described below.
T1 Measurement
The T1 measurement technique consisted of an Inversion Recovery sequence,
with EPI image acquisition (IR-EPI). The preparation pulse was a 180◦ hy-
perbolic secant pulse followed by a crusher gradient to destroy residual trans-
verse magnetisation. This was then followed by a set of 10 inversion delay
(TI) times tailored to the field strength at which the experiment was per-
formed. A further set of inversion times was selected for the experiments on
samples containing contrast agent, and were used across all field strengths.
These inversion times are summarised in table 3.1. Following the inversion
delay a 90◦ RF pulse was applied and 19 lines of k-space acquired using a GE
EPI switched gradient with blipped phase encoding. Due to the small sample
size it was possible to acquire a 64 × 19 imaging matrix. This reduced the
scan duration, and TE, as a complete image could be acquired following each
inversion pulse in a single shot. The shortest TE was selected as 4.7 ms. An
in-plane resolution of 1 mm × 1 mm was acquired, with a slice thickness of
3.3 mm. A repetition time, TR, of 10 s was used for the oxygenation samples.
It was possible to use a shorter TR of 6 s for the contrast agent samples, due
to the much reduced T1. The total scan durations at these TR values were
101 s and 60.5 s, respectively.
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1.5 T 3.0 T 7.0 T Gd
100 ms 150 ms 200 ms 50 ms
250 ms 350 ms 400 ms 100 ms
400 ms 550 ms 800 ms 200 ms
600 ms 800 ms 1100 ms 300 ms
800 ms 1100 ms 1400 ms 400 ms
1100 ms 1500 ms 1900 ms 500 ms
1500 ms 2000 ms 2600 ms 600 ms
2000 ms 2700 ms 3200 ms 700 ms
3000 ms 4000 ms 4500 ms 900 ms
5000 ms 6000 ms 7000 ms 1150 ms
Table 3.1: Inversion times for T1 mapping across field strengths. The final
column lists the inversion times used at all field strengths for measurement
of T1 in the samples containing contrast agent.
T ∗2 Measurement
The T ∗2 measurement sequence utilised a single RF excitation pulse followed
by an EPI switched gradient and acquisition module. However unlike a
conventional EPI module the phase encoding blips were removed and replaced
by an initial phase encode gradient. The phase encoding gradient was then
stepped between repeats of the sequence [102]. This approach causes the
same phase encoding to be applied to all of the gradient recalled echoes of
each sequence block, allowing the acquisition of many closely spaced echoes
for each line of k-space. These individual lines were recombined to produce
63 images with a matrix size of 128×128. The spacing of the echo times,
∆TE, was determined by the EPI switching frequency employed at each
field strength. Hence ∆TE was 1.39 ms, 1.12 ms and 1.16 ms at 1.5 T, 3.0 T
and 7.0 T, respectively. The slightly larger echo spacing at 1.5 T was due to
lower specification gradient hardware. This did not effect the measurement
of T ∗2 due to the comparatively slow relaxation rate at this field strength. A
field of view of 128 mm was chosen giving an in-plane resolution of 1 mm
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× 1 mm with a 3.3 mm slice thickness. This was identical to the resolution
used for the T1 relaxation measurements. A TR of 267 ms was used giving a
total scan duration of 35.2 s.
3.3.3 Analysis
Data analysis was performed in MATLAB [77] using custom written code.
Transverse relaxation was measured by fitting a linear function to log intens-
ity data versus echo time on a pixel by pixel basis.
logS = −TE R∗2 + logS0 (3.16)
The matrix inversion technique was used to perform this fit, in which weight-
ing was applied to earlier high intensity echoes. An intensity threshold, of
3× the background noise, was applied to each of the echoes. This was par-
ticularly important at 7.0 T as the transverse signal decayed to zero within
30 echoes (∼ 35 ms).
Mapping R∗2 at high and ultra-high field magnetic fields is a challenge.
Macroscopic susceptibility changes, in this case at the sphere-air boundary,
cause enhanced signal decay. This leads to an artificially enhanced measure-
ment of R∗2. It has been shown [102] that a linear magnetic field gradient
along the z-axis causes additional signal decay with a sinc profile. This sinc
component perturbs the general monoexponential decay of the sample caus-
ing an error in the calculation of R∗2. In order to avoid pixels with large sinc
components from biasing the overall result, the significance of each point
was assessed by calculating the χ2 value. These values were converted to
p-values, to remove the bias due to varying numbers of echoes included in
the fit. Regions of interest were then created by thresholding these maps,
and the mean and standard error calculated. The only major susceptibility
distortions were caused by small air bubbles at the top of the spheres.
Longitudinal relaxation was measured by fitting a non-linear function to
the data using least squares fitting. Equation 2.36, reproduced below, was
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Figure 3.2: Inversion recovery pulse sequence with EPI image readout.
 RF
Slice
Switch
Phase
Signal
90° 90° 90°
Figure 3.3: Rapid gradient echo pulse sequence.
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used to model the data.
Mz =M0(1 + (cos θ − 1)e−TI R1) (3.17)
The angle θ was included in the fit to model imperfect inversion of the spin
system. The shortest attainable echo time (TE=4.7 ms) was used for all
TI s. Susceptibility induced distortion was therefore reduced to a minimum
and region of interest selection by significance was not required. The region
of interest was selected by thresholding an intensity image to create a mask.
The mean and standard error of these time-courses could then be calculated.
3.4 Results
The results of this study can be separated into three sections. The following
sections consider the changes in the relaxation times T1 and T
∗
2 as a func-
tion of oxygenation, contrast agent concentration and main magnetic field
strength. In each case these parameters are plotted as the relaxation rates
R1 and R
∗
2 which are equivalent to the reciprocal of the relaxation times T1
and T ∗2 , respectively.
3.4.1 Oxygenation
Figure 3.4 plots the longitudinal relaxation rate, R1, as a function of deoxy-
haemoglobin content, 1− Y . Each sample data point is plotted as the mean
and the error bars represent the standard error. Due to the relatively large
number of pixels in the maps of R1 the standard error is rather small. How-
ever this neglects the errors introduced during production of the samples
which probably accounts for the dispersion from the line of best fit. These
errors consist of differences in oxygenation and haematocrit, as well as the
amount of heparin dissolved in the sample and damage caused to the red
blood cells during handling and storage. The best fit to this data has a linear
form and represents the longitudinal relaxivity of whole blood as a function
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B0/T r
dHb
1 / ms
−1 rGd1 / ms
−1mM−1
1.5 (−5.2± 7.6)× 10−5 (3.6± 0.5)× 10−3
3.0 (4.1± 8.9)× 10−5 (2.9± 0.5)× 10−3
7.0 (7.6± 2.9)× 10−5 (3.4± 0.4)× 10−3
Table 3.2: Longitudinal relaxivity of whole blood as a function of deoxy-
haemoglobin content and contrast agent concentration.
B0/T r
∗ dHb
2 / ms
−1 r∗ Gd2 / ms
−1mM−1
1.5 (5.4± 1.1)× 10−2 (1.5± 0.2)× 10−2
3.0 (16.9± 2.2)× 10−2 (3.7± 0.5)× 10−2
7.0 (34.7± 4.7)× 10−2 (8.2± 2.3)× 10−2
Table 3.3: Transverse relaxivity of whole blood as a function of deoxyhaemo-
globin content and contrast agent concentration.
of deoxyhaemoglobin content, rdHb1 , the values of which are summarised in
table 3.2.
Figure 3.5 plots the transverse relaxation rate, R∗2, against deoxyhaemo-
globin content, 1− Y . The errors in the plotted data points are quite small.
As noted above these errors do not take into account the variability intro-
duced during sample preparation. Li et al. [86] have previously shown that
for physiologically plausible values of Y these variables display a linear re-
lationship. Hence the solid lines represent linear fits to the data from each
field strength. The gradients of these lines represent the transverse relaxivity
of whole blood as a function of deoxyhaemoglobin content, r∗ dHb2 , and are
summarised in table 3.3. These values were then used to model the change
in R∗2 during activation.
3.4.2 Contrast Agent
Figure 3.6 plots R1 as a function of contrast agent concentration. As sugges-
ted by NMRD data, the effect of the contrast agent on R1 does not depend
on magnetic field, for the range of fields tested. From a theoretical stand-
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Figure 3.4: Longitudinal relaxation rate, R1, of human blood plotted as a
function of deoxyhaemoglobin content.
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point this would suggest that at these field strengths the electron and proton
Larmor frequencies do not occur at the same frequencies as the peak of the
spectral density function. This is manifested by the tight grouping of the
data points across field strengths. A linear fit to this data, at each field
strength, yields the contrast agent relaxivity in whole blood, rGd1 . These
values are summarised in table 3.2.
Figure 3.7 plots R∗2 versus contrast agent concentration. The relationship
between these quantities is typically thought to be linear. However this
result was not observed. The data in figure 3.7 display a parabolic form.
An explanation for this result was sought and Monte Carlo simulations were
performed to confirm the parabolic nature. The hypothetical origin of this
effect is discussed in more detail in section 3.5. Due to this effect, relaxivity,
r∗ Gd2 , was measured by fitting a linear function to the positive slope region,
beyond the null point. These values are summarised in table 3.3, allowing a
cross field relaxivity comparison to be performed.
3.4.3 Magnetic Field
Figure 3.8 shows the relationship between longitudinal relaxivity, rdHb1 , and
magnetic field strength, B0. The error in this data is the error in gradient of
the curve fit performed to calculate r1. Despite this relatively large error the
data appears to suggest that deoxyhaemoglobin relaxivity increases approx-
imately linearly with magnetic field strength. As was noted in section 3.2 it
was not possible to find a NMRD profile in the literature for deoxyhaemo-
globin. Work performed on Gadolinium chelates shows that at high field the
T1 shortening effect is expected to reach a maximum. This is not the case for
deoxyhaemoglobin and obviously requires further research. Figure 3.9 plots
the effect of B0 on r
Gd
1 . As expected the relaxivity appears to have reached
a maximum in the range 1.5 T to 7.0 T.
Figure 3.10 plots transverse relaxivity, r∗ dHb2 , as a function of magnetic
field strength. The relationship between r∗ dHb2 and field is approximately
linear, but appears to depart slightly from linearity at ultra-high field. Fig-
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Figure 3.6: Longitudinal relaxation rate, R1, of human blood plotted as a
function of Gadolinium concentration in mM.
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ure 3.11 shows a linear relationship between r∗ Gd2 and magnetic field strength.
In both cases this linearity suggests that susceptibility effects are still con-
tributing in a linear manner. Hence Curie’s law may still hold.
3.5 Simulation
As a consequence of the anomalous result recorded in the contrast agent ex-
periments (figure 3.7) a description of the theoretical mechanism was sought.
It is suggested that the origin of this effect is the inhomogeneous distribu-
tion of paramagnetic species in the blood. In terms of magnetic properties,
whole blood can be separated into two main components. Red blood cells
account for between 38 % and 54 % of blood volume. These cells incorporate
molecules of haemoglobin which contain iron. The magnetic state of these
molecules is dependent on their oxygenation. Oxygenated haemoglobin, or
oxyhaemoglobin, is diamagnetic and deoxygenated haemoglobin, or deoxy-
haemoglobin, is paramagnetic. Diamagnetic plasma makes up the majority
of the remaining blood volume, as white blood cells and platelets make up
less than 0.5 %. Microscopic magnetic field gradients are set up between
paramagnetic deoxyhaemoglobin containing red blood cells and diamagnetic
plasma. Water protons diffusing through these gradients are dephased, in-
creasing the relaxation rate R∗2. Contrast agents such as ProHance dissolve
in blood plasma. They cannot cross the intact blood brain barrier or pass
through the plasma membrane of red blood cells. Therefore the contrast
agent acts to increase the susceptibility of the plasma, reducing the suscept-
ibility difference between the red blood cells and the plasma. This results in a
reduction in the magnitude of the microscopic field gradients, reducing deph-
asing and reducing R∗2. When the susceptibility of the plasma matches that
of the deoxyhaemoglobin, magnetic field gradients are neutralised and an R∗2
minimum is observed. Increases in contrast agent concentration beyond this
point reverse the polarity of the microscopic magnetic field gradients and
the dephasing effects return. In order to investigate this hypothesis further
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a model of intravascular susceptibility was developed and combined with a
Monte Carlo simulation to simulate R∗2.
3.5.1 Susceptibility Model
A model of the susceptibility differences present in blood was produced in
order to test the hypothesis in the preceding section. In this context the
R∗2 null-point represents the point where the susceptibility difference, ∆χ,
between red blood cells and plasma is zero. For this to be the case, the
susceptibilities of the various diamagnetic and paramagnetic components of
blood would have to be delicately balanced. The components present in the
model are deoxyhaemoglobin, χdHb, oxyhaemoglobin, χHb, plasma, χplasma,
and contrast agent, χCA. These components represent the major components
of blood. The overall susceptibility is a sum of these components weighted by
several factors. The red blood cell compartment is weighted by the haemato-
crit (HCT ), with the plasma space making up the remainder. In the case of
haemoglobin, the susceptibility is dependent on the oxygenation state of the
cells. It is assumed that each red blood cell has the same oxygenation state,
i.e. the oxygen saturation, Y , in each cell is equal.
∆χ = HCT{(1−Y )χdHb+Y χHbO}−(1−HCT ){χplasma+χCA[CA]} (3.18)
Measurements of the susceptibility components were taken from the work of
Spees et al. [103]. In this work SQUID magnetometry was used to measure all
four components, using pure water as a reference standard. The experiment-
ally measured Y and HCT values of 0.66±0.05 and 0.43±0.02, respectively,
were used. In common with the experiment the contrast agent concentration
was varied between 0 mM to 3 mM. The resulting susceptibility difference
ranged from +2.39× 10−8 to −4.42× 10−8 (cgs). Figure 3.12 plots the abso-
lute value of ∆χ versus contrast agent concentration. The R∗2 null-point of
figure 3.7 falls within the range of the susceptibility model null-point.
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Component Variable χ (SI) ∆χb (cgs)
Deoxyhaemoglobin χdHb −0.483 ppm +1.814× 10−7
Oxyhaemeoglobin χHbO −0.749 ppm −0.275× 10−7
Plasma χplasma −0.714 ppm 0
Gadolinium χGd +11.55 ppm
a +0.193× 10−7 mM−1
Table 3.4: The components of the blood susceptibility model and their re-
spective susceptibility values [103]. All values are dimensionless unless oth-
erwise stated. aVolume susceptibility of a 0.5 M Gadolinium based contrast
agent Omniscan. b∆χ calculated relative to plasma.
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Figure 3.12: Blood susceptibility model as a function of contrast agent con-
centration, from 0 to 3 mM. The solid line represents the effect of the mean
oxygenation and haematocrit (Y = 0.66, HCT = 0.43). Dashed lines reflect
the maximum range of the oxygenation and haematocrit standard errors, i.e.
(Y = 0.62, HCT = 0.45)→ (Y = 0.71, HCT = 0.41).
3.5.2 Monte Carlo Simulation
Monte Carlo simulations followed the method of Weisskoff et al. [104]. The
MR signal was calculated from the expectation value of the proton phase.
S = 〈eiφ〉 (3.19)
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The expectation value was calculated over both the starting position of the
proton and the random path taken due to diffusion. Therefore this expecta-
tion can be separated into two parts.
S(t) =
1
V
∫
v
dx︸ ︷︷ ︸
Starting Position
∫
dφp(φ, t;x)eiφ︸ ︷︷ ︸
Random Path
(3.20)
Here p(φ, t;x) represents the probability of a proton, starting at position x,
acquiring a phase φ in time t. In the method of Weisskoff et al. the integrals
of equation 3.20 are combined to produce,
S(t) =
1
N
N∑
n=1
eiφn(t) (3.21)
where N represents the total number of proton random walks and φn(t) is
the accumulated phase of the nth proton at time t. Monte Carlo estimation is
used to calculate the expectation value over different starting positions and
the stochastic random walk of the protons.
For the purposes of this simulation it is assumed that red blood cells can
be described as spheres with a radius R. It is also assumed that the vast
majority of measured signal is derived from water protons diffusing through
plasma. Free water within the red blood cells is severely constrained and
subject to large field perturbations in deoxygenated cells. Therefore only
extracellular protons were simulated and red blood cells were considered to
be impermeable. The simulation consisted of a loop of the following 4 steps;
1. Randomly distribute M red blood cells throughout space to give a
volume fraction equal to the blood haematocrit (HCT = Vspheres/Vtotal).
Set the susceptibility difference between the red blood cells and plasma
to a nominal value, i.e. 1 × 10−7. Place a single proton at the centre
of the system.
2. For every time step, ∆t, displace the proton by a random amount in
the x, y and z dimensions. Estimate displacement by using a nor-
mally distributed random number generator with mean 0 and standard
deviation
√
2D∆t, where D is the diffusion coefficient.
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3. Evaluate the magnetic field at this new location by summing over the
field contributions for all perturbers.
4. Evaluate the accumulated phase by trapezoidal integration, ∆φ =
γB∆t.
For each proton, steps 2-4 were repeated, recording the evolution of phase,
∆φ, in 5 ms steps. Steps 1-4 were repeated for a proton count, N , of 10,000.
Phase increments were stored for 5 ms blocks. This allowed the simulation
of both Hahn spin echo and gradient echo pulse sequences. For a spin echo
sequence the phase of a given TE was calculated by inverting the phase value
beyond TE/2 prior to summation e.g. ΦSE20 = φ5+ φ10− φ15− φ20. Similarly
for a gradient echo measurement the phase at a given TE is the sum of the
preceding phase measurements e.g. ΦGE20 = φ5 + φ10 + φ15 + φ20. The signal
was then estimated using equation 3.21. A simulated R∗2 value can then be
calculated by fitting a mono-exponential decay to this data.
The slowest stage of the simulation was the random distribution of red
blood cells (step 1). In the work of Weisskoff et al. the volume fraction of
particles was chosen to be 0.02. However in order to simulate a realistic
haematocrit (HCT) the volume fraction must be between 0.30 and 0.50. A
cube with sides of 100 µm and HCT=0.40 requires the placement of almost
1500 spheres, with a radius of 4 µm. Initial experiments showed that for
HCT≤0.40 placement of red blood cells using the following method was feas-
ible;
1. Generate the x, y and z co-ordinates of the red blood cell centre using
a uniformly distributed random number generator.
2. Check that the distance between this newly generated red blood cell
and existing red blood cells is greater than 2R. If this distance is less
than 2R, discard new co-ordinates and return to step 1.
Steps 1 and 2 were repeated M times to produce M randomly distributed
spheres. However for HCT>0.40 this method was unfeasible due to the less
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than optimal packing of the spheres. In order to simulate a physiological
range of HCT values a different distribution method was required. This new
method shares some of its attributes of the simulated annealing technique
described in chapter 5. All M red blood cells are initially generated with
disregard for overlapping of adjacent spheres. Overlaps are then removed by
randomly perturbing one red blood cell and testing whether it improves the
minimum spacing between that sphere and the remaining spheres. In more
detail this method processes through the following steps;
1. Generate the x, y and z co-ordinates of M red blood cell centres using
a uniformly distributed random number generator.
2. Randomly select one red blood cell using a uniformly distributed ran-
dom number generator. Calculate the minimum distance between this
sphere and the other M − 1 spheres.
3. Perturb the co-ordinates of this sphere in the x, y and z dimensions
by adding a small value generated by a normally distributed random
number generator.
4. Re-calculate the minimum distance between this sphere and the other
M − 1 spheres. If the minimum distance is increased then retain this
new configuration, otherwise discard this solution.
These steps were repeated until no overlaps between adjacent spheres exist.
Unlike the first distribution method this algorithm allows higher HCT values
of between 40 % and 50 % to be achieved.
The field perturbation resulting from each spherical particle [104] has the
following form,
∆Bz(r, θ)
B0
=
4π
3
∆χ
(
R
r
)3
(3 cos2 θ − 1) (3.22)
where r and θ are the usual spherical co-ordinates and R is the radius of
the particle. In order to simulate R∗2 as a function of field strength and
susceptibility only a single simulation is required for each HCT and R value.
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The magnetic field, ∆Btotz , at the protons current location is a sum of the
contributions from each of the red blood cells.
∆Btotz (ri, θi) =
4π
3
∆χB0
M∑
i=1
(
R
ri
)3
(3 cos2 θi − 1) (3.23)
Hence the total magnetic field, B = B0 +∆B
tot
z ,
∆φ = γB0∆t+ γ∆B
tot
z ∆t (3.24)
and therefore ∆φ is a sum of a constant magnetic field component and a
time-dependent component, which differs for each proton due to the differ-
ent random paths they follow. The additional phase shift due to the main
magnetic field, γB0∆t, can be neglected during the Monte Carlo simulation
and its effect added in post-processing. Similarly the nominal susceptibility,
added in step 2 of the Monte Carlo simulation, can be divided out and any
value multiplied in. Equation 3.24 reduces simulation time greatly and allows
a much larger range of susceptibility values, and all three field strengths, to
be simulated. Susceptibility values were calculated using equation 3.18.
3.5.3 Method
Following optimisation of the Monte Carlo simulation parameters (see below),
the effect of varying haematocrit and sphere radius on the simulated value of
R∗2 could then be determined. Male haematocrit values vary between 0.40 and
0.54 (mean 0.47), whilst females have a range of 0.38 to 0.46 (mean 0.42) [46].
For the purposes of simulation a haematocrit range between 0.30 and 0.50,
in steps of 0.05 was chosen. The dependence of R∗2 on sphere radius was also
investigated due to the significant difference in shape between a sphere and
the biconcave disc form of a red blood cell. The average radius of a human
red blood cell is ∼4 µm. Hence a range of R values were chosen between
3 µm and 5 µm, in steps of 0.5 µm. Simulations were performed on a 10
node HPC cluster. Each node consisted of two dual-core AMD Opteron 2.0
GHz processors and 8 Gb of RAM. Jobs were submitted in batches of 250
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protons to a Sun Grid Engine queuing system, allowing 10,000 protons to
be simulated simultaneously by utilising the entire cluster. With an average
utilisation of 90 %, these simulations were performed over the course of two
weeks.
These results were used to select an appropriate sphere radius and haemato-
crit. It was difficult to select a sphere radius that would adequately approx-
imate a biconcave disc. It has previously been shown that the magnetic field
distribution of a biconcave disc is very different to that of a sphere [105].
Hence a sphere radius was chosen such that its volume matched that of
an average red blood cell. Using the measurements described by Gilles et
al. [105] the volume of an average red blood cell was calculated. It was found
that an equivalent sphere would have a radius of ∼3 µm. The haematocrit
was chosen to approximate that measured in the preceding experiments as
HCT = 0.40.
Optimisation
The simulated space was chosen to be a 100 µm × 100 µm × 100 µm cube.
The diffusion coefficient, D, of the protons was set at 1.3 µm2ms−1 [104] to
represent diffusion in blood plasma. Therefore the maximum displacement of
the proton following the maximum TE of 80 ms is 14.4 µm. A large maximum
displacement may cause the protons to experience edge effects, whereby the
contribution from distant particles is reduced due to the absence of spheres
beyond the simulated universe dimensions. In practice the maximum dis-
placement of the proton with respect to the universe centre will be much
smaller. The high density of impermeable spheres used in this experiment
reduces the mobility of the protons, reducing the chances of them travelling
in a straight line for 80 ms.
Echo times between 5 ms and 80 ms were recorded, in steps of 5 ms.
Each 5 ms echo time was further subdivided into smaller steps, allowing the
proton to more accurately sample the magnetic field gradients. In order to
investigate the optimum step size for this operation a number of step sizes
CHAPTER 3. BLOOD RELAXOMETRY 100
were evaluated, see table 3.5. A set of 50,000 red blood cell distributions
were produced and reused for each step size. By simulating a large number
of protons the accuracy of the result could be improved, and by reusing the
same red blood cell distributions the time burden of this accuracy could be
reduced. By summing the resulting phase measurements in blocks of 10,000
it was possible to calculate 5 separate measurements of R∗2. This allowed a
calculation of the standard error in these results to be determined from the
standard deviation of this data. Table 3.5 summarises the step sizes evalu-
ated and the mean and standard error of the R∗2 measurements. Figure 3.13
plots the R∗2 value versus the step size, given a sphere radius of 4 µm and
∆χ = 1 × 10−6. The value of R∗2 appears to plateau beyond 0.003125 ms,
equivalent to 1600 steps per TE. Selecting the appropriate step size is a com-
promise between accuracy and computational speed, therefore an experiment
was performed to assess the duration of a single proton simulation. This in-
cluded the distribution of the red blood cells as well as the random walk of
the proton. A comparison was made between the simulations perceived to
be the fastest and slowest, which consisted of HCT values of 0.30 and 0.50,
respectively, with a sphere radius of 4 µm. Ten protons were simulated for
each step size and the mean and standard error of the simulation duration
calculated. These results are plotted in figure 3.14 and show that the distri-
bution of the red blood cells dominates the simulation duration. It was also
important to determine how many protons had to be simulated in order to
produce an accurate result. Using the data from the step size investigation
(HCT=0.40) it was possible to calculate R∗2 and the error in this value for
proton counts varying between 1,000 and 50,000. In this investigation ten
simulated measurements were performed and the mean and standard error
plotted in figure 3.15.
From these investigations a step size of 0.00078125 ms was chosen. The
position of this step size on the plateau of figure 3.13 suggests that it is ad-
equately sampling the magnetic field gradients of the spherical perturbers. As
shown by figure 3.14 this does not add significantly to the overall processing
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time. A proton count of 10,000 was chosen with reference to figure 3.15. This
value was the minimum requirement to ensure acceptable results.
3.5.4 Results
The results of the Monte Carlo simulation provide an interesting insight into
the intravascular component of the MR signal. The manifestations of this
component will only be visible when imaging the macrovasculature. Fig-
ure 3.16 shows the relationship between haematocrit and R∗2 for a nominal
susceptibility, ∆χ = 1 × 10−7. This result shows that this dependency is
relatively weak. There is only a 15 % reduction in R∗2 for a 60 % reduction
in haematocrit. Hence the value of R∗2 is only slightly effected by the density
of the particles present. This is not the case at lower packing fractions (data
not shown), as R∗2 → 0 when HCT → 0
Figure 3.17 considers R∗2 as a function of sphere radius. A much larger
effect is observed here. A reduction in sphere radius by 60 % yields a decrease
in R∗2 of 60 %. A plateau in R
∗
2 is not observed until the sphere radius
surpasses 30 µm (data not shown). Hence the choice of sphere radius is very
important. However a sphere is only a first approximation of a biconcave
disc, as was previously noted. It is difficult to predict the effect of a more
realistic field pattern, although it is likely that R∗2 would increase due to
steeper and less spatially smooth magnetic field gradients.
By substituting the susceptibility model values (from equation 3.18) into
a Monte Carlo simulation with HCT = 0.4 and R = 3 µm it was possible to
calculate the effect of a contrast agent. Susceptibility values were calculated
assuming a blood oxygen saturation of Y = 0.633 and a contrast agent
concentration between 0.1 mM and 3 mM. This gave a susceptibility range
of +1.87× 10−8 cgs to −3.91× 10−8 cgs. Figure 3.18 plots this dependence
at field strengths of 1.5 T, 3.0 T and 7.0 T. The error bars represent the
standard error calculated from 10 simulations of R∗2. Of note is the prediction
of a quadratic dependence of R∗2 on contrast agent concentrations. This
function was used to empirically model the experimental data in figure 3.7,
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Step Size (ms) Number R∗2 × 10−3
of Steps Mean S.E.
0.2 25 7.16 0.05
0.1 50 7.24 0.03
0.05 100 7.35 0.07
0.025 200 7.39 0.01
0.0125 400 7.49 0.04
0.00625 800 7.59 0.08
0.003125 1600 7.72 0.05
0.0015625 3200 7.74 0.06
0.00078125 6400 7.72 0.05
Table 3.5: Step size range investigated during the optimisation of the Monte
Carlo simulation.
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Figure 3.13: The effect of step size on calculated R∗2. A plateau is observed
at small step values. Sphere radius R = 4 µm, ∆χ = 1× 10−6.
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Figure 3.14: The effect of different step sizes on the time required to simulate
a single proton. Sphere radius R = 4 µm, ∆χ = 1× 10−6.
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Figure 3.15: The effect of total proton count on the measured value, and
error, of R∗2. Sphere radius R = 4 µm, ∆χ = 1× 10−6.
CHAPTER 3. BLOOD RELAXOMETRY 104
0
0.001
0.002
0.003
0.004
0.005
0.006
0.007
0.008
0.25 0.3 0.35 0.4 0.45 0.5 0.55
R
∗ 2
(m
s−
1
)
HCT
Figure 3.16: The relationship between R∗2 and blood haematocrit. Sphere
radius R = 4 µm, ∆χ = 1× 10−6.
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Figure 3.17: The relationship between R∗2 and sphere radius. ∆χ = 1×10−6.
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Figure 3.18: The effect of contrast agent on R∗2 as simulated using Monte
Carlo methods. Error bars represent the standard error in the simulation
of R∗2. Susceptibility values calculated using equation 3.18. Sphere radius
R = 3 µm, Y = 0.663, HCT = 0.4.
by performing a least squares fit.
Discrepancies between the simulated and experimental results are likely
to be due to deficiencies in the model. As noted above, one of the largest
sources of error is the approximation of red blood cell geometry to a sphere.
It is also assumed that all of the signal is extracellular, i.e. due to protons
in the plasma diffusing through magnetic field gradients. The spherical red
blood cells are considered to be impenetrable. This means that intracellular
signal is completely neglected and that exchange into, and out of, this space
is not possible. If protons were allowed to diffuse within impenetrable spheres
the signal contribution is likely to be negligible. However if these protons
were allowed to exchange, with the bulk, an increase in the relaxation rate
might be observed. In addition the model does not simulate dipole-dipole
relaxation, giving rise to R∗2 = 0 at ∆χ = 0.
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Figure 3.19: Range of 7.0 T simulation result given error in the measurement
of blood oxygenation. The solid and dashed lines represent the mean and
standard error range of Y , respectively. Susceptibility values calculated using
equation 3.18. Sphere radius R = 3 µm, Y = 0.615→ 0.711, HCT = 0.4.
Finally the expected range of the R∗2 curve was estimated based on the
measured range of blood oxygenations. The susceptibility was re-calculated
assuming a fixed haematocrit but with a variation of Y equal to the range
of the standard error in the measurement of the blood oxygenation (Y =
0.61 → 0.71). Figure 3.19 was calculated for a magnetic field of 7.0 T and
clearly shows the sensitivity of this result to blood oxygen saturation.
3.6 Discussion
In this study the R1 and R
∗
2 of whole human blood has been measured using
imaging techniques. This was achieved using small samples of blood and high
resolution imaging techniques at three different field strengths. These values
were then used to calculate the R1 and R
∗
2 relaxivities of deoxyhaemoglobin
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and contrast agent in blood. A measurement of contrast agent relaxivity,
r∗ Gd2 , and deoxyhaemoglobin relaxivity, r
∗ dHb
2 was of particular importance
to the modelling work of chapter 5 where the BOLD signal is split into intra-
and extravascular compartments. Whereas the extravascular compartment
is well modelled theoretically [85], the intravascular compartment has tradi-
tionally been described by empirical results [106].
It was found that R1 of blood is dependent on oxygenation for field
strengths greater than 1.5 T. The deoxyhaemoglobin relaxivity, rdhb1 , increases
with field strength, but appears to plateau for ultra high field clinical MRI
systems. Within the errors of this experiment the dependence of R1 on con-
trast agent concentration is independent of field strength, as is rGd1 . This is
as predicted by NMRD measurements [89, 94].
Measurements of R∗2 show a linear dependence on oxygenation, as would
be expected for the narrow range of oxygenation values measured [86]. The
deoxyhaemoglobin relaxivity, r∗ dHb2 , increases linearly as a function of mag-
netic field strength. It was expected that R∗2 as a function of contrast agent
concentration would follow a similar trend. However what was observed was a
quadratic dependence, with a minimum which was dependent on the oxygen-
ation of the blood. Data points preceding the minimum therefore represented
a negative relaxivity. This effect has previously been observed [107] in in vivo
relaxivity measurements of guinea pig kidneys. In this thesis it was hypothes-
ised that this effect was due to microscopic field gradients within the blood
formed by the inhomogenous distribution of susceptibility. The minimum
would then be due to a nulling of these magnetic field gradients. A similar
hypothesis was later found in the work of Mulkern et al. [108]. They per-
formed a similar experiment using dairy cream and a contrast agent, yielding
similar results. In this case they hypothesised that the inhomogenous distri-
bution of susceptibility was caused by lipid droplets in the cream.
Monte Carlo simulations were performed to test the magnetic field gradi-
ent hypothesis. The results of this simulation predicted a quadratic depend-
ence of R∗2 on contrast agent concentration. They also offered an insight into
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the factors affecting the intravascular MR signal. The dependence of R∗2 on
haematocrit was shown to be weak. This is consistent with the experimental
work of others [99]. These results also showed the weakness of the simplified
blood cell geometry chosen, as R∗2 was strongly dependent on sphere radius.
In addition the minimum was found to be very sensitive to oxygenation, as
was demonstrated by figure 3.19.
In future work the application of this technique to measuring blood oxy-
genation will be investigated. It is hoped this will allow measurements to be
performed clinically in vivo. This would be particularly useful, for example,
in the treatment of cancer. The blood oxygenation in the vessels surrounding
tumours is useful in diagnosing cancer types and treatment methods. How-
ever there are obstacles to overcome. The maximum licensed contrast agent
dose is a 0.3 mM kg−1. A rapid infusion of this amount would only give
a plasma concentration of 1.4 mM. A concentration range between 0 and 3
mM is required to give a large enough dynamic range to measure the full
range of Y values. It may be possible to gain a larger susceptibility range
by using USPIO contrast agents. This could be tested through the use of
the Monte Carlo technique described here. There are many improvements
that could be made to the Monte Carlo simulation. In the first instance this
technique could be extended to the use of realistic red blood cell shaped per-
turbers. It would also be interesting to model the dipole-dipole contribution
to relaxation. Processing such models would require a substantial increase in
computational power. Fortunately the University has invested in a 1000 node
AMD Opteron cluster, which would allow such a simulation to be performed.
Chapter 4
Cerebral Blood Volume Change
During Neural Activation
4.1 Introduction
The aim of this study was to investigate the time-course of cerebral blood
volume (CBV) change following a short visual stimulus. This was achieved
by measuring the change in R∗2 on activation during an infusion of a paramag-
netic contrast agent (ProHance [100]). Previous work [95] at the SPMMRC
produced measurements of the fractional change in CBV during a 12 s block
stimulus paradigm with a 2 s temporal resolution. This work was itself
preceded by similar animal [109] and human [110] studies involving SPIO
contrast agents.
To further improve understanding of the BOLD effect this work [95] has
been extended to a temporal resolution of 300 ms and an event related stim-
ulus paradigm. A 16 minute triple dose of contrast agent was infused whilst
multi-echo EPI images were acquired. Neuronal activation of the visual cor-
tex was stimulated through the use of red LED goggles flashing at a frequency
of 8Hz. This chapter describes the theory and methodology used to measure
fractional CBV change in human visual cortex.
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4.2 Theory
The aim of this section is to introduce the underlying theory behind the
methods used later in this chapter. Section 4.2.1 describes how it is theor-
etically possible to measure the total blood volume change of the cerebral
vasculature during focal neural activation. This requires the use of an exo-
genous contrast agent, the use of which requires certain precautions to be
undertaken. Section 4.2.2 describes the potential risks and details additional
exclusion criteria used during subject selection. Finally the theoretical phar-
acokinetics of the contrast agent used in this study (ProHance) are described
in section 4.2.3.
4.2.1 Fractional Cerebral Blood Volume Change
Assuming, as Kennan et al. [109] suggest, that the transverse relaxation rate,
R∗2, is a function of the susceptibility difference, χ, between blood and tissue
and the tissue blood volume, V , then:
R∗2 = κV χ+ c (4.1)
where κ is a proportionality constant dependent on vascular geometry and c
is a constant dependent upon field homogeneity, other sources of dephasing
and T2. Recent research [111] suggests that CBV change during neuronal ac-
tivation occurs not only in venous vessels, but also in the arterial vasculature,
and therefore equation 4.1 can be reformulated to reflect this.
R∗2 = κvVvχv + κaVaχa + c (4.2)
The cerebral vasculature is modelled as two compartments; arterial and ven-
ous. In equation 4.2, κv and κa represent the effect of tissue morphology
on local field perturbations, Vv and Va represent venous and arterial blood
volume, and χv and χa the susceptibility difference between venous and ar-
terial blood, respectively, and the surrounding tissue.
During neural activation BOLD contrast occurs due to a change in local
CBV, ∆V , and blood susceptibilty, ∆χ. Susceptibility change is brought
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about by increased venous oxygenation, which reduces the amount of para-
magnetic deoxyhaemoglobin in the blood. By performing a two-dimensional
Taylor expansion the following equation is produced.
∆R∗ act2 = κv(∆Vvχv + Vv∆χv +∆Vv∆χv)
+κa(∆Vaχa + Va∆χa +∆Va∆χa) (4.3)
It is assumed that arterial blood is nearly fully oxygenated (χa = 0), that
its oxygenation will not change during activation (∆χa = 0) and that all
contrast is endogenous (i.e. due to increased venous oxygenation). Therefore
∆R∗ act2 will be determined by the negative ∆χv terms. With the addition of
an exogenous paramagnetic contrast agent to the vascular space the change
in R∗2 during neuronal activation becomes,
∆R∗ act2 agent = κv(∆Vv(χv+χagent)+(Vv+∆Vv)∆χv)+κa∆Va(χa+χagent) (4.4)
where χagent represents the susceptibility difference between the contrast
agent and surrounding tissue. This additional susceptibility contribution is
opposite in sign to ∆χv. The change in ∆R
∗act
2 due to the presence of contrast
agent can be calculated by considering the difference between equations 4.3
and 4.4;
δ(∆R∗ act2 )agent = (κv∆Vv + κa∆Va)χagent (4.5)
Likewise the difference between the resting value of R∗2 and its value in the
presence of contrast agent is given by,
δ(R∗ rest2 )agent = (κvVv + κaVa)χagent (4.6)
With the final assumption that the blood vessels within an imaging voxel
are uniformly and randomly distributed (κv = κa) it is possible to combine
equations 4.5 and 4.6 to yield the following,
δ(∆R∗ act2 )agent
δ(R∗ rest2 )agent
=
∆Vtot
Vtot
(4.7)
where ∆Vtot = ∆Vv + ∆Va and Vtot = Vv + Va. Therefore by varying the
contrast agent concentration whilst stimulating neuronal activation the frac-
tional change in total CBV (i.e. venous and arterial) can be measured. This
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is achieved by slowly infusing a contrast agent whilst performing multiple
cycles of a stimulus paradigm. The gradients of plots of ∆R∗ act2 agent and
R∗ rest2 agent versus contrast agent concentration can then be used to calculate
fractional CBV change (∆CBV) using equation 4.7.
In theory it is also possible to measure blood oxygen saturation, Y , using
this technique. At the point where the susceptibility change, due to oxygen-
ation, change is balanced out by the susceptibility due to the contrast agent,
∆R∗ act2 = 0. The contrast agent susceptibility at this point is known as
χnullagent. It is then possible to rearrange equation 4.4 to calculate the change
in venous susceptibility, ∆χv, again assuming κv = κa.
∆χv = −
∆Vv(χv + χ
null
agent) + ∆Va(χa + χ
null
agent)
Vv +∆Vv
(4.8)
In previous experiments of this type it has been assumed that ∆Va is zero,
and so ∆Vv = ∆Vtot. Under this assumption the derivation can be simplified,
∆χv = −
(χv + χ
null
agent)∆Vv
Vv +∆Vv
= −χv + χ
null
agent
fvVtot
∆Vtot
+ 1
(4.9)
where fv = Vv/Vtot, the venous blood volume fraction. Using the known
molar magnetic susceptibility of ProHance it would then be possible to cal-
culate ∆χv. From this information it is then possible to calculate Y using a
simple model of blood susceptibility. In this model it is assumed that oxy-
genated blood has the same susceptibility as tissue [48] and hence only the
susceptibility of deoxygenated blood, relative to tissue, is required.
χblood = HCT (1− Y )χdHb (4.10)
Technically it is only possible to calculate the HCT (1− Y ) product without
further assumptions about the haematocrit (HCT ) in the activated voxel.
The haematocrit of venous blood can be measured ex vivo. However it is
known that blood within the capillary bed has a reduced HCT due to the
narrow dimensions of the vessels. Therefore blood drawn from large venous
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veins will exhibit a higher haematocrit than would be observed for capillary
blood, which in practice is unobtainable.
Experimental evidence suggests that the arterial volume does change dur-
ing activation. Pears et al. [95] showed that equation 4.9 is particularly sens-
itive to the estimation of venous blood volume fraction. In their simulations
they suggested that a 20 % error in the estimation of fv would lead to a 15 %
error in ∆Y . To correct this error they developed a varying arterial volume
model from equation 4.8.
∆χv = −∆Vtot
Vtot
Vtot
∆Vv
(
1
Vv
∆Vv
+ 1
)(
χv + χ
null
agent
)
−∆Va
∆Vv
(
χa − χv
Vv
∆Vv
+ 1
)
(4.11)
To calculate ∆χv using the varying arterial volume model, the relative pro-
portion of venous and arterial blood volume must be known during rest
and activation. When the study presented in this chapter was performed,
measuring arterial CBV change was not possible, therefore Y could not be
estimated.
4.2.2 Contrast Agents
During this experiment a paramagnetic contrast agent was infused in order
to alter the characteristics of the haemodynamic response. Most clinical MR
contrast agents are based on Gadolinium, which has the largest number of
unpaired electrons in the periodic table. In a review paper by Caravan et
al. [88] the relative merits of two other lanthanide metals are discussed. They
are Dysprosium and Holmium which have larger magnetic moments due to
orbital contributions to electron angular momentum. However due to the
asymmetric nature of these states this leads to a very rapid electron relaxa-
tion time. Gadolinium(III) has a more stable symmetric S-state producing
a much slower relaxation rate.
There are several Gadolinium-based agents approved for human use. The
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Figure 4.1: Gadoteridol structural formula [100].
most commonly encountered are gadopentetate dimeglumine, gadoversetam-
ide, gadodiamide and gadoteridol (ProHance). Gadoteridol was considered
to be the safest contrast agent and it was used throughout these experiments.
The reasons for this decision are discussed in the following paragraphs.
The two main issues regarding contrast agent safety are toxicity and os-
molality. When using power injectors a third problem, extravasation, may be
encountered. Gadolinium is toxic in its ionic form, as well as being relatively
insoluble at neutral pH values. Therefore it is commonly administered in a
chelated form. Figure 4.1 shows the structural formula of gadoteridol. The
ligand protects the body from the toxic Gadolinium ion within. However the
free ligand can be similarly toxic. Dissociation of the complex could occur in
several ways, via equilibration of the solution or a lack of chemical inertness.
Dissociation through the former process would occur if the Gadolinium ions
became substituted by endogenous metals or anions. To test this Wedeking
et al. (see Caravan et al. [88]) studied bone deposition of Gadolinium in mice
by the addition of radioactive isotopes, such as Gd-153 or Gd-159. Their
results show that the percentage of the initial dose of gadoteridol deposited
in bone was so small as to be undetectable (Table 4.1). The second method
of dissociation would occur if the chelate could be broken down chemically.
Caravan et al. [88] state that “...an accumulated body of literature has shown
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that macrocyclic complexes tend to be significantly more inert.” and that in
particular analogues of DOTA, such as that used in gadoteridol, are “...ex-
ceptionally inert as well as thermodynamically stable.”.
Table 4.1 notes the osmolality of the four most common agents. It is
notable that gadodiamide and gadoteridol have the lowest osmolalities and
were approved most recently. If an agent has an osmolality greater than that
of blood, the osmolar pressure difference between the blood and the cells will
cause an outflow of water from the cells. This will cause cell shrinkage and can
ultimately result in cell death. Agents that act in this way are hypertonic.
To compare how hypertonic each agent is, the ratio of the osmolalities of
plasma (285 mOsmol/kg) and contrast agent can be calculated. At 2.2 times
the osmolality of plasma gadoteridol is the lowest.
Finally the effect of extravasation was considered. Extravasation occurs
when an agent is accidentally injected into tissue rather than into a venous
vessel. It is thought that this is a greater problem when contrast agents
are infused using power injectors, such as in this experiment. Runge et
al. [112] studied the effects of extravasation of the same four contrast agents
as discussed above. The study involved injecting 0.3 mL of each contrast
agent into the hind limb of mice. After 48 hours the tissue was graded
for necrosis, edema and inflammation. At all times the investigators were
blinded to the identity of the contrast agent used in each mouse. The results
show that gadoteridol causes the least tissue damage, and are summarised
in table 4.2.
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Brand Generic Chemical % Initial Osmolalityb
Name Name Name Dosea
Magnevist Gadopentetate dimeglumine [Gd(DTPA)(H2O)]
2− 0.005 1960
Optimark Gadoversetamide [Gd(DTPA-BMEA)(H2O)] –
c 1110
Omniscan Gadodiamide [Gd(DTPA-BMA)(H2O)] 0.03 789
ProHance Gadoteridol [Gd(HP-DO3A)(H2O)] NDR
d 630
Table 4.1: Currently approved Gadolinium Chelates. aEstimated mean percentage of initial dose/g in femur at 14
days [88]. bmOsmol/kg at 37◦C [112]. cData unavailable. dNo detectable radiation.
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Commercial Name Necrosis Edema Inflammation
Magnevist 1.3 0.3 1.6
Optimark 0.7 0.3 0.9
Omniscan 0.3 0.1 0.7
ProHance 0.1 0.1 0.7
Table 4.2: Tissue histopathology results of extravastion at 48 hours [112].
Average rank scores (Higher score indicates more severe tissue damage).
The main acute side effect of these agents is a small risk of anaphylaxis.
Anaphylaxis is characterised by respiratory, cardiovascular, or cutaneous re-
actions. In most previously examined cases of anaphylaxis due to contrast
agent injection, the patient has had a history of respiratory difficulty or an
allergic respiratory problem, such as asthma. There are a large range of
anaphylactoid responses with acute reactions being relatively rare. The ex-
act rate of occurrence of these reactions is difficult to determine but it has
been suggested [113] to be between 1:100,000 and 1:500,000 of the whole
population.
As a result of these investigations a number of exclusion criteria were
used when selecting volunteer subjects, see table 4.3.
4.2.3 Pharmacokinetic Model
The work of McLachlan et al. [114] shows that the pharmacokinetics of Pro-
Hance are accurately modelled by an open two compartment model with
renal clearance. Compartment 1 represents the vascular space, in essence
the entire blood plasma volume, and compartment 2 the extracellular fluid
space (e.g. tissue, muscle, etc.), see figure 4.2. This approach [115, 116] was
applied in order to theoretically model the infusion and renal clearance phases
of the experiment. The rate of change of the amount of contrast agent, A,
within a compartment can be modelled by the following differential equation.
dA
dt
= −kA (4.12)
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Criteria Reason
Known hypersensitivity to any MR or Risk of anaphylaxis
X-ray contrast agent
A history of allergies Risk of anaphylaxis
Any history of renal failure Clearance
Any history of circulation problems Extravasation
(Vascular disease)
Pregnancy or breast feeding Crosses placenta
A history of diabetes Extravasation
Table 4.3: Exclusion criteria for subject recruitment
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Figure 4.2: Open two compartment pharmacokinetic model.
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The variable k represents a first order rate constant describing the clearance
from the compartment. Consequently the following differential equations
describe the changing amounts of contrast agent in each of the compartments,
plus the amount excreted via the kidneys.
dA1
dt
= k0 + k21A2 − k12A1 − k10A1 (4.13)
dA2
dt
= k21A2 − k12A1 (4.14)
dAu
dt
= k10A1 (4.15)
Rate constants k12 and k21 characterise the movement of contrast agent
between compartments and k10 is the rate of renal elimination from the sys-
tem. Input into the system is denoted by a zeroth order rate constant, k0,
for intravascular injection. These rate constants are usually referred to as
the microscopic rate constants. However the microscopic rate constants are
not experimentally measurable. In practice the rate at which the agent is
distributed, α, throughout the body and its elimination, β, from the body
are measured. They are known as the hybrid rate constants.
α+ β = k12 + k21 + k10 (4.16)
αβ = k21k10 (4.17)
If it is assumed that ProHance is a freely diffusable tracer then k12 is equal to
k21. Rearranging equations 4.16 and 4.17 gives equation 4.18 and its solution,
equation 4.19.
k210 − (α+ β)k10 + 2αβ = 0 (4.18)
k10 =
(α+ β)±√(α+ β)2 − 4 · 2αβ
2
(4.19)
McLachlan et al. obtained values for the distribution and elimination half-
lives of (0.20 ± 0.04) hours and (1.57 ± 0.08) hours, respectively. The dis-
tribution and elimination half-lives are converted to rate constants using the
following relationship.
k =
ln 2
t 1
2
(4.20)
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In addition, the rate constants α and β are converted into units of minutes
and are presented in table 4.4, alongside the solutions of equation 4.19.
Equations 4.13 to 4.15 were solved numerically in MATLAB to produce
time-courses of the amount of contrast agent present in the plasma, tissue
and urinary compartments. The infusion rate k0 is normally expressed in
units of mL min−1. However by expressing k0 in units of moles min
−1 kg−1 it
is possible to use equation 4.21 to calculate the plasma concentration, Cp, of
contrast agent. A triple dose (0.6 mL kg−1 or 0.3 mmol kg−1) of ProHance
infused over 16 minutes gives a k0 value of 1.875× 10−5 moles min−1 kg−1.
Cp =
A1
Vd
(4.21)
The volume of distribution, Vd, is defined as the volume in which the amount
of contrast agent would need to be distributed to produce the observed
plasma concentration. This does not necessarily reflect the true plasma
volume and for ProHance it has been measured as (204± 58) mL kg−1. The
right hand y-axis of figure 4.3 displays the plasma concentration of ProHance
in units of mM.
4.3 Method
Ethical approval for this study was obtained from the University of Notting-
ham Medical School Ethics Committee in September 2003. The experimental
paradigm of the study is described in section 4.3.1. This section is followed by
details of the method used to determine in vivo contrast agent concentration
and a description of the image analysis used.
4.3.1 Imaging
Imaging was performed on the 3.0 T EPI scanner which was purpose built
at the SPMMRC in the early 1990’s. Excitation was via a TEM volume
coil and reception by means of an occipital surface coil [117] located beneath
the subject’s head. Two images were acquired after a single excitation using
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Rate Constant Solution 1 Solution 2
α 0.0578
β 0.0073
k10 0.0471 0.0181
k12 0.0090 0.0235
k21 0.0090 0.0235
Table 4.4: Distribution and elimination rate constant solutions for a com-
partmental model of Gadoteridol pharmacokinetics (min−1)
0
5e-05
0.0001
0.00015
0.0002
0.00025
0 10 20 30 40 50 60
0
0.2
0.4
0.6
0.8
1
1.2
A
m
ou
n
t
(m
ol
es
k
g
−
1
)
C
p
(m
M
)
Time (minutes)
Plasma
Tissue
Urine
Figure 4.3: Numerical solution to equations 4.13 to 4.15 during a 16 minute
infusion of a triple dose of ProHance (starting at 4 minutes, ending at 20
minutes). The rate constants used are listed in table 4.4 (Solution 1) and
the right hand y−axis displays the plasma concentration in mM.
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Regime 1 Regime 2
Echo Times 27 ms, 52 ms 23 ms, 41 ms
Switch Frequency 1.38 kHz 1.90 kHz
Resolution 4 × 3 × 4 mm 3 × 3 × 4 mm
Table 4.5: Parameters used in scanning regimes.
a multi-echo EPI sequence, and a matrix size of 64 × 64. The cartesian
MBEST [17] technique was used to encode EPI images. Initially echo times
of 27 ms and 52 ms were used but were later superseded by shorter echo times
of 23 ms and 41 ms. The parameters used in each regime are summarised in
table 4.5. By increasing the switching frequency, shorter echo times could be
selected and an increase in SNR was achieved, particularly in the case of the
second echo. In turn this improved the estimation of R∗2. In both regimes
the volume repetition time was 300 ms. During scanning the RF power was
controlled such that the flip angle operated at the approximate value of the
Ernst angle.
Manual shimming was performed using a body shim set. A 16 slice single
echo image set was initially acquired. These images were used to locate the
three sagittal slices in the visual cortex to be used for the fMRI experiment.
Prior to the fMRI experiment a multi-slice inversion recovery sequence was
performed acquiring 5 slices per excitation at 10 different inversion times
between 100 ms and 3000 ms (volume repetition rate 4 s). This was achieved
by non-selectively inverting the whole volume and sampling each slice with a
slice-selective 90◦ pulse. This results in a spread of inversion times across the
slices, each slice being separated by the time taken to acquire the preceding
image. Additionally the same 5 slices were acquired at 4 different echo times
(∆TE = 25 ms or 18 ms), with a slice repetition rate of 2 s. This data was
used to create resting state maps of T1 and T
∗
2, respectively.
Intravenous cannulation of both of the subject’s forearms was performed
prior to positioning them within the scanner. Extension tubing was used to
connect the right arm cannula to two infusion pumps, located outside the
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magnet room. Parallel pumps were used to achieve sufficient flow rate to
infuse a triple dose of contrast agent over a period of 16 minutes. The left
hand cannula was used to sample the blood at a selection of time points (see
section 4.3.2). Additionally the subject was kept warm in order to retain
patency of the cannulas and their head immobilised in the volume coil with
foam padding to reduce motion.
The stimulus for the fMRI experiment was provided by a pair of red LED
goggles, flashing at 8 Hz. The paradigm consisted of 20 cycles, each cycle
comprising 4.8 s on and 55.2 s off periods. Each cycle of the paradigm
produced 200 volumes of three slice, double-echo data. In addition the ex-
periment was preceded by 20 volumes to allow a steady state condition to
be attained, yielding a total of 4020 volumes. Contrast agent infusion com-
menced 4 minutes after the start of the experiment and ended 16 minutes
later. During the visual stimulus paradigm, subjects were asked to press a
button following an audible cue in order to maintain alertness. This addi-
tional button-press paradigm was placed 30 s after the visual stimulation
had ended. By placing this stimulus at this time point it was hoped that
it would not interfere with the visual haemodynamic response. Any small
effect of the button-press would also have decayed prior to the onset of the
subsequent visual stimulus cycle. A second set of T1 and T
∗
2 maps were then
acquired, following the fMRI experiment.
4.3.2 Determination of Contrast Agent Concentration
In order to determine the blood contrast agent concentration in vivo a num-
ber of 4 mL blood samples were taken from the left hand cannula. In early
experiments time points spanned the length of the fMRI paradigm and in
later experiments time points were spread post-infusion, see table 4.6. This
allowed the pharmacokinetics of the infusion and clearance periods to be de-
termined. Blood samples were stored in 5 ml heparinised bottles and main-
tained at a temperature of 37 ◦C. Prior to the start of the fMRI experiment
a further seven 4 ml blood samples were taken and a measured volume of a
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Sample 1 2 3 4 5
Infusion 7 11 15 19 29
Post-Infusion 3 6 13 20 30
Table 4.6: Approximate blood sample time points in minutes after the start
of the fMRI experiment (Infusion) and after the end of the fMRI experiment
(Post-Infusion), respectively.
50 mM contrast agent solution added; 10 µl, 20 µl, 30 µl, 40 µl, 50 µl, 60
µl. At the conclusion of the fMRI experiments the scanner was re-configured
to slice coronally and both sets of blood samples were subjected to a single
slice inversion recovery sequence, at 42 separate inversion times, between 14
ms and 4012 ms, to cover the whole range of expected T1 values.
The samples containing added contrast agent were used to produce a T1
versus contrast agent concentration calibration curve. Blood oxygenation was
not measured and was assumed to change little during sample preparation.
Calibration curves from all subjects were combined and a linear regression
performed, figure 4.4a. In turn this was used to produce in vivo time-courses
of contrast agent concentration, figure 4.4b. The maximum blood concen-
tration of contrast agent was relatively consistent with the pharmacokinetic
model of section 4.2.3, given the errors in the hybrid rate constants, α and β.
To improve the model these constants would require measurement on a scale
of minutes, rather than hours. However the appreciable difference between
individuals means that accurate prediction is very difficult.
4.3.3 Image Analysis
Data from the fMRI experiment was treated with a number of post-processing
techniques prior to analysis. Processes that would have applied signific-
ant temporal smoothing to the data were avoided, to retain features of the
haemodynamic response that occur on short time scales. Similarly spatial
smoothing was also omitted. For each of the steps described below, in-house
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Figure 4.4: Contrast agent (CA) blood measurements: (a) R1 calibration
curve (n = 3), (b) example in vivo concentration curve. Infusion timing
designated by the filled red box.
software was used unless otherwise stated.
Initially complex time data was Fourier transformed to the image domain
and stored in the Analyze [74] format. Two separate files were created,
containing each of the echoes, and motion correction was performed on the
first echo data set in SPM2 [75]. The resulting motion transformations were
applied to the second echo data set using a custom batch script. Realigned
data was then used to create maps of T∗2.
Activation maps were created from first echo data in SPM2, using an
average in vivo contrast agent time-course as a regressor. This allowed the
confounding effect of a continually changing baseline to be approximately
corrected for, and therefore 20 stimulus cycles could be tested. Resultant
activation maps were thresholded to produce a cluster of 20 pixels. Region
of interest time-courses were then extracted from the T∗2 maps, using the
cluster as a mask. These time-courses were averaged to produce a single
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time-course. Subsequent analysis was performed in MATLAB to calculate
the fractional change in total CBV (∆Vtot/Vtot).
The extracted T∗2 time-course was converted to R
∗
2 and plotted versus
contrast agent concentration. Therefore R∗2 and ∆R
∗
2 can be found to be
a linear function of contrast agent concentration. Using equation 4.7 it is
possible to calculate ∆Vtot/Vtot from this plot. Firstly the 1
st time point of
each stimulus cycle was plotted as a function of contrast agent concentration.
The gradient of a linear fit to this data yields δ(R∗ rest2 )agent. Secondly the
difference between the 1st and nth time points of each cycle were calculated
and plotted versus contrast agent concentration. In this analysis the 1st time
point was chosen to represent a resting blood volume level. The nth time
point is a point for which a ∆CBV value is required. The gradient of a linear
fit to this data gives δ(∆R∗ act2 )agent. These values can then be substituted
into equation 4.7. The gradient and intercept, of the linear fits described
above, were calculated using a matrix inversion technique. The fitting error
of the gradient was then calculated in order to estimate the error in the
measured value of ∆Vtot/Vtot.
4.4 Results
BOLD activation was detected in the visual cortex across all subjects (see
figure 4.5). As the blood concentration of contrast agent increased a baseline
drift was observed, as expected (see figure 4.6a). It was also observed that the
peak amplitude of the BOLD response reduces with increasing concentration,
figure 4.6b. An interesting feature of this experimental data is the increase
in BOLD signal for the average of stimulus cycles 5-8, i.e. average contrast
agent concentration 0.11 mM. This increase in signal may be caused by the
infused contrast agent. At low concentrations the contrast agent can act to
reduce microscopic magnetic field gradients in the blood, therefore reducing
dephasing. For a more detailed discussion of this effect, see chapter 3.
Figure 4.7 shows an example of a fractional CBV (∆Vtot/Vtot) measure-
CHAPTER 4. CBV CHANGE DURING NEURONAL ACTIVATION 127
A
P
SI
Figure 4.5: Activated cluster of 20 pixel time-courses located in the visual
cortex determined using BOLD contrast. Base images were acquired in the
sagittal plane.
ment, as described in section 4.2.1. Using this technique the peak volume
change of each subject was calculated and these are summarised in table 4.7.
It is unclear whether the magnitude of the BOLD response is related to that
of the CBV change, figure 4.8. A 1st order fit to the data is statistically
insignificant giving a p-value of 0.18. Many more subjects and a wider range
of stimuli would be required to increase the statistical power. The fractional
change in CBV is calculated to have a mean value of 0.23±0.10. This agrees
well with previous work [95] where a mean value of 0.28±0.02 was calculated.
It is likely that the difference in results is due to the length of the stimulus.
In the previous work visual stimulus was applied for 12s, compared to 4.8 s
in this experiment. It is a commonly held belief that the venous vessels post-
capillary exhibit a visco-elastic ballooning effect. In this case a lower peak
volume change might be expected if the visco-elastic limit of this balloon has
not been reached.
Finally the same technique was applied to every time point, with respect
to the same resting reference, to produce a volume change time-course, fig-
ure 4.9. Figure 4.9 suggests that total volume change lags behind the BOLD
signal, particularly in the post-stimulus phase, and may not display a negat-
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Figure 4.6: Experimental results: (a) inter-subject average BOLD signal
(n = 5) and (b) baseline corrected data averaged as blocks of four cycles. A
single vertical black line denotes the timing of the button-press paradigm.
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Figure 4.7: R∗2 values extracted at peak and baseline of the haemodynamic
response, for each stimulus cycle (3205).
Subject ∆CBV ∆BOLD
3133 0.12±0.05 0.08±0.01
3204 0.27±0.16 0.10±0.01
3205 0.38±0.08 0.07±0.01
3259 0.22±0.10 0.04±0.01
3264 0.16±0.13 0.05±0.01
Mean 0.23±0.10 0.07±0.01
Table 4.7: Peak change in ∆CBV calculated at peak BOLD signal alongside
BOLD signal change, both as a fraction of their resting values.
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Figure 4.8: Peak ∆CBV versus peak ∆BOLD, from table 4.7, with a linear
regression to the data. Each data point represents an individual subject.
ive initial dip. The BOLD post-stimulus undershoot (15 - 45 s) appears to
continue beyond the point at which the volume returns to baseline, although
it is difficult to confirm this in a quantitative way. It has previously been
suggested [118] that the post-stimulus undershoot is due to a delayed com-
pliance of the venous vessels. If confirmed this result would suggest that this
is not the only cause of the post-stimulus undershoot.
4.5 Discussion
This study shows that it is possible to measure fractional CBV during an
event related stimulus. Furthermore it shows that it is possible to produce
high temporal resolution fractional CBV time-courses in humans.
This experimental methodology provides an interesting way of probing
the BOLD haemodynamic response and teasing out one of the underlying
contributors to the BOLD signal; volume change. This is due to the way
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Figure 4.9: Experimental inter-subject average of BOLD and CBV meas-
urements (n = 5). A single vertical black line denotes the timing of the
button-press paradigm.
that temporal characteristics of the response are differentially affected by
the contrast agent. Aspects of the response that are strongly dependent on
volume change will see the greatest decrease in signal intensity, and hence
increased R∗2. In a qualitative way comparing the different curves of fig-
ure 4.6b demonstrates the volume dependence of the major features of the
BOLD response. The BOLD overshoot signal intensity drops by a factor of
4 during the 16 minute infusion due to the contrast agent. This shows that
this feature has the greatest dependence on volume change. The other major
feature of the response is the post-stimulus undershoot, occurring between
15 seconds and 45 seconds (although possibly longer). Figure 4.6b suggests
this feature has only a limited dependence on volume change. Variation
in the magnitude of the signal could easily be explained by inter-stimulus
variability, which can be appreciable. As noted in section 4.4, convention-
ally the post-stimulus undershoot is thought to be the result of a delayed
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return to baseline of CBV relative to cerebral blood flow (CBF). However
there is increasing evidence to suggest this is not the case. Lu et al. [70]
measured CBF, CBV and BOLD and used this data to produce maps of
activity. They then extracted the time courses of voxels that were activated
in all three techniques. This enabled them to show that there were negli-
gible changes in CBF and CBV during the post-stimulus undershoot present
in the BOLD weighted time courses. This led them to the conclusion that
oxidative metabolism is sustained beyond the recovery of flow and volume
to baseline levels. In order to justify this conclusion they reference several
pieces of supporting evidence. Firstly in the work of Devor et al. [119] it is
suggested that their spectroscopic optical images show an increased concen-
tration of deoxyhaemoglobin following the return to baseline level of total
haemoglobin content. In this context the total haemoglobin content is the
corpuscular equivalent of CBV. However this change is quite small and in
their later work [120] deoxyhaemoglobin content appears to reduce in this
time period. Secondly, Thompson et al. [121] performed measurements of
pO2 and spiking activity using the orientation selective visual pathway. As
the optimal grating orientation of the neuron was approached, the spike rate
increased to a maximum. This was accompanied by an increase in the ex-
tent of both the initial dip and post-stimulus undershoot in pO2. Thirdly,
Ances et al. [122] performed simultaneous Laser Doppler Flowmetry and pO2
measurements. They showed a sustained tissue pO2 decrease following the
recovery of CBF.
Further evidence can be found in the literature. Toronov et al. [123] per-
formed simultaneous fMRI and Near Infrared Spectroscopy (NIRS) of the
motor cortex. They state that the lag between CBF and CBV change can-
not account for the post-stimulus undershoot and suggest that it is due to
an undershoot in CBF. This view is in disagreement with some of the work
described above [70, 122]. In the work of Schroeter et al. [71] simultaneous
fMRI and NIRS is also performed. However, this study concentrates specific-
ally on the origin of the post-stimulus undershoot. They conclude that the
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temporal characteristics of the deoxyhaemoglobin time course were highly
correlated with those of the BOLD response and that the contribution of a
delayed return to baseline of blood volume was ‘ambiguous’.
In summary, the results presented in this chapter lend added support to
the hypothesis that the post-stimulus undershoot is a feature of sustained
oxidative metabolism. These results are in general agreement with the liter-
ature surveyed above.
Future work will involve modelling this experiment through the Balloon
model [47]. This will allow an even greater insight into the underlying hae-
modynamic mechanisms to be gained. It will also help to test the response
of existing models to an event related paradigm. There is also much to be
gained by repeating this experiment. As was noted in section 4.2.1, by meas-
uring arterial CBV, in an additional experiment within the same session, it
will be possible to measure ∆χ, leading to in vivo measurements of blood
oxygen saturation. Since this study a newly developed technique has emerged
to measure arterial CBV [124], allowing the varying arterial volume model
to be utilised. This experiment could also be performed at 7.0 T yielding a
considerable increase in SNR. This will also allow total CBV change to be
measured with higher spatial resolution, allowing the spatial specificity of
the BOLD response to be probed.
Chapter 5
Modelling the BOLD Response
5.1 Introduction
Many theoretical models of the BOLD response have been proposed in recent
years. However little has been done to validate these models experimentally.
Therefore, the aim of the simulation work presented in this chapter is to test
models of the BOLD response against experimental data. As was noted in
chapter 4 the experimental paradigm, described therein, is an interesting way
to probe the underlying mechanisms of the BOLD response. In this work an
infusion protocol is simulated using the Balloon model proposed by Buxton
et al. [47]. A multi-component signal model is also developed in order to
account for susceptibility changes in the arterial vasculature.
5.2 State of the Art
In this section the current state of BOLD modelling is reviewed. The most
significant attempt at modelling the BOLD response, thus far, was contrib-
uted by Buxton et al. [47] in 1998 in the description of the balloon model.
This original work has been built upon to improve the predictive power of
the BOLD model. The balloon model is based on a set of assumptions; (1)
that there is no capillary recruitment, (2) volume change due to arteriolar
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dilation is negligible and (3) that all of the deoxyhaemoglobin in the vascu-
lature is present in the venule. In essence the BOLD response is presumed
to be entirely due to the venous vasculature.
Input to the system is provided by a flow function, Fin(t), mimicking
the effect of arteriolar dilation. In order to simplify the model the flow out,
Fout(V, t), of the venule is defined as a function of volume. Conventionally this
would be considered a function of the pressure into and out of the system, and
the vascular resistance. However Fout(V ) is defined such that the difference
between flow into and out of the system is equal to the change in volume of
the venule.
dV (t)
dt
= Fin(t)− Fout(V, t) (5.1)
Similarly by considering the amount of deoxyhaemoglobin, Q(t), entering
and leaving the system the change in deoxyhaemoglobin can be defined as,
dQ(t)
dt
= Fin(t)CaE(t)− Fout(V, t)Q(t)
V (t)
(5.2)
where Ca is the arterial oxygen concentration and E(t) is the oxygen ex-
traction fraction. The first term on the right hand side of this equation is
equivalent to the steady state definition of the cerebral rate of oxygen meta-
bolism (CMRO2).
CMRO2 = Fin(t)CaE(t) (5.3)
The variables in equations 5.1 and 5.2 can be normalised by their respect-
ive baseline values to aid simulation, and are signified as such by lowercase
letters.
dv(t)
dt
=
1
τMTT
[
fin(t)− fout(v, t)
]
(5.4)
dq(t)
dt
=
1
τMTT
[
fin(t)
E(t)
E0
− fout(v)q(t)
v(t)
]
(5.5)
The constant τMTT is the mean transit time and is equal to V0/F0, where V0
is the resting volume fraction and F0 is the resting flow. Also note that it is
assumed that arterial blood is fully oxygenated (Ca = 1) and therefore does
not contribute to BOLD signal changes.
CHAPTER 5. MODELLING THE BOLD RESPONSE 136
Three variables in the equations above require model definitions; fin(t),
fout(v, t) and E(t), where fout(v, t) is also dependent on v(t). The models of
these variables are described in the following sections.
5.2.1 Flow Models
Three models of neurovascular coupling were drawn from the literature and
investigated. The first model was proposed by Miller et al. [125] and takes
a largely empirical approach by considering non-linearity in cerebral blood
flow measurements. The second model by Friston et al. [72] takes a more
theoretical approach and relates flow to a flow inducing signalling mechanism.
Lastly the model of Behzadi et al. [126] extends the work of Friston et al. by
proposing that the signalling mechanism induces changes in the muscular
compliance of the cerebral arteriole, which in turn leads to changes in flow.
All three models represent a more realistic description of blood flow than the
box car employed in the original work of Buxton et al. [47]. The following
sections describe the models cited above.
Miller et al.
The model presented by Miller et al. [125] was based on experimental flow
measurements acquired using the QUIPPSII arterial spin labelling pulse se-
quence. Visual and motor paradigms were performed with three separate
stimulus lengths; 2, 6 and 18 s. The stimulus lengths were chosen specifically
to allow linearity comparisons to be made. For example, the result from the
2 s stimulus was time shifted by 0, 2 and 4 s and summed. This summation
was then compared with the 6 s stimulus. They observed that for the motor
experiment flow was slightly over predicted by the summation, whereas for
the visual paradigm it was strongly over predicted. With this in mind they
postulated that non-linearities in the flow response were already present in
the neural response, preserving a linear relationship between the two. A two
step modelling approach was used to link stimulus to flow; stimulus input to
neural activity and neural activity to flow change. The form of the neural
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Paradigm a τn τh m td c
Visual 3.0 0.5 1.5 3.0 1.5 54
Motor 0.25 0.25 1.25 3.0 0.65 65
Table 5.1: Parameter values obtained by Miller et al. [125] by simultaneously
fitting their model to experimental flow measurements.
response was chosen to model neural adaptation, characterised by a decay
from a high initial neural firing rate to a lower steady state value during stim-
ulation. This pattern has been observed in magnetoencephalography (MEG)
recordings [127] and can be described by the following function,
n(t) =
{
1 + ae−t/τn 0 ≤ t < T
0 otherwise
(5.6)
where a represents the amplitude of the initial overshoot, τn a time constant
regulating the decay and T the time at which stimulation ceases. In the
second stage of the model the neural function n(t) was convolved with a
gamma-variate h(t), representing the haemodynamic impulse function,
h(t) =
c
τhm!
(
t− td
τh
)m
e−(t−td)/τh (5.7)
where τh controls the falling edge of the curve, m affects the shape of the
function, td delays the onset of the curve and c scales the response. Figure 5.1
plots equations 5.6 and 5.7 along with the convolution of the functions.
Miller et al. then performed a six parameter fit of this model to the ex-
perimental flow data. Interestingly little variation in the parameters of the
model across paradigms was observed. The exception, however, was the
parameter a which varied from 0.25 in the motor experiment to 3.0 for the
visual paradigm, see table 5.1. This parameter determines the magnitude of
the high initial neural firing rate and hence adaptation in the response. Es-
sentially this may distinguish passive (visual) stimulation from self-initiated
(finger tapping) stimulation as the latter will likely involve less adaptation.
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Figure 5.1: Model relating a 4.8 s stimulus to flow response using the fitted
parameters for a visual paradigm described in Miller et al. [125]: (a) neuronal
response n(t), (b) haemodynamic response h(t), (c) convolution of neuronal
and haemodynamic responses, n(t) ⊗ h(t), to produce the normalised flow
response.
Friston et al.
Although the model of Miller et al. satisfies their hypothesis it does not
attempt to suggest an underlying mechanism for flow change. In the work of
Friston et al. [72] such a mechanism was proposed. They suggested that flow
change was mediated by a signalling mechanism that was dependent on the
stimulus input function. As was suggested in Miller et al. this relationship
was assumed to be linear, giving the following relationship between flow and
a flow inducing signal, s(t).
dfin(t)
dt
= s(t) (5.8)
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Figure 5.2: Mechanistic model (proposed by Friston et al. [72]) relating a 4.8
s stimulus to a corresponding flow change: (a) flow input response, and (b)
signalling response.
The change in the flow inducing signal was assumed to be generated by
neural activity, u(t), but controlled by feedback from both the signal itself
and autoregulation of flow. Autoregulation describes the capacity of the vas-
culature to maintain constant blood flow despite changes in arterial pressure.
ds(t)
dt
= ǫu(t)− s(t)
τs
− (fin(t)− 1)
τf
(5.9)
The parameters ǫ, τs and τf determine the temporal characteristics of the
change in flow. The constant, ǫ, was named the neuronal efficacy, and drives
the increase in signal, τs represents the decay of the signal and τf controls
autoregulatory feedback from flow.
Figure 5.2 shows the result of solving equations 5.8 and 5.9. The resultant
model curves are consistent with the empirical data presented in Miller et al..
In addition the suggested mechanism linking neural activity to increase in
flow is physiologically plausible. For some time it has been known that astro-
cytes are involved in the clearance of glutamate and its conversion to glutam-
ine [128]. The physiological analogue of this model could be the glutamate
mediated release of vasodilators causing changes in flow.
CHAPTER 5. MODELLING THE BOLD RESPONSE 140
Behzadi et al.
The model proposed by Behzadi et al. [126] was a reformulation of the work
of Friston et al.. This model was named the Arteriolar Compliance model,
and proposed a simplified picture of arteriolar vessel compliance. The vessel
walls are expected to experience both intravascular and extravascular forces.
The balance of these forces changes during increases in flow and hence the
radius of the arteriole varies. In order to simplify the modelling of arteriolar
compliance they assumed that the extravascular forces were constant and
that therefore the overall compliance of the vessel was determined by the
circumferential stress of the vessel wall. The circumferential stress was de-
scribed as being due to active and passive components. The active stress was
attributed to changes in smooth muscle tone and the passive stress to elastic
connective tissues. Over the operating range of the arteriole the relative con-
tributions of these components was assumed to vary. It was suggested that at
rest the compliance was dominated by the active component, whilst at large
arteriole radii the passive stress component would dominate. This led to the
dependence of total compliance on muscular compliance, for which a model
was derived. Figure 5.3a presents the numerical results of this model show-
ing the increasing dominance of passive stress at large radii. The muscular
compliance, Cm, was a non-linear function of radius, as shown in figure 5.3b.
The implication being that small changes in radius, and hence blood flow,
were easily achievable.
A link was then established between normalised muscular compliance, cm,
and neural activity by adapting equations 5.8 and 5.9.
dcm(t)
dt
= s(t) (5.10)
ds(t)
dt
= ǫu(t)− s(t)ks − (r(cm)γb − 1)gf (5.11)
Constants ks and gf control signal and flow feedback mechanisms, and are
the reciprocal of τs and τf used by Friston et al. [72]. The change in arteri-
olar muscular compliance was then described as a function of the signalling
quantity, s(t). Similarly the flow term in equation 5.9 was replaced by the
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Figure 5.3: Model of the muscular compliance of an arteriole [126]: (a) bal-
ance of circumferential stresses in the vessel wall and (b) muscular compliance
as a function of vessel radius.
arteriolar radius raised to the power gamma. Changes in arteriolar radius
are dependent on muscular compliance. The value of gamma depends on the
assumed relationship between flow and radius. For laminar flow γb = 4 and
for plug flow γb = 2. In this work, flow was assumed to be laminar. In or-
der to solve equations 5.10 and 5.11, the equation modelling the relationship
between muscular compliance and arteriolar radius must be inverted. In-
verting this relation is very difficult and therefore a look up table was used.
Changes in CBF were calculated by raising the radius r to the power 4. Sim-
ilarly the arteriolar volume change was calculated by r3. Figure 5.4 shows
the numerical solution produced by the parameters suggested by Behzadi et
al. Whilst it appears that this solution is not consistent with the empirical
data of Miller et al., it was possible to produce curves resembling this work
through judicious choice of the controlling parameters ǫ, ks and gf .
5.2.2 Volume Models
Three models of venous compliance were investigated. The first model is
based on empirical observations by Grubb et al. [129]. The application of
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Figure 5.4: Mechanistic model (proposed by Behzadi et al. [126]) relating a
4.8 s stimulus to a corresponding flow change: (a) flow input response, and
(b) signalling response.
this experimental evidence is best described in the work of Mandeville et
al. [68] and relates blood flow to blood volume via a power law. The second
model extends this work to account for dynamic changes in flow [130], and the
third model, proposed by Kong et al. [131], extends the delayed compliance
implicit in the Windkessel model [68]. All three models are described in
further detail in the following sections.
Grubb et al.
Experiments to measure the relationship between cerebral blood flow and
total cerebral blood volume were performed by Grubb et al. [129]. Flow and
blood volume were measured in rhesus monkeys at different levels of PaCO2
using Positron Emission Tomography. The PaCO2 level was lowered by hy-
perventilation and raised by hypoventilation. A steady state was established
at each PaCO2 level by waiting at least 15 minutes prior to imaging. From
these experiments the relationship between flow and total blood volume was
found to be best described by a power law, where the power constant is now
known as Grubb’s constant. In equation 5.12 CBV is defined as the total
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cerebral blood volume and CBF as the cerebral blood flow.
CBV = 0.80 CBF 0.38 (5.12)
Mandeville et al. [68] described the significance of this equation best, and
reformulated the static model as equation 5.13. The sum of α and β (hence-
forth denoted γm) are equivalent to the reciprocal of Grubb’s constant. It
is assumed that α = 2 for laminar flow and that β > 0 and is a function of
the balloon’s compliance and capacitance. Mandeville et al. [68] measured
γm = 5.5± 0.9 following a 6 second forepaw stimulation in rat. On extrapol-
ating this result to the steady state they measured γm = 2.8 ± 0.7, within
the error of the value measured by Grubb.
fout(v) = v
α+β (5.13)
This result shows that the Grubb relation is only valid in the steady state.
During dynamic changes in flow Grubb’s constant changes to reflect the
current state of the compliance of the venous balloon. Therefore typical
functional experiments cannot be accurately modelled and a dynamic model
is required.
Buxton et al.
In Buxton et al. [47] it was noted that whilst the Grubb relation does predict
the steady state relationship between flow and total blood volume, it fails to
adequately model transitions between states. As a solution to this problem
they proposed modelling fout as the sum of a linear component and a power
law [130].
fout(v) = v
1/α + τ±
dv
dt
(5.14)
Viscoelastic effects in the venous balloon were modelled by making fout(v) a
function of the rate of volume change. At the onset of activation the balloon
will resist a change in volume, but eventually a new steady state will be
realised. For non-zero values of τ± the flow-volume curve of the balloon will
experience hysteresis. As a further generalisation of the model the value of
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τ± was allowed to vary on inflation (+) and deflation (−), allowing greater
fine tuning when fitting this model to data.
Kong et al.
The modified windkessel model with compliance was described by Kong et
al. [131]. It is an enhancement of the earlier windkessel model produced by
Mandeville et al. [68].
fout(v, t) =
vα+β
A(t)
(5.15)
The function A(t) is exponential and is adjusted when fitting to experimental
data in order to control the vascular compliance. Kong et al. sought to gener-
alise equation 5.15 by introducing an additional state variable, the normalised
delayed compliance, c(t).
dc(t)
dt
=
1
τc
(
vβ − c(t)) (5.16)
By substituting c(t) for A(t) in equation 5.15 they derived a new form for
fout.
fout(v, t) =
v(t)α+β
c(t)
(5.17)
During changes in blood volume c → 1 and fout → vα+β whereas at steady
state c = eβ and fout = v
α. Therefore at steady state equation 5.17 reduces
to Grubb’s relation.
5.2.3 Oxygen Extraction Models
An integral part of a Balloon model simulation is the determination of the
oxygenation of the venous blood. The majority of the BOLD signal is de-
rived from the change in oxygenation of venous blood. The BOLD signal
model [106] discussed later in this section estimates that the ratio of signal
derived from oxygenation change versus volume change is 3.4 : 1 at 1.5 T.
Three models of oxygen extraction from the blood were investigated. The
first model [130] was empirical in nature and assumed that blood flow and
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oxygen metabolism can be linearly related. The second model [57] described
the vasculature by a two-compartment model and provides a greater under-
standing of the underlying mechanism. This model, known as the oxygen
limitation model, explains the large increase in blood flow which accompan-
ies small changes in oxidative metabolism. This explanation is both intuitive
and maintains linearity between blood flow and oxidative metabolism. The
third model [132] compensates for deficiencies in the oxygen limitation model
such as its invalidity during dynamic changes in flow and metabolism. All
three models are described in greater detail in the following sections.
Empirical Model
Despite the simplicity of this model it was the most recently proposed of
the three models in this section. Buxton et al. [130] state that this model
was based on the experimental observation that during modest increases in
activity, CBF increases linearly with CMRO2 [133]. At steady state CMRO2
is related to CBF (Fin(t)) by equation 5.3. In this work these variables were
normalised to their resting values, giving equation 5.18. In this expression
m is the normalised CMRO2 and the arterial oxygenation fraction, Ca, is
assumed to be unity.
m =
E
E0
fin (5.18)
Given the linearity assumption above, the empirical model described the
relationship between changes in CBF and CMRO2 by a constant n. Equa-
tion 5.20 is quoted in normalised units.
n =
∆CBF/CBF 0
∆CMRO2/CMRO20
(5.19)
n =
fin − 1
m− 1 (5.20)
Buxton et al. referenced experimental studies [133–137] that suggested that
n = 2 − 3. They note that the fact that n > 1 suggests that the oxygen
extraction fraction decreases with increasing flow. This is a central principle
of the oxygen limitation model described below.
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Oxygen Limitation Model
The oxygen limitation model was motivated by the observation [55] that
during neuronal activation blood flow and the metabolic rate of glucose con-
sumption rose by 30-50 %, whereas oxygen consumption only rose by 5 %.
This seemed to suggest that blood flow and oxygen metabolism were de-
coupled, at least during dynamic changes in activity. This goes against con-
ventional philosophy that these quantities are tightly coupled. Buxton and
Frank sought to prove that the observations could still be explained by tight
coupling of flow and oxygen metabolism. Their argument is based on four
assumptions;
1. At rest all capillaries are perfused. There is no capillary recruitment.
2. Oxygen metabolism is efficient. All oxygen entering tissue is metabol-
ised.
3. Exchange of O2 between plasma and erythrocytes is very rapid.
4. Each O2 molecule in the capillary has a probability per unit time of
being extracted.
The transport of oxygen to the tissue was described as an oxygen concentra-
tion gradient between the capillary and tissue mitochondria. During activity
the mitochondrial oxygen demand increases and in order to supply this de-
mand the concentration gradient must also increase. They state that this
can be achieved in one of two ways; capillary recruitment or increased blood
velocity. They describe capillary recruitment as the ability of the vasculature
to open up previously non-perfused capillaries. By recruiting capillaries the
oxygen source can be brought closer to the mitochondria and hence the gradi-
ent can be increased. However they argue that this mechanism does not
exist, and the only way to increase the concentration gradient is by increas-
ing capillary oxygenation. The only other way to increase capillary oxygen
concentration is by increasing blood flow. As the change in capillary volume
on activation is assumed to be negligible this is manifested as an increase
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in blood velocity. Therefore the transit time of an oxygen molecule through
the capillary will be reduced and so by assumption 4 the probability of it
being extracted will also be reduced. This led to the observation that in or-
der to satisfy a small increase in oxygen metabolism a large increase in flow
was required. Buxton and Frank formalised these arguments to produce a
mathematical model of oxygen transport under the oxygen limitation model.
An element of blood with oxygen concentration, CB, moving along the
capillary loses oxygen as a function of the plasma oxygen concentration, Cp,
and the probability of extraction, k.
dCB(t)
dt
= −kCp(t) (5.21)
Equation 5.21 follows assumption 2 and therefore tissue oxygen concentration
was assumed to be zero.
The oxygen extraction at time t was described as the change in the capil-
lary blood oxygen concentration relative to time t = 0. Time t = 0 represents
the point at which arterial blood flows into the capillary and time t the time
at which blood leaves the capillary to pass into the veins.
E(t) =
CB(0)− CB(t)
CB(0)
(5.22)
The oxygen extraction fraction was dependent on the average transit time
of an oxygen molecule through the capillary. Assuming that the ratio, r =
Cp/CB, was constant and that all capillaries had the same mean transit time,
τMTT = V/F (from the central volume principle).
E = 1− e−k r τMTT (5.23)
Equation 5.23 was then solved for the active and rest conditions of oxygen
extraction and flow i.e. at rest E = E0 and F = F0. The variables k, r, and
V remained the same during both conditions leading to the oxygen extraction
fraction being a function of blood flow, fin.
E = 1− (1− E0)1/fin (5.24)
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Oxygen Transport to Tissue
The Oxygen Transport to Tissue (OTT) model of Zheng et al. [132] sought
to improve upon the work of Buxton and Frank [57] in several important
areas. These areas included the incorporation of a tissue oxygen buffer, im-
plementation of a dynamic model of oxygen extraction and the establishment
of a link between tissue oxygenation and metabolic demand. The results of
their work are discussed below, without mathematical proof.
The introduction of a tissue oxygen buffer removed assumption 2 of the
oxygen limitation model. This was achieved by adding a second compartment
to equation 5.21 and allowing exchange between these compartments,
dCB(x, t)
dt
= −k(Cp(x, t)− Ct(t)) (5.25)
where Ct represents the tissue oxygen concentration. The solution of this
equation allowed the blood oxygen concentration, at any point along the
capillary, to be derived,
CB =
(
CaB −
Ct
r
)
eAkrx/Fin +
Ct
r
(5.26)
where CaB represents the arterial blood oxygen concentration, A the capillary
cross-sectional area, and x the distance along the capillary, where x = 0 is
the beginning of the capillary bed. In turn this equation can be used to
calculate the oxygen extraction fraction for a system in a steady state.
E = 1− C
v
B
CaB
= (1− g)
[
1−
(
1− E0
1− g0
)1/fin]
(5.27)
The variable g was introduced to represent the tissue oxygen buffer and was
defined as the ratio of the arterial plasma and tissue oxygen concentrations.
g =
Ct
Cap
0 < g < 1− E (5.28)
However this relation does not hold during dynamic changes in blood flow.
Changes in flow cause the spatial profile of the blood oxygen concentration
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to vary with time. If the capillary transit time was zero then changes in
oxygenation would be instantaneous, but unrealistic. Therefore Zheng et al.
attempted to describe the temporal change in blood oxygen concentration, at
a given location along the capillary, by a first order differential equation. This
equation was based on the steady state relation and an additional dynamic
component controlled by a time constant, τ . As τ was related to the capillary
transit time it was redefined as a function of blood flow, to account for a
reduced transit time at increased blood flow levels,
τ =
ϕ
fin
(5.29)
where ϕ is a characteristic time constant of the system. For non-zero tissue
oxygenation the blood oxygen concentration at a point L is given as,
ϕ
fin
∂CB
∂t
+ CB = C
a
B(1− g)
(
1− E0
1− g0
)x/finL
+ CaBg (5.30)
and in turn the oxygen extraction fraction is given by,
ϕ
fin
∂E
∂t
+ E = (1− g)
(
1−
(
1− E0
1− g0
)1/fin)
(5.31)
Finally in order to solve for g, Zheng et al. produced a model to link tissue
oxygen concentration to metabolic demand. They defined the rate at which
oxygen accumulates in the tissue to be a mismatch between the rate at which
oxygen leaves the capillary (CMRO2) and the rate at which it is metabolised
(M).
Vtis
dCt
dt
= CMRO2 −M (5.32)
The variable Vtis represents the volume of blood in the tissue. Models of
CMRO2 and M were substituted into equation 5.32 to produce,
J
VtisrT
VcapE0
dg
dt
=
(
C¯B − gCaB
C¯B0 − g0CaB
− 1
)
−Ku (5.33)
where J and K represent scaling constants, Vcap the capillary blood volume
and C¯B the mean blood oxygen concentration, defined by equation 5.34.
φ
fin
dC¯B
dt
+ C¯B = − C
a
BE
ln
(
1− E
1−g
) + CaBg (5.34)
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Figure 5.5: Comparison of models of oxygen extraction.
Equations 5.31, 5.33 and 5.34 form the basic equations of the OTT model.
They are integrated into the Balloon model, along with the flow model of
Friston et al. in the implementation of Zheng et al..
Whilst this model is very complex it does not produce dramatically differ-
ent results to the previous models, see figure 5.5. However it does have several
advantages. Firstly it makes it possible to model experiments where hyper-
capnia is induced in subjects [133]. The metabolic load can be retained at a
consistent level, whilst the effect of increased blood flow on oxygen extraction
can be simulated. Secondly the OTT model makes it possible to investigate
metabolic loads that are de-coupled from neural activity. This would allow
the possibility of post-stimulus metabolic activity to be simulated within the
framework of an integrated model such as this.
5.2.4 BOLD signal model
The solution of the Balloon model equations 5.4 and 5.5 produces timecourses
of deoxyhaemoglobin content, q, and volume, v. In order to relate these
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quantities to an approximation of the measured BOLD signal a model of
the MR signal is required. A simple and flexible model was proposed by
Buxton et al. [47] whereby changes in signal brought about by changes in q
and v can be calculated. This model was revised and updated by Obata et
al. [106] and is presented below.
In the work of Obata et al. the signal at rest, S0, resulting from an imaging
voxel was assumed to be a volume weighted sum of the intravascular, SI , and
extravascular, SE, signal. The intravascular signal was assumed to represent
a venous volume fraction V0, for which blood vessels were assumed to be
randomly and isotropically distributed. The intravascular contribution due
to arterial blood was assumed to be negligible, and the capillary component
was merged into the venous compartment. The signal components were
modelled as a monoexponential decay dependent on R∗2, where ǫs represents
the intrinsic ratio of blood to tissue signal.
S0 = (1− V0)SE + V0SI (5.35)
SE = SE0e
−TER∗
2E (5.36)
SI = SI0e
−TER∗
2I (5.37)
ǫs =
SI
SE
(5.38)
During neural activity the R∗2 of both signal components was increased by
an amount ∆R∗2 due to the change in oxygenation, and the venous volume
fraction changed from V0 to V . On activation the signal was given by,
S = (1− V )SEe−TE∆R∗2E + V SIe−TE∆R∗2I (5.39)
The fractional signal change was then found from equations 5.35, 5.38 and
5.39,
∆S
S0
=
1
1− V0 + ǫsV0
[
(1− V )e−TE∆R∗2E + ǫsV e−TE∆R∗2I − (1− V0)− ǫsV0
]
(5.40)
This expression was then simplified further. Assuming that signal changes
were small the exponent can be expanded as a first order linear approxim-
ation. Furthermore, by assuming a small fractional blood volume it was
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also possible to equate the multiplicative factor to 1, yielding the following
simplified expression.
∆S
S0
≈ −TE∆R∗2E − ǫsV TE∆R∗2I + (V0 − V )(1− ǫs) (5.41)
Models of ∆R∗2E and ∆R
∗
2I were then described as follows.
Extravascular Signal Change
Obata et al. based their model of ∆R∗2E on the numerical simulations of
Ogawa et al. [84].
R∗2 = 4.3νV (5.42)
The frequency offset at the outer surface of the magnetised vessel was de-
scribed as ν = ν0(1 − Y ), where ν0 represents the frequency offset for fully
deoxygenated blood and Y the fractional oxygen saturation of the blood.
Therefore the transverse relaxation of the extravascular space was described
as,
R∗2 = 4.3ν0V (1− Y ) (5.43)
and relative to the resting state (subscript 0) it was found that,
∆R∗2E = 4.3ν0[V (1− Y )− V0(1− Y0)] (5.44)
With the knowledge that the total deoxyhaemoglobin content was described
by Q = V (1−Y )[Hb], Obata et al. derived the normalised deoxyhaemoglobin
content, q.
q =
Q
Q0
=
V (1− Y )
V0(1− Y0) (5.45)
By combining equations 5.44 and 5.45, along with the resting oxygen extrac-
tion fraction E0 = 1− Y0, ∆R∗2E became a function of q.
∆R∗2E = 4.3ν0V0E0(q − 1) (5.46)
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Intravascular Signal Change
The intravascular signal change was modelled with reference to the experi-
ments of Li et al. [86]. This work involved the in vivo measurement of the
relationship between R∗2 and blood oxygen saturation. As expected this rela-
tionship was best approximated by a second-order curve fit. However it was
suggested that for the normal physiological range of oxygenation a linear fit
was adequate,
R∗2 = rd(1− Y ) (5.47)
where rd represents the relaxivity of deoxyhaemoglobin and Y the fractional
oxygen saturation. This was confirmed by the experiments of chapter 3, as
shown in figure 3.5. At 3.0 T rd was measured to be 16.9± 2.2× 10−2 ms−1.
Consequently the change in R∗2 was,
∆R∗2I = rd
[
(1− Y )− (1− Y0)
]
(5.48)
This was rearranged in terms of the normalised deoxyhaemoglobin content
and volume.
q
v
=
Q
Q0
V0
V
=
1− Y
1− Y0 (5.49)
To give the expression,
∆R∗2I = rdE0
(q
v
− 1
)
(5.50)
Fractional Signal Change
Equations 5.46 and 5.50 were combined with equation 5.41.
∆S
S0
= −4.3ν0V0E0TE(q − 1)− ǫsV rdE0TE
(q
v
− 1
)
+ (1− ǫs)(V0 − V )
= V0
[
k1(1− q)− k2v
(q
v
− 1
)
− k3(1− v)
]
= V0
[
(k1 + k2)(1− q)− (k2 + k3)(1− v)
]
(5.51)
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The constants k1 to k3 were defined as,
k1 = 4.3ν0E0TE (5.52)
k2 = ǫsrdE0TE (5.53)
k3 = ǫs − 1 (5.54)
5.3 Method
Two BOLD models were formed from the theory components discussed in
section 5.2. Each model was described by a different number of parameters,
allowing a comparison to be made between empirical (low number of para-
meters) and more sophisticated model elements. The composition of each
model is described in section 5.3.1. Each model was fitted using a simulated
annealing algorithm (section 5.3.4) to the experimental data of chapter 4
and the fitting process is described in section 5.3.2. In order to calculate
the signal changes due to contrast agent in arterial vessels (typically neg-
lected in conventional models) a multi-component signal model was derived
(section 5.3.3) by generalising the equations of Obata et al. [106].
5.3.1 Models Studied
Two combinations of model components were chosen to reflect an empirical
approach and a more sophisticated mechanistic approach. These approaches
are most noticeable in the modelling of the flow input (section 5.2.1) to the
system, fin. The Miller model is dependent only on the duration of the
stimulus as it was determined by fitting to experimental data. However, the
Behzadi model is dependent on four parameters; neuronal efficacy (ǫ), signal
decay (ks), feedback gain, (gf ), and arteriolar radius (rmax). These extra
parameters are required to describe the mechanism behind changes in CBF.
In choosing a model of flow output, fout, the conventional hypothesis was
adopted (section 5.2.2). This states that the post-stimulus undershoot can be
described by a lag between flow into the system and the return to baseline of
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Model Flow Volume Oxygen No.
No. Model Model Extraction Parameters
1 Miller et al. Buxton et al. Empirical 3
2 Behzadi et al. Buxton et al. Empirical 7
Table 5.2: Components of models 1 and 2. For a detailed description of these
components see section 5.2.
CBV. It was clear that a dynamic model of venous outflow was required. For
simplicity the model of Buxton et al. was chosen. This model is dependent
on two time constants describing the inflation (τ+) and deflation (τ−) of the
venous balloon. However it can be shown that this model and the model of
Kong et al. can simulate equivalent venous outflow curves, and are as such
interchangeable for the purposes of this simulation. The model of Kong et
al. does offer the possibility of a greater understanding of venous outflow,
but was not investigated.
The selection of an oxygen extraction model (section 5.2.3) followed the
hypothesis described above. As it is assumed that volume change alone can
describe the post-stimulus undershoot, the simplest model of oxygen extrac-
tion was used. This Empirical model of oxygen extraction produces com-
parable results to the Oxygen Limitation and Oxygen Transport to Tissue
models.
In summary, both models shared the same basic dynamic volume model
of Buxton et al., describing venous volume change, and the empirical oxygen
extraction model, to describe changes in oxygenation. However differences
between the models were achieved by using different forms for the arterial
input function. In the case of model 1 this element was supplied by the
empirical Miller et al. model. For model 2 the Arteriolar Compliance model
described by Behzadi et al. was used. One final parameter was added to
model the time delay (td) between the onset of stimulus and the haemody-
namic response. Overall model 1 was described by 3 parameters and model
2 by 7 parameters.
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5.3.2 Model Parameter Estimation
Each BOLD model combination was fitted to experimental data from chapter
4. This data consisted of a total CBV timecourse (figure 4.9) and a BOLD
signal timecourse (figure 4.6a). A least squares fit was performed for each
model to each data set to estimate the model parameters in each case. Para-
meters were constrained to the ranges described by Behzadi et al. [126] and
are listed in table 5.3. In order to fit each model to the total CBV data a
simulated timecourse was required. This was created by performing a volume
weighted sum of the arterial and venous volume change. These variables are
produced when the Balloon model equations are numerically solved. The
weighting was based on an arterial:venous vessel volume ratio of 1:3 [111].
Simulation of the BOLD signal timecourse required a multi-component
BOLD signal model to be developed, see section 5.3.3. In a conventional
BOLD signal model changes in blood signal are assumed to occur in venous
and capillary vessels due to changes in blood oxygenation, whilst arterial
blood is fully oxygenated. The addition of contrast agent to the blood causes
the blood signal to decrease and will affect all vessels, both arterial and
venous. By adopting a multi-component model the arterial blood signal
contribution can be determined in the absence of changes in oxygenation.
The BOLD signal data consisted of 20 cycles of a visual stimulus. The
final 16 cycles were acquired during a 16 minute infusion of contrast agent.
Preliminary fitting to this data caused the fitting algorithm to ignore the fea-
tures of the BOLD haemodynamic response and concentrate on fitting the
much larger baseline drift due to the infusion of the contrast agent. There-
fore in the final fits the baseline drift was removed by linearly interpolating
between the first and last data points of each cycle. In addition the results
of fitting to the total CBV data revealed an overestimation in the simulated
BOLD signal. In this case a vascular volume fraction of 4 % was used. How-
ever the vascular volume fraction, V0, in equation 5.68 effectively represents
the fraction of vessels involved in the haemodynamic response. All other
vessels, remaining in the steady state, will not contribute to BOLD signal
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change but will contribute to baseline drift due to the contrast agent. The
BOLD signal data were acquired from a large region of interest encompassing
a volume of ∼0.8 cm3. Evidently there will be dilution of the BOLD signal
due to the partial volume effect. Therefore an additional fitting parameter
was added to vary the activated vessel volume fraction, giving a total para-
meter count of 4 and 8 for models 1 and 2, respectively.
Due to the large number of fitting parameters, and the generous con-
straints, it was possible that local minima could exist in the fitting space.
This problem was exacerbated by the noise present in the data. In order to in-
vestigate this effect, models 1 and 2 were fitted to the total CBV timecourse.
A non-optimised simulated annealing (SA) algorithm was used, allowing the
final solution to be independent of initial starting position. Assuming that
local minima were present in the data, the solutions produced by a descent
based algorithm would be highly dependent on starting position. Multiple
random starting positions could have been selected, but many low signific-
ance local minima would have been found. The SA technique bypasses these
minima and only selects minima of high significance. An optimised SA al-
gorithm will theoretically find a single global minimum. By de-tuning the
algorithm it was possible to discover multiple local minima. Whilst these
minima were spread over a range of sum of square residual values, this range
was narrow. This allowed the distribution of these minima to be investig-
ated and the possibility of a single global minima assessed. De-tuning the
SA algorithm was achieved by choosing a sub-optimal cooling schedule, see
section 5.3.4 for further details. A total of 100 least squared SA fits were
performed for each model.
Figure 5.6 plots τ+ versus τ− for each of 100 parameter estimations. For
model 1 (figure 5.6a) it is clear that a single minima is possible as the values
of τ+ and τ− are very tightly clustered. However for model 2 (figure 5.6b)
the values show a great deal of scatter and suggest that there may well be
multiple local minima. Figure 5.7 shows the value of τ+ against the sum
of the squared residuals generated for that estimation. Again in model 1
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Parameter Variable Constraint
Inflation Time Constant τ+ 0− 30
Deflation Time Constant τ− 0− 30
Neuronal Efficacy ǫ 0− 1
Signal Decay Constant ks 0− 2
Flow Feedback Gain gf 0− 2
Max. Normalised Radius rmax 1.2− 1.3
Time Delay td 0− 5
Table 5.3: Parameter constraints used in least squares fit to data [126].
(figure 5.7a) this result suggests that the data can be described by a single
global minima within certain error bounds determined by the noise in the
data. For model 2 (figure 5.7b), however, there appear to be many local
minima which could describe the data. Determining which minima is the
global minima is complicated by the noise incorporated in the data.
The theoretical minimum sum of squared residuals value can be calcu-
lated using a Monte Carlo technique. A model curve solution was randomly
chosen and subtracted from the experimental data to assess the level of noise.
The noise was assumed to be Gaussian in nature and its mean and stand-
ard deviation was calculated. It was then assumed that the original model
curve described the data perfectly. Random Gaussian noise, with the same
distribution as that calculated from the data, was then added to the model
curve. The sum of square residuals was calculated and this process repeated
100 times. This allowed a mean and standard deviation of 0.35 and 0.04,
respectively, to be calculated. There are many distinct solutions to model 2
which surpass this threshold. Determining which solution is the global min-
imum is extremely difficult. It is not even meaningful to quote the mean and
standard error of the parameter estimates as this average is unlikely to fall
within a minima itself. It is still possible, however, to assess the form and
variation of the curve solutions. In figure 5.8 the variation in the solutions is
visualised by plotting all 100 solutions.
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Figure 5.6: Model parameter solution: τ+ versus τ− for (a) model 1 and (b)
model 2.
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Figure 5.8: Model parameter solutions: 100 solutions of model 2 for variables
fin, vtot and simulated BOLD signal change. BOLD signal change calculated
using the multi-component signal model.
As a final check of the independence of the minima determined in fig-
ure 5.6 a Monte Carlo error estimation technique was used to calculate the
error in the parameter estimation of 5 randomly selected solutions, with mean
sum of squares 0.35 and standard deviation 0.01. Initially each of the solu-
tions were subjected to a constrained descent based minimisation algorithm
in order to find the absolute minimum for each solution. It was assumed
that each model curve described the data perfectly and that the residuals
represent additive Gaussian noise. The mean and standard deviation of this
noise was calculated. Gaussian noise with the same characteristics was added
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to the model curve and a constrained least squares optimisation performed.
This process was repeated 100 times to sample the range of possible solutions
given the noise in the data. The parameter estimates generated were used to
calculate mean values along with an error estimate and are summarised in
table 5.4. It is clear from these results that each of the solutions show very
little overlap, and as such represent distinct local minima.
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1 2 3 4 5
τ+ 21.13± 0.02 8.48± 0.13 13.11± 0.04 14.09± 0.04 5.82± 0.11
τ− 15.19± 0.02 11.57± 0.12 16.27± 0.04 14.75± 0.04 12.81± 0.10
ǫ 0.49± 0.01 0.77± 0.01 0.43± 0.01 0.36± 0.01 0.74± 0.01
ks 1.00± 0.01 1.61± 0.01 0.99± 0.01 0.80± 0.01 1.61± 0.02
gf 0.43± 0.01 0.82± 0.01 0.42± 0.01 0.38± 0.01 0.83± 0.01
rmax 1.247± 0.001 1.229± 0.001 1.253± 0.001 1.242± 0.001 1.218± 0.001
td 1.77± 0.02 2.39± 0.03 1.93± 0.02 1.80± 0.02 1.94± 0.03
Table 5.4: Calculated error in parameter estimations of model 2 using the bootstrap technique. Five solutions chosen
randomly from total of 100 solutions.
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5.3.3 Multi-Component Signal Model
It was noted in section 5.2 that the Balloon model effectively assumes all
changes in volume and susceptibility occur in venous vessels. However when
modelling an infusion of contrast agent, as performed in chapter 4, the arterial
susceptibility resulting from the infusion must also be considered. Therefore a
multi-component signal model based on the methodology of Obata et al. [106]
was developed. In this model it is assumed that the cerebral vasculature can
be partitioned into two components: arterial and venous. The capillary
blood volume is shared between these compartments as it is assumed to
have mixed oxygenation levels and constant volume. The intravascular signal
components of each compartment are modelled as separate monoexponential
decays. However the extravascular signal is summed over the effect of both
compartments, as they both effect the same tissue volume. In this model the
reference signal, S0, is redefined as the signal at time t = 0, to reflect the
condition that the system is at rest and the contrast agent concentration is
zero. Equations 5.35 and 5.39 can be rewritten to reflect these assumptions
and modifications,
S0 = (1− Va0 − Vv0)SE + Va0SIa + Vv0SIv (5.55)
S = (1− Va − Vv)SEe−TE∆R∗2E
+VaSIae
−TE∆R∗
2Ia + VvSIve
−TE∆R∗
2Iv (5.56)
where subscripts a and v represent the arterial and venous compartments,
respectively, and subscript 0 defines the value of a variable at time t = 0.
In order to derive the fractional signal change the ratio of venous signal to
arterial signal, βs, at time t = 0 is introduced.
ǫs =
SIv
SE
→ SIv = ǫsSE (5.57)
βs =
SIv
SIa
→ SIa = SIv
βs
=
ǫsSE
βs
(5.58)
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Using the same simplifying assumptions as described in section 5.2.4 produces
the following expression.
∆S
S0
≈ −TE∆R∗2E − Va
ǫs
βs
TE∆R∗2Ia − VvǫsTE∆R∗2Iv
+(Va0 − Va)
(
1− ǫs
βs
)
+ (Vv0 − Vv)(1− ǫs) (5.59)
This now leaves models of ∆R∗2E, ∆R
∗
2Ia and ∆R
∗
2Iv to be defined in the
presence of a contrast agent. In the context of this derivation, ∆R∗2 represents
a change in R∗2 which is due to changes in contrast agent concentration and/or
blood oxygenation.
Extravascular Signal Change
In this work the analytical solutions of Yablonskiy and Haacke [85] were used
in the definition of ∆R∗2E,
R∗2 =
4π
3
V ω0χ (5.60)
where R∗2 is a function of the volume fraction, V , the Larmor frequency, ω0,
and the susceptibility relative to the surrounding medium, χ. It is possible
to compare this expression with equation 5.42 used by Ogawa et al. [84]. The
susceptibility of venous blood can be modelled [95] as χv = χd(1 − Y ) and
similarly from Ogawa et al. νv = χd(1− Y )ω0, where χd is the susceptibility
of fully deoxygenated blood relative to tissue. Hence the only difference
between the expressions is the multiplicative factor, which at 4π/3 is within
the errors of the numerical result calculated by Ogawa et al. of 4.3± 0.3.
In order to model the signal change the susceptibility at time t is con-
sidered with reference to the susceptibility at time t = 0. It is assumed that
the susceptibility due to the contrast agent increases linearly with concen-
tration, [Gd], where χg is the molar susceptibility of the contrast agent.
χ0 = (1− Y0)χd + [Gd]χg but at t = 0, [Gd] = 0
= (1− Y0)χd (5.61)
χ = (1− Y )χd + [Gd]χg (5.62)
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By substituting equations 5.61 and 5.62 into equation 5.60, along with equa-
tion 5.45, the change in the extravascular R∗2 due to venous blood, with
increasing contrast agent concentration, can be estimated.
∆R∗2Ev =
4π
3
ω0
[
Vv(1− Y )χd + Vv[Gd]χg − Vv0(1− Y0)χd
]
=
4π
3
ω0
[
Vv0E0(q − 1)χd + Vv[Gd]χg
]
(5.63)
Similarly the change in extravascular R∗2 due to arterial blood can be derived.
∆R∗2Ea =
4π
3
ω0Vv[Gd]χg (5.64)
A unified extravascular ∆R∗2 can then be realised by performing a volume
weighted sum of equations 5.63 and 5.64.
∆R∗2E =
Va
Va + Vv
∆R∗2Ea +
Vv
Va + Vv
∆R∗2Ev (5.65)
Intravascular Signal Change
For the purposes of this simulation it is assumed that the intravascular signal
change due to the presence of a contrast agent increases R∗2 linearly with
increasing concentration. By definition the concentration of contrast agent
is zero at time t = 0 therefore,
∆R∗2Ia = rg[Gd] (5.66)
where rg is the relaxivity of contrast agent in blood. At 3.0 T rg was meas-
ured, in chapter 3, to be 3.7±0.5×10−2 ms−1mM−1. Similarly the change in
venous R∗2 can be modelled with reference to the derivation of equation 5.50,
∆R∗2Iv = rdE0
(q
v
− 1
)
+ rg[Gd] (5.67)
In fact a linear relationship may not always hold true, and an explanation of
why this is the case can be found in chapter 3.
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Fractional Signal Change
Equations 5.65, 5.66 and 5.67 can now be substituted into equation 5.59 to
give,
∆S
S0
= −4π
3
ω0TE
Vv
Va + Vv
Vv0E0(qv − 1)χd − 4π
3
ω0TE
Vv
Va + Vv
Vv[Gd]χg
−4π
3
ω0TE
Va
Va + Vv
Va[Gd]χg − Va ǫs
βs
TErg[Gd]
−VvǫsTErdE0
(q
v
− 1
)
− VvǫsTErg[Gd]
+(Va0 − Va)
(
1− ǫs
βs
)
+ (Vv0 − Vv)(1− ǫs)
= Vv0
[
k1
Vv
Va + Vv
(1− qv)− k2vv
(qv
vv
− 1
)
− k3(1− vv)
−k4 Vv
Va + Vv
vv[Gd]− k5Vv0Vv[Gd]
]
+Va0
[
− k4 Va
Va + Vv
va[Gd]− k6va[Gd]− k7(1− va)
]
(5.68)
Constants k1 to k5 are defined as,
k1 =
4π
3
ω0TEE0χd (5.69)
k2 = ǫsTEE0rd (5.70)
k3 = ǫs − 1 (5.71)
k4 =
4π
3
ω0TEχg (5.72)
k5 = ǫsTErg (5.73)
k6 =
ǫs
βs
TErg (5.74)
k7 =
ǫs
βs
− 1 (5.75)
By assuming a singular vascular compartment, and that the concentration
of contrast agent is zero, equation 5.68 reduces to equation 5.51. Therefore
this model is a generalisation of the previously described model [106].
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5.3.4 Simulated Annealing
The SA optimisation algorithm is analogous to the cooling of solids form-
ing crystalline structures. Annealing is the process whereby a solid is first
heated to a high temperature, below its melting point, and is then cooled
slowly. At high temperatures the atoms within the solid are highly mobile,
and hence can change their positions within the lattice structure. If the solid
is cooled sufficiently slowly all of the atoms will find positions within the
lattice structure with minimum energy. Alternatively if a solid is cooled rap-
idly mobility is quickly reduced and atoms will be trapped in positions that
have energies greater than the minimum value. Hence conventional descent
based algorithms are analogous to quench cooling a solid. By following a
downward trend in the cost function these algorithms will find the nearest
local minima, and are therefore dependent on starting conditions. However
the SA technique is an approximation algorithm. It aims to find a good ap-
proximation to the global optima when a brute force approach is impractical
or where it is likely that local minima may exist. Therefore a trade-off must
be made between speed and accuracy.
In this section the SA algorithm will be described through a simple ex-
ample. The Travelling Salesman Problem (TSP) is a computationally dif-
ficult question. The problem is stated as; given a number of cities, n, and
the distance travelled between these cities, what is the most efficient route?
When n is small this problem can be solved using the brute force method of
calculating the total distance incurred by every permutation of city visits, n!.
However as n increases the total number of permutations increases rapidly
and solving the problem in this way becomes impractical. The SA technique
proves to be particularly adept at solving this problem. Figure 5.9 schem-
atically represents the SA algorithm. Initially n random city co-ordinates
are generated and a cost function evaluated. In this case the cost function
is the total journey length for the current order of visits, or state, s. The
result of this cost function is commonly known as the current energy. The
system is then perturbed in a random way to form state s′. For the TSP
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this may occur by choosing two cities randomly and swapping their positions
in the journey order. The cost function is then re-evaluated and acceptance
testing of this new energy state performed. Acceptance testing consists of
the following two step process. If the difference in energy, ∆E, between state
s and state s′ is less than zero, then the current state s is replaced by s′.
However if ∆E is greater than zero, then the Metropolis criteria is applied.
This probabilistic criteria allows the algorithm to escape local minima by
permitting up hill steps in the cost function. Therefore states with positive
∆E are accepted using equation 5.76, where r is a random number between
0 and 1, kB is Boltzmann’s constant and T is the current temperature.
P =
{
1 if e−∆E/kBT > r
0 otherwise
(5.76)
This sequence is repeated many times for the current temperature in analogy
to the thermal motion of atoms in a solid. In order for the parameter space
to be adequately sampled at this temperature, a system for deciding when
thermal equilibrium is achieved is required. For this simple case this was
empirically determined to be a number of iterations. However there are
more sophisticated alternatives.
At thermal equilibrium the temperature is decremented subject to a cool-
ing schedule. Again this can be achieved in many ways, but the simplest is
to multiply the current temperature by a cooling factor, α.
Tnew = αTcurrent (5.77)
Finally a freezing point must be determined. Due to the exponential nature
of the cooling schedule T = 0 will take an infinitely long time to achieve.
Therefore the algorithm must be terminated after a certain number of itera-
tions or when a temperature threshold is passed. The former method is used
in this simple example.
In order to compare simulated annealing versus the brute force technique
a TSP validation experiment was performed. Twenty co-ordinates in the
x − y plane were uniformly distributed along the circumference of a circle.
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Figure 5.9: A schematic representation of the SA algorithm.
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Figure 5.10: Validation of the SA algorithm for a simple example. Twenty
co-ordinates are randomly distributed on the circumference of a circle (a)
and subjected to an SA optimisation (b) to find the shortest route between
all the points.
The resultant co-ordinates were placed in a random order and subjected to
an SA optimisation. Optimisation was performed on an Apple PowerBook
with a 1 Ghz PowerPC G4 processor and 512 Mb of RAM using MATLAB.
The SA optimisation took approximately 5 minutes to reach the expected
minima, see figure 5.10. The brute force technique could not be simulated,
so an estimated processing time was calculated. A co-ordinate count of 20
requires over 2.4 × 1018 evaluations of the cost function. By running the
cost function 100,000 times it was found that on average each evaluation
takes 111.5 µs, giving a total run time of 8.6 × 106 years. This figure does
not include the time to calculate all of the order permutations, which would
add considerably to the total. It is obvious that despite the relatively crude
algorithm described above, the SA technique is significantly faster than the
brute force technique. This technique is also less susceptible to problems
with multiple local minima.
In order to optimise models 1 and 2, described in section 5.3.1, a similarly
crude implementation of the algorithm was used. Initially each model para-
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meter was set to lie at the centre of the constraint range, see table 5.3. The
model was then solved for the current state, and a cost function evaluated.
The cost function, in this case, was the sum of squared residuals between
the experimental and simulated curves. Perturbation of the solution was
achieved by selecting one parameter and adding a random number. The ran-
dom number was scaled to the full range of the constraint, was proportional
to temperature and was uniformly distributed. This new parameter value
was then tested for compliance with the constraint. If the new value was re-
jected then an alternative value was generated. The acceptance criteria used
in the TSP example are then applied. The initial temperature was chosen
as 2000, thermal equilibrium was determined to have occurred following 100
randomisation iterations and the freezing point was selected to be 5. These
values were selected with the aim of trading-off speed and accuracy, as the
aim of this investigation was not to find the absolute global minima, but to
assess the likelihood of their presence.
5.4 Results
As was noted in section 5.3.2, mutiple minima are present in higher dimen-
sional fits to the total CBV data from chapter 4. A similar pattern was
found whilst fitting the signal data. Therefore all time course data in this
section have been plotted in a similar manner to figure 5.8. As noted the
mean values of the estimated parameters cannot be quoted, as simulations
based upon these values are unlikely to fit the experimental data.
The following sections describe the results of fitting to both the total
CBV and BOLD signal data gathered in chapter 4.
5.4.1 Volume Fitting Results
Figure 5.11 shows the results of fitting models 1 and 2 to the total CBV data
from chapter 4. Both models show good correlation with the data and have
mean sum of squared residuals of 0.346 and 0.354, for models 1 and 2 respect-
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Figure 5.11: Model total CBV (∆CBVtot) curves from fit to experimental
CBV data for (a) model 1 and (b) model 2. Experimental data points are
plotted as crosses along with all 100 curve solutions.
ively. The standard deviation of the respective sum of squared residuals was
0.003 and 0.015, respectively. Due to the higher number of dimensions used
in the fitting of model 2, there are a greater range of solutions. However
during the period between 15 and 25 s model 2 appears to provide a solu-
tion giving a better fit to the change of slope, evident in the experimental
data. This feature may be created in the summation of arterial and venous
volume change, which creates the total CBV change. Arterial volume change
is closely linked to changes in CBF. In turn venous volume change is depend-
ent on CBF (fin), but with a longer timescale due to smoothing introduced
by viscoelastic effects in the venous balloon. By allowing more flexibility in
the form of fin, model 2 is capable of describing temporal dynamics of total
CBV change that the rigid flow model of model 1 cannot. The feature present
in the data beyond 35 s cannot be simulated by either model. This feature is
an artefact of the button-press paradigm used to retain the attention of the
subject and as such is not accounted for in either model.
Figure 5.12 plots the model variables simulated using models 1 and 2 for
the model fits to the experimental CBV data. The variability across curve
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Figure 5.12: Model variable curves from fit to experimental CBV data for
(a-c) model 1 and (d-f) model 2. Simulated variables include arterial flow
input to the system, fin, venous outflow, vv, and venous deoxyhaemoglobin
content, qv. Data consists of 100 curve solutions to ∆CBV data.
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Figure 5.13: Simulated BOLD response using model variables and the multi-
component signal model ([Gd] = 0). All 100 curve solutions plotted.
solutions for the model 2 variables is much greater than that present in the
model 1 variables. As can be seen in figure 5.13, variation in the underlying
model variables causes increased variability in the BOLD signal calculation.
The simulation predictions for an infusion of contrast agent could now be
compared using the following method.
1. Remove baseline drift due to the contrast agent infusion.
2. Group the 20 cycles into 5 blocks of 4 continuous stimulus cycles, with
mean [Gd] = 0, 0.11, 0.35, 0.53 and 0.70 mM.
3. Average across the stimulus cycles in each block
4. Overlay each of the 5 averaged blocks
In order to improve the visualisation of this figure all 100 curve solutions were
averaged to produce a representative solution. In both cases the amplitude
of the predictions was larger than seen experimentally. This is most likely
due to unknowns such as the vascular volume fraction and the partial volume
effect.
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Both models display a reduction in signal at the peak of the BOLD re-
sponse with increasing contrast agent that is relatively consistent with the
experimental data. Experimental data shows a uniform decrease in amp-
litude of the response with little change in the trailing edge, whereas the
models show greater attenuation of the trailing edge. The reasons for this
are unclear, but it may be due to the form of the flow model used in each
case. Further experimental measurement of CBF are required to attempt to
disentangle the total CBV measurements. The post-stimulus undershoot is
also poorly modelled. At baseline, model 1 does not exhibit a post-stimulus
undershoot. With increasing contrast agent concentration an undershoot ap-
pears, but earlier in the response than expected. This undershoot is due to
the mismatch between the arterial and venous volume curves. Therefore it is
likely that the form of the flow model curve is inconsistent with the experi-
mental data. Model 2 exhibits an undershoot at baseline and with increasing
contrast agent concentration. It occurs only slightly earlier than expected
in the experimental data. The modelling of arterial flow would benefit from
experimental measurements of the changes in CBF and arterial CBV in order
to fine tune the form of the response.
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Figure 5.14: Baseline normalised data averaged in blocks of four stimulus
cycles for model fits to (a) model 1, (b) model 2 and for (c) experimental
data.
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Figure 5.15: Model BOLD signal curves from fit to experimental signal data for (a) model 1 and (b) model 2.
Experimental data points are plotted as dots.
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5.4.2 Signal Fitting Results
Figure 5.15 shows the result of fitting models 1 and 2 to the experimental
BOLD signal data of chapter 4. Mean sum of squared residuals for these fits
to models 1 and 2 were 0.256 and 0.257, respectively. The standard devi-
ation of the respective sum of squared residuals was 0.001 and 0.011. Both
models follow the trend of a reduction in peak BOLD response with increas-
ing contrast agent concentration. This is despite the confounding effects of
inter-stimulus variability in the BOLD response and any instability in the
MR signal. Model 2 shows particularly good correlation of the positive over-
shoot throughout. Each model displays a post-stimulus undershoot, which
becomes more negative with increasing contrast agent concentration.
Figure 5.16 plots the model variables simulated using models 1 and 2 for
the model fits to the experimental signal data. A slightly larger variability
in curve solutions for model 1 can be seen when compared to the total CBV
fitting. However the variability in model 2 is far greater than before. This is
due to the highly unconstrained nature of the model. A large parameter space
has to be defined, as it is difficult, or impossible, to measure suitable ranges
for the parameters that describe the model. This allows the fitting algorithm
to try many combinations of the variables fin, vv and qv to achieve the same
total BOLD signal. Fitting would benefit from experimental measures of
these variables in order to reduce the number of plausible solutions.
Using the same technique as figure 5.14, the effect of an infusion of con-
trast agent can be compared. The form of both models differs markedly from
their corresponding fits to the volume data. However contrary to the volume
data both fits to the signal data are very similar in form. The timing of the
initial edge of the post-stimulus undershoot described by both models shows
good correlation with the data. The correlation of the form of the response is
more difficult to discern, due to noise in the experimental data. Similarly the
increasingly negative signal of the undershoot with increasing contrast agent
concentration is difficult to compare with the data. This is due to errors in
the baseline correction and the small magnitude of the effect.
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Figure 5.16: Model variables curves from fit to experimental signal data for
(a-c) model 1 and (d-f) model 2. Simulated variables include arterial flow
input to the system, fin, venous outflow, vv, and venous deoxyhaemoglobin
content, qv. Data consists of 100 curve solutions to the BOLD signal data.
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In both model fits, the reduction of the positive overshoot with increasing
contrast agent concentration does not correlate well with the experimental
result. This is most likely due to an underestimation of CBV during this
feature. One other interesting feature of the experimental data, compared
with the simulations, is the increase in BOLD signal for the average of stim-
ulus cycles 5-8. Magnetic field gradients within the blood, which surround
paramagnetic red blood cells, are reduced in magnitude at low concentra-
tions of contrast agent. As the contrast agent is also paramagnetic and is
only present in the plasma, the susceptibility difference between red blood
cells and plasma is reduced and the MR signal is increased. A more detailed
description of the effect can be found in chapter 3.
As a final comparison the simulated total volume curves are plotted in
figure 5.18, along with the measured data. The curve predicted by model
1 underestimates total CBV during the positive overshoot and overestim-
ates it during the post-stimulus undershoot. This underestimated overshoot
value helps to explain why this feature doesn’t decrease rapidly enough with
increasing contrast agent. However the overestimation of undershoot CBV
suggests that the negative BOLD signal is similarly overestimated. Without
this overestimation it is unlikely that a post-stimulus undershoot would be
observed. Due to the large variation of solutions provided by model 2 there
are several which would match the measured CBV data. It is likely that
model 2 would suffer the same problems as model 1, by displaying an overes-
timation of post-stimulus blood volume. In order to fit model 2 accurately a
measurement of CBF (fin(t)) is needed. This could be simultaneously fitted
alongside the signal data, thereby reducing the number of possible solutions.
5.5 Discussion
In this study an enhanced Balloon model has been applied to describe the
experimental paradigm of chapter 4. This involved implementing all of the
models described in section 5.2 in order to evaluate their suitability for this
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Figure 5.17: Baseline normalised data averaged in blocks of four stimulus
cycles for model fits to (a) model 1, (b) model 2 and for (c) experimental
data.
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Figure 5.18: Model total CBV (∆CBVtot) curves from fit to experimental
signal data for (a) model 1 and (b) model 2. Experimental data points are
plotted as crosses along with all 100 curve solutions.
modelling effort. A multi-component BOLD signal model was analytically
derived, based on the work of Obata et al. [106]. This was necessary since
the infusion of contrast agent meant that the blood susceptibility was varied
in both arterial and venous compartments. This situation was made more
complex by the stimulus induced variations in susceptibility brought about
by changing oxygenation states in the venous vasculature. Due to the high
dimensional nature of the model fitting, it was a concern that multiple local
minima may exist, particularly for model 2. Therefore the implementation
of the simulated annealing fitting algorithm, and the subsequent discovery
of local minima, was also important. This technique was also applied whilst
fitting the models to both total CBV data and BOLD signal data.
The vascular model used in this work was originally described by Bux-
ton et al. [47]. The Balloon model was chosen for its simplicity and versatility.
The changing vascular state is modelled as the flow of an incompressible fluid
through a network of tubes. An alternative model such as the one proposed
by Mandeville et al. [68] follows a more abstract approach and describes this
state in terms of an electrical circuit. Whilst this approach produces the
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same result it can be less intuitive.
The versatility of the Balloon model is evident in its modular construc-
tion. The model is dependent on three main effects; arterial flow input,
venous volume change and capillary oxygen extraction. Ancillary models
of these quantities can be substituted into the Balloon model to produce a
detailed description of the haemodynamic response. Section 5.2 details a
selection of these Balloon model elements.
From the investigations in this chapter it is clear that flow input into the
system is important in determining the form of the BOLD signal. Indeed
the multi-component model described in section 5.3.3 suggests that arterial
volume change contributes to BOLD signal even in the absence of susceptib-
ility change. The form of the flow input also determines the venous volume
change as the venous vasculature is assumed to be an essentially passive struc-
ture. Therefore venous volume change is determined by the elastic properties
of the vessel walls.
The three models of flow described in section 5.2.1 represent an evolution
in the modelling of this quantity. The Miller model determines the arterial
input function empirically using an arterial spin labelling technique. This
proved to be a very accurate method, but does not improve understanding
of the underlying mechanism. In contrast the Friston model aimed to im-
prove understanding by postulating a feed-forward mechanism relating neural
activity to increases in flow. Whilst this benefits understanding, a greater
number of parameters are required to describe this model. These hidden
parameters are unmeasurable and so the range of valid values is unclear.
Determining these ranges would require measurement of neural activity and
flow across a range of stimuli.
Similarly the model of Behzadi extends the Friston model by modelling
the coupling of neural activity to changes in arteriole radius, rather than flow.
The model includes a realistic biomechanical model of arteriolar resistance
describing the balance between passive and active components of the vessel
wall. As a consequence an additional descriptive parameter is added. By
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inclusion of a model of arteriole resistance, flow changes become increasingly
smoothed. It has yet to be proven that this added level of complexity is
required or realistic.
The volume models described in section 5.2.2 all have a common mod-
elling ancestor. This model is conventionally known as Grubb’s model. He
noted that the relationship between CBF and CBV can be modelled by a
power law. The major caveat of this work is that the measurements were
carried out at steady state. Hence the other two models in this section at-
tempt to describe this relationship when CBF is dynamically changing from
one steady state to another. The dynamic volume model represents this as a
transient lag of volume change and is controlled by a time constant. This time
constant is allowed to take different values during inflation and deflation of
the venous balloon. This allows the mechanical properties of the vessel walls
to display viscoelastic effects. The modified windkessel model with compli-
ance is also applicable during dynamics changes in blood volume. This model
is an extension of the work of Grubb et al. [129] and Mandeville et al. [68].
As such the parameters required for its solution are more physiologically
plausible and hence more easily measurable.
The models of oxygen extraction described in section 5.2.3 form the basis
of the oxygenation level dependent effect. The oxygen limitation model [57]
proposed that tight coupling between oxidative metabolism and blood flow
could exist despite the evidence of Fox and Raichle [55] to the contrary.
Whilst technically this model is only valid in the steady state it does de-
scribe oxygen extraction very well. However the assumption that all oxygen
leaving the capillary is metabolised means that oxygen extraction and ox-
idative metabolism cannot be independently investigated. The OTT model
solves both of these problems by extending the oxygen limitation model to
the dynamic case and allowing a reservoir of oxygen in the tissue space. These
changes allow future investigation into the the transient de-coupling of blood
flow and metabolism, as an alternative explanation of the post-stimulus un-
dershoot.
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However, it appears that improvements in the theoretical understanding
of the underlying effect come with a cost attached. This cost is in the preci-
sion of the solution. As was shown in section 5.3.2, given noisy experimental
data and high numbers of parameters to estimate, the likelihood of an exact
solution may diminish. A similar effect seems to have been observed in the
work of Behzadi et al. [126]. In this work fitting was performed as a two
step process. The first step consisted of a coarse grid covering the whole
parameter space. The parameters which minimised the sum of squares cost
function were then subjected to a constrained descent based algorithm. This
method allows a reasonable fit to be achieved, which would be difficult if ar-
bitrary initial estimates had been chosen. The added benefit of a simulated
annealing technique is that the initial estimates are unimportant. No matter
where the algorithm starts it will still try to sample the entire parameter
space, bypassing local minima. However the cost of this method is compute
time. Whilst much quicker than the brute force technique this algorithm
is compute intensive. This problem is compounded by the need for repeat
applications of the algorithm in order to sample the range of solutions.
As noted above it was necessary to derive a multi-component BOLD sig-
nal model due to changing susceptibility in both the arterial and venous
vasculature. The model is a generalisation of the model of Obata et al. [106]
and collapses back to their relation under their assumptions. This enables the
arterial and venous volume changes, along with the venous oxygenation, cal-
culated by the extended Balloon model to be incorporated into the simulated
BOLD signal. Under zero contrast agent conditions the arterial component
of the signal model produces a small correction due to the changing volume
of the compartment. However when contrast agent concentration is non-zero
this component acts to considerably reduce the BOLD signal and is weighted
by changes in volume. The same effect is introduced into the venous signal
using similar relations.
Using the multi-component model it was possible to fit the data from
chapter 4. This model was fitted to either calculated total CBV data or
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measured BOLD signal data. With respect to the total CBV data, models
1 and 2 provided a reasonable description of the total CBV curve. Model
2 was better at describing more subtle features, such as the change of slope
between 15 s and 25 s. These parameter estimations were used to produce
simulated BOLD signal timecourses. The correlation between the temporal
dynamics of the major features of the response was good, despite the fit be-
ing performed on a single component of the BOLD signal model. Results
suggest that the positive overshoot is well described by the model. However
the post-stimulus period is less well described. The temporal dynamics of the
post-stimulus undershoot produced by model 1 are particularly poor. This
is not unexpected as the input to the model is purely empirical, and hence is
extrapolated from other data [125]. The post-stimulus undershoot produced
by model 2 correlates more closely with the experimental data. However
the duration of this modelled response is shorter than seen experimentally.
This is a consequence of the hypothesis for the origin of the post-stimulus
undershoot. This theory suggests that the undershoot is due to the mis-
match between CBF and CBV [69]. However this work was performed on
α-chloralose anaesthetised rats and it has recently been shown [138] that this
anaesthetic prolongs CBV dynamics. Therefore the experimental measure of
total CBV, performed in chapter 4, does not support the hypothesis that the
post-stimulus undershoot is due to a mismatch between CBF and CBV.
Both models showed good correlation when fitted to experimental BOLD
signal data from the same experiment. The temporal characteristics of the
post-stimulus undershoot compare well with the experimental data. However
this effect is achieved by overestimating blood volume changes during this
time period. Therefore the role of blood volume changes on the form of the
post-stimulus undershoot is inconclusive, given these results. Volume change
during the positive overshoot is underestimated leading to reduced signal loss
as contrast agent concentration increases.
The results of this chapter suggest that a greater understanding of cereb-
ral haemodynamics and metabolism are required to improve models of the
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BOLD response. In addition greater emphasis needs to be place on testing
new models using suitably designed experiments. In particular perturbations
of the BOLD signal through introduction of contrast agents or physiological
challenges can help to elucidate the underlying mechanisms. The Balloon
model provides a good description of the positive overshoot, but improve-
ments to the description of other features are required. It has been shown
that fitting models with a high number of parameters leads to multiple in-
dependent minima. Evidently experiments with higher SNR would help to
reduce this effect. It has been shown that these minima can be discovered by
using a simulated annealing fitting algorithm. Fitting data using an empir-
ical model (model 1) provides reasonably accurate results. However, despite
the problems associated with fitting a high number of parameters, theoretical
models (model 2) of the BOLD response are still preferable. These models
push forward understanding of the technique that will help to discover the
limits associated with BOLD fMRI. Ultimately experimental measurements
of other model variables are required to reduce the number of valid solutions,
such as CBF (fin(t)), arterial CBV (va) and neuronal firing rates (u(t)). Fu-
ture work should concentrate on this multi-mode approach.
Chapter 6
Conclusions
6.1 Summary
In this thesis, work was performed with the aim of elucidating the underlying
mechanisms of the BOLD response. Investigations were centred around ex-
isting models of the BOLD response, in particular the Balloon model and its
variants. A selection of model components were selected from the literature
and tested against experimental data.
Total CBV changes were measured by an infusion of a paramagnetic con-
trast agent. The technique described in chapter 4 enabled fractional changes
in blood volume to be measured with high temporal resolution (300 ms). This
allowed the dynamics of blood volume change to be measured in response
to a 4.8 s visual stimulus with high fidelity. Aside from the blood volume
measurement, this experiment also provided an interesting way to probe the
dynamics of the BOLD response. The introduction of contrast agent into
the blood reduces MR signal. The signal reduction associated with temporal
characteristics of the BOLD response were differentially affected by the con-
trast agent. Aspects of the response that were strongly dependent on volume
change saw a greater reduction in signal intensity, relative to the resting state.
This allowed a qualitative understanding of the volume contribution to each
of these characteristics to be gathered.
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Previously the dynamics of venous CBV change were thought [69] to be
delayed with respect to CBF. In this work experiments were performed on
α-chloralose anaesthetised rats. It has since been shown [138] that this anaes-
thetic prolongs CBV dynamics. The experiments of chapter 4 show that CBV
does not exhibit a pronounced lag with respect to CBF. This would mean
that the post-stimulus undershoot could not be due to a mismatch between
CBF and venous CBV. An alternative explanation [70] for this character-
istic is that metabolism could remain elevated beyond the cessation of the
stimulus. The exact origin of this prolonged metabolic activity has yet to be
determined.
An enhanced Balloon model was applied to describe this experiment us-
ing components derived from the literature. In order to describe the BOLD
signal accurately, under the conditions of an infusion of contrast agent, a
multi-component BOLD signal model was required. This requirement was
caused by changing susceptibility in the arterial blood, as well as the venous
blood, due to the contrast agent. A model was derived based on the work
of Obata et al. and shown to be equivalent to this model under their as-
sumptions. Intravascular blood signal was assumed to be dependent on the
relaxivity of the blood and measurements were performed in chapter 3 to
measure this.
Two models of the BOLD response were fitted to the experimental data
of chapter 4. An investigation was performed to see whether a more sophist-
icated mechanistic model of the BOLD response would perform better than
an empirical model. The differences between these two models was largely
based on a differing number of descriptive parameters. Although evidently
the more sophisticated model provided a much more detailed description of
the underlying mechanism of the BOLD response. Due to the high number
of fitting parameters involved there was a concern that multiple local minima
would be present in the parameter space. This was shown to be the case for
the sophisticated model, but not for the empirical model. A simulated an-
nealing algorithm was employed for this work as the results it produced were
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independent of the starting conditions. This method also had the advantage
of only finding fits with high correlation to the data, which would have been
harder to find using a descent based algorithm. This work shows that whilst
more sophisticated models provide a better description of the mechanisms
they are very difficult to fit accurately. Without experimental measurements
of other quantities associated with BOLD signal, such as CBF, arterial CBV,
and neural firing rates, it is not possible to narrow the range of solutions to
those that are plausible.
In chapter 3 the relaxivity of whole blood as a function of oxygenation
and contrast agent concentration was measured in order to model intravascu-
lar blood signal. The R1 and R
∗
2 of whole blood were measured at 1.5 T, 3.0
T and 7.0 T. These measurements used high resolution imaging techniques
and small samples of human blood. It was found that R1 was dependent
on oxygenation at field strengths above 1.5 T. The transverse relaxation
rate R∗2 was shown to be linear over the physiological range of oxygenation
values used and the R∗2 relaxivity increased with field strength. The R1 de-
pendence of contrast agent in blood was independent of field strength giving
almost identical relaxivity values. This was as predicted by NMRD exper-
iments [89, 94]. An interesting result was found when the R∗2 dependence
of contrast agent in blood was measured. A non-linear relationship between
R∗2 and contrast agent was encountered. Monte Carlo simulations showed
that this relationship was quadratic in nature and highly sensitive to blood
oxygenation. This result also provided an explanation for the anomalous
increase in BOLD signal observed during the total CBV measurements in
chapter 4. Stimulus cycles 5-8, which were measured in the presence of a low
concentration of contrast agent in the blood, showed a higher BOLD signal
than cycles 1-4, where contrast agent was not present.
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6.2 Conclusions
The work presented in this thesis suggests that there is still much work to
be performed before a full description of the BOLD response can be pro-
duced. Section 5.2 shows that there have been many good attempts at
modelling the underlying causes of the response. However relatively little
work has been performed on validating this work experimentally. Part of
this problem lies in the design of suitable experiments to test models under
a variety of physiological conditions. In this regard the experiment per-
formed in chapter 4 provided a good way to perturb the MR signal and
to see how BOLD models could cope with this disturbance. A secondary
problem is the measurement of physiological parameters which directly, or
indirectly, influence the BOLD response. Parameters such as CBF and arter-
ial CBV can be measured directly using MRI techniques and would greatly
aid the validation of flow models. Similarly neurovascular coupling could be
investigated through the use of MEG. However many sophisticated models
introduce many variables that are immeasurable in reality. For instance it
is not possible to test the model of arteriolar compliance developed by Be-
hzadi et al. [126] as it is impossible to measure the circumferential stresses
hypothesised by the theory.
The results presented by chapters 4 and 5 contribute to the idea that the
post-stimulus cannot be adequately modelled by a temporal lag between CBF
and total CBV. The experiments show that the post-stimulus period is not
very dependent on volume change. Similarly current BOLD models cannot
adequately predict the post-stimulus undershoot, given that in reality the
lag between CBF and CBV is so small. In order to advance understanding
of the post-stimulus undershoot a model to describe post-stimulus metabolic
activity is required. Such a model would require a working hypothesis of the
origin of this metabolic activity, which at present has not been determined.
In conclusion, the fact that the positive BOLD response is used to infer
changes in neural activity means that modelling the BOLD response is an
important endeavour. The basic mechanism behind the positive overshoot is
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well understood and forms a framework from which a more accurate model
can be built. Other transient features, such as the post-stimulus undershoot,
are less well modelled and require further research. A greater understanding
of the BOLD response will give researchers greater confidence in this fMRI
technique and possibly deliver better spatial specificity.
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